[
  {
    "objectID": "technical-details/unsupervised-learning/main.html",
    "href": "technical-details/unsupervised-learning/main.html",
    "title": "Breast (BRCA) and Cervical (CESC) Cancer Patient Clustering and Mortality Analysis",
    "section": "",
    "text": "This analysis applies unsupervised learning techniques to identify distinct patient subgroups within breast cancer (BRCA) and cervical cancer (CESC) cohorts from The Cancer Genome Atlas (TCGA) dataset.\nResearch Question: What patient subgroups exist within BRCA and CESC, and how do mortality patterns differ between these cancers?\n\n\n\nDimensionality Reduction - Principal Component Analysis (PCA): A linear technique that identifies orthogonal axes of maximum variance, transforming correlated features into uncorrelated principal components - t-SNE: A non-linear technique optimized for visualization that preserves local neighborhood structure\nClustering Methods - K-Means: Partitions data into k spherical clusters by minimizing within-cluster variance - DBSCAN: Density-based clustering that identifies arbitrarily shaped clusters and labels outliers as noise - Hierarchical Clustering: Builds nested cluster hierarchies"
  },
  {
    "objectID": "technical-details/unsupervised-learning/main.html#unsupervised-learning-clustering-and-dimensionality-reduction",
    "href": "technical-details/unsupervised-learning/main.html#unsupervised-learning-clustering-and-dimensionality-reduction",
    "title": "Breast (BRCA) and Cervical (CESC) Cancer Patient Clustering and Mortality Analysis",
    "section": "",
    "text": "This analysis applies unsupervised learning techniques to identify distinct patient subgroups within breast cancer (BRCA) and cervical cancer (CESC) cohorts from The Cancer Genome Atlas (TCGA) dataset.\nResearch Question: What patient subgroups exist within BRCA and CESC, and how do mortality patterns differ between these cancers?\n\n\n\nDimensionality Reduction - Principal Component Analysis (PCA): A linear technique that identifies orthogonal axes of maximum variance, transforming correlated features into uncorrelated principal components - t-SNE: A non-linear technique optimized for visualization that preserves local neighborhood structure\nClustering Methods - K-Means: Partitions data into k spherical clusters by minimizing within-cluster variance - DBSCAN: Density-based clustering that identifies arbitrarily shaped clusters and labels outliers as noise - Hierarchical Clustering: Builds nested cluster hierarchies"
  },
  {
    "objectID": "technical-details/unsupervised-learning/main.html#import-libraries",
    "href": "technical-details/unsupervised-learning/main.html#import-libraries",
    "title": "Breast (BRCA) and Cervical (CESC) Cancer Patient Clustering and Mortality Analysis",
    "section": "Import Libraries",
    "text": "Import Libraries\n\nimport pandas as pd\nimport numpy as np\nimport matplotlib.pyplot as plt\nimport seaborn as sns\nfrom pathlib import Path\nfrom sklearn.preprocessing import StandardScaler\nfrom sklearn.decomposition import PCA\nfrom sklearn.manifold import TSNE\nfrom sklearn.cluster import KMeans, AgglomerativeClustering, DBSCAN\nfrom sklearn.metrics import silhouette_score, calinski_harabasz_score\nfrom sklearn.neighbors import NearestNeighbors\nfrom scipy.cluster.hierarchy import dendrogram, linkage\nfrom scipy.stats import chi2_contingency, mannwhitneyu\nimport warnings\nwarnings.filterwarnings('ignore')"
  },
  {
    "objectID": "technical-details/unsupervised-learning/main.html#data-loading-and-processing",
    "href": "technical-details/unsupervised-learning/main.html#data-loading-and-processing",
    "title": "Breast (BRCA) and Cervical (CESC) Cancer Patient Clustering and Mortality Analysis",
    "section": "Data Loading and Processing",
    "text": "Data Loading and Processing\n\n# Load datasets\nbrca_df = pd.read_csv('data/processed-data/brca/brca-clinical-processed.tsv', sep='\\t')\ncesc_df = pd.read_csv('data/processed-data/cesc/cesc-clinical-processed.tsv', sep='\\t')\n\n# Filter valid survival times\nbrca_df = brca_df[brca_df['survival_time_days'] &gt;= 0].copy()\ncesc_df = cesc_df[cesc_df['survival_time_days'] &gt;= 0].copy()\n\n# Add cancer type identifier\nbrca_df['cancer_type'] = 'BRCA'\ncesc_df['cancer_type'] = 'CESC'\n\nprint(f\"BRCA samples: {len(brca_df)}\")\nprint(f\"CESC samples: {len(cesc_df)}\")\n\ndef deduplicate_by_treatment(df):\n    df['treatments.count'] = df.groupby('cases.submitter_id')['cases.submitter_id'].transform('count')\n    treatment_col = df['treatments.treatment_or_therapy'].astype(str).str.lower()\n    df['sort_priority'] = (~treatment_col.isin(['true', 'yes'])).astype(int)\n    df_sorted = df.sort_values(['cases.submitter_id', 'sort_priority'])\n    df_dedup = df_sorted.drop_duplicates(subset=['cases.submitter_id'], keep='first')\n    df_dedup = df_dedup.drop('sort_priority', axis=1)\n    return df_dedup\n\nbrca_dup = deduplicate_by_treatment(brca_df)\ncesc_dup = deduplicate_by_treatment(cesc_df)\n\nprint(f\"BRCA: {len(brca_df)} -&gt; {len(brca_dup)} (removed {len(brca_df) - len(brca_dup)} duplicates)\")\nprint(f\"CESC: {len(cesc_df)} -&gt; {len(cesc_dup)} (removed {len(cesc_df) - len(cesc_dup)} duplicates)\")\n\nbrca_df = brca_dup.copy()\ncesc_df = cesc_dup.copy()\n\nBRCA samples: 4920\nCESC samples: 872\nBRCA: 4920 -&gt; 1081 (removed 3839 duplicates)\nCESC: 872 -&gt; 184 (removed 688 duplicates)\n\n\n\nStage Normalization\nBRCA uses AJCC staging while CESC uses FIGO staging. We normalize both to a common ordinal scale (1-4) representing disease severity.\n\ndef normalize_ajcc_stage(stage):\n    \"\"\"Normalize AJCC pathologic stage to ordinal severity (1-4)\"\"\"\n    if pd.isna(stage):\n        return 0\n    stage = str(stage).lower().strip()\n    if any(x in stage for x in ['stage i', 'ia', 'ib']) and 'ii' not in stage:\n        return 1\n    elif 'stage ii' in stage and 'iii' not in stage:\n        return 2\n    elif 'stage iii' in stage and 'iv' not in stage:\n        return 3\n    elif 'stage iv' in stage:\n        return 4\n    else:\n        return 0\n\ndef normalize_figo_stage(stage):\n    \"\"\"Normalize FIGO stage to ordinal severity (1-4)\"\"\"\n    if pd.isna(stage):\n        return 0\n    stage = str(stage).lower().strip()\n    if any(x in stage for x in ['stage i', 'ia', 'ib']) and 'ii' not in stage:\n        return 1\n    elif 'stage ii' in stage and 'iii' not in stage:\n        return 2\n    elif 'stage iii' in stage and 'iv' not in stage:\n        return 3\n    elif 'stage iv' in stage:\n        return 4\n    else:\n        return 0\n\nbrca_df['stage_severity'] = brca_df['diagnoses.ajcc_pathologic_stage'].apply(normalize_ajcc_stage)\ncesc_df['stage_severity'] = cesc_df['diagnoses.figo_stage'].apply(normalize_figo_stage)\n\nprint(\"BRCA Stage Severity:\")\nprint(brca_df['stage_severity'].value_counts().sort_index())\nprint(\"\\nCESC Stage Severity:\")\nprint(cesc_df['stage_severity'].value_counts().sort_index())\n\nstage_labels = {0: 'Unknown', 1: 'Stage 1', 2: 'Stage 2', 3: 'Stage 3', 4: 'Stage 4'}\nprint(\"\\nStage Key: 0=Unknown, 1=Stage 1, 2=Stage 2, 3=Stage 3, 4=Stage 4\")\n\nBRCA Stage Severity:\nstage_severity\n0     15\n1    207\n2    613\n3    246\nName: count, dtype: int64\n\nCESC Stage Severity:\nstage_severity\n1    117\n2     45\n3     22\nName: count, dtype: int64\n\nStage Key: 0=Unknown, 1=Stage 1, 2=Stage 2, 3=Stage 3, 4=Stage 4"
  },
  {
    "objectID": "technical-details/unsupervised-learning/main.html#feature-selection-and-one-hot-encoding",
    "href": "technical-details/unsupervised-learning/main.html#feature-selection-and-one-hot-encoding",
    "title": "Breast (BRCA) and Cervical (CESC) Cancer Patient Clustering and Mortality Analysis",
    "section": "Feature Selection and One Hot Encoding",
    "text": "Feature Selection and One Hot Encoding\nWe select common clinical features and apply one-hot encoding to categorical variables, transforming them into numeric format suitable for distance based algorithms.\n\ncommon_features = [\n    'diagnoses.age_at_diagnosis',\n    'demographic.race',\n    'demographic.vital_status',\n    'survival_time_days',\n    'treatments.treatment_or_therapy',\n    'treatments.treatment_type',\n    'stage_severity',\n    'cancer_type'\n]\n\ncombined_df = pd.concat([brca_df[common_features], cesc_df[common_features]], ignore_index=True)\nprint(f\"Combined dataset shape: {combined_df.shape}\")\n\ncombined_df['is_deceased'] = (combined_df['demographic.vital_status'].str.lower() == 'dead').astype(int)\n\ncategorical_cols = ['demographic.race', 'treatments.treatment_or_therapy', 'treatments.treatment_type']\n\nfor col in categorical_cols:\n    combined_df[col] = combined_df[col].astype(str).fillna('Unknown')\n\ncombined_df_encoded = pd.get_dummies(combined_df, columns=categorical_cols, drop_first=True)\nprint(f\"Shape after one-hot encoding: {combined_df_encoded.shape}\")\n\nanalysis_df = combined_df_encoded.dropna(subset=['diagnoses.age_at_diagnosis', 'survival_time_days', 'cancer_type']).copy()\nprint(f\"Analysis dataset after dropping NA: {len(analysis_df)} samples\")\n\nrace_cols = [col for col in analysis_df.columns if col.startswith('demographic.race_')]\ntreatment_cols = [col for col in analysis_df.columns if col.startswith('treatments.treatment_or_therapy_')]\ntreatment_type_cols = [col for col in analysis_df.columns if col.startswith('treatments.treatment_type_')]\n\nfeature_cols = (['diagnoses.age_at_diagnosis', 'stage_severity'] + race_cols + treatment_cols + treatment_type_cols)\n\nX = analysis_df[feature_cols].values\ny_cancer = analysis_df['cancer_type'].values\ny_deceased = analysis_df['is_deceased'].values\n\nscaler = StandardScaler()\nX_scaled = scaler.fit_transform(X)\nprint(f\"\\nFeature matrix shape: {X_scaled.shape}\")\n\nfeature_names_short = (\n    ['Age', 'Stage'] +\n    [col.replace('demographic.race_', 'Race:') for col in race_cols] +\n    [col.replace('treatments.treatment_or_therapy_', 'Treated:') for col in treatment_cols] +\n    [col.replace('treatments.treatment_type_', 'TxType:') for col in treatment_type_cols]\n)\n\nCombined dataset shape: (1265, 8)\nShape after one-hot encoding: (1265, 32)\nAnalysis dataset after dropping NA: 1265 samples\n\nFeature matrix shape: (1265, 28)"
  },
  {
    "objectID": "technical-details/unsupervised-learning/main.html#k-means-clustering",
    "href": "technical-details/unsupervised-learning/main.html#k-means-clustering",
    "title": "Breast (BRCA) and Cervical (CESC) Cancer Patient Clustering and Mortality Analysis",
    "section": "K-Means Clustering",
    "text": "K-Means Clustering\nAssumptions: Spherical clusters, equal feature contribution (requires standardization)\nModel Selection: We use silhouette score to evaluate cluster quality.\n\nk_range = range(2, 11)\nsilhouette_scores = []\ncalinski_scores = []\ninertias = []\n\nfor k in k_range:\n    kmeans = KMeans(n_clusters=k, random_state=42, n_init=10)\n    labels = kmeans.fit_predict(X_scaled)\n    silhouette_scores.append(silhouette_score(X_scaled, labels))\n    calinski_scores.append(calinski_harabasz_score(X_scaled, labels))\n    inertias.append(kmeans.inertia_)\n\noptimal_k_silhouette = k_range[np.argmax(silhouette_scores)]\noptimal_k_calinski = k_range[np.argmax(calinski_scores)]\n\ninertia_series = pd.Series(inertias)\ninertia_diff2 = inertia_series.diff().diff().dropna().values\noptimal_k_elbow = k_range[np.argmax(np.abs(inertia_diff2))]\n\n# Select final k\noptimal_k_candidates = [optimal_k_silhouette, optimal_k_calinski, optimal_k_elbow]\noptimal_k = 3\nprint(f\"\\nSelected optimal k: {optimal_k}\")\n\n# Silhouette Score\nfig, ax = plt.subplots()\nax.plot(list(k_range), silhouette_scores, 'go-', linewidth=2, markersize=8)\nax.axvline(x=optimal_k_silhouette, color='r', linestyle='--', \n           label=f'Optimal k={optimal_k_silhouette}')\nax.set_xlabel('Number of Clusters (k)')\nax.set_ylabel('Silhouette Score')\nax.set_title('K-Means: Silhouette Score by Cluster Count', fontweight='bold')\nax.legend()\nax.grid(True, alpha=0.3)\nplt.tight_layout()\nplt.show()\n\n# Calinski-Harabasz Score\nfig, ax = plt.subplots()\nax.plot(list(k_range), calinski_scores, 'bo-', linewidth=2, markersize=8)\nax.axvline(x=optimal_k_calinski, color='r', linestyle='--', \n           label=f'Optimal k={optimal_k_calinski}')\nax.set_xlabel('Number of Clusters (k)')\nax.set_ylabel('Calinski-Harabasz Score')\nax.set_title('K-Means: Calinski-Harabasz Score by Cluster Count', fontweight='bold')\nax.legend()\nax.grid(True, alpha=0.3)\nplt.tight_layout()\nplt.show()\n\n# Elbow Method\nfig, ax = plt.subplots()\nax.plot(list(k_range), inertias, 'mo-', linewidth=2, markersize=8)\nax.axvline(x=optimal_k_elbow, color='r', linestyle='--', \n           label=f'Elbow at k={optimal_k_elbow}')\nax.set_xlabel('Number of Clusters (k)')\nax.set_ylabel('Inertia (Within-Cluster Sum of Squares)')\nax.set_title('K-Means: Elbow Method for Optimal k', fontweight='bold')\nax.legend()\nax.grid(True, alpha=0.3)\nplt.tight_layout()\nplt.show()\n\n\nSelected optimal k: 3\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nkmeans = KMeans(n_clusters=optimal_k, random_state=42, n_init=10)\ncluster_labels = kmeans.fit_predict(X_scaled)\nanalysis_df['cluster'] = cluster_labels\n\nprint(f\"\\nK-Means Cluster distribution:\")\nprint(analysis_df['cluster'].value_counts().sort_index())\n\nbase_colors = ['#E74C3C', '#3498DB', '#2ECC71', '#9B59B6', '#F39C12']\ncluster_colors = base_colors[:optimal_k]\n\nfig, ax = plt.subplots()\nfor i in range(optimal_k):\n    mask = cluster_labels == i\n    ax.scatter(X_pca[mask, 0], X_pca[mask, 1], c=cluster_colors[i], label=f'Cluster {i}', alpha=0.5, s=30)\nax.set_xlabel(f'PC1 ({variance_explained[0]*100:.1f}%)')\nax.set_ylabel(f'PC2 ({variance_explained[1]*100:.1f}%)')\nax.set_title('K-Means Clusters (PCA)', fontweight='bold')\nax.legend()\nax.grid(True, alpha=0.3)\nplt.tight_layout()\nplt.show()\n\nfig, ax = plt.subplots()\nfor i in range(optimal_k):\n    mask = cluster_labels == i\n    ax.scatter(X_tsne_final[mask, 0], X_tsne_final[mask, 1], c=cluster_colors[i], label=f'Cluster {i}', alpha=0.5, s=30)\nax.set_xlabel('t-SNE 1')\nax.set_ylabel('t-SNE 2')\nax.set_title('K-Means Clusters (t-SNE)', fontweight='bold')\nax.legend()\nax.grid(True, alpha=0.3)\nplt.tight_layout()\nplt.show()\n\nfig, ax = plt.subplots()\ncluster_cancer = pd.crosstab(analysis_df['cluster'], analysis_df['cancer_type'], normalize='index') * 100\ncluster_cancer.plot(kind='bar', ax=ax, color=['#E74C3C', '#3498DB'], edgecolor='black')\nax.set_xlabel('Cluster')\nax.set_ylabel('Percentage')\nax.set_title('Cancer Type Distribution by Cluster', fontweight='bold')\nax.legend(title='Cancer Type')\nax.tick_params(axis='x', rotation=0)\nplt.tight_layout()\nplt.show()\n\nfig, ax = plt.subplots()\ncluster_status = pd.crosstab(analysis_df['cluster'], analysis_df['demographic.vital_status'], normalize='index') * 100\ncluster_status.plot(kind='bar', ax=ax, color=['#2ECC71', '#E74C3C'], edgecolor='black')\nax.set_xlabel('Cluster')\nax.set_ylabel('Percentage')\nax.set_title('Vital Status Distribution by Cluster', fontweight='bold')\nax.legend(title='Vital Status')\nax.tick_params(axis='x', rotation=0)\nplt.tight_layout()\nplt.show()\n\nfig, ax = plt.subplots()\ncluster_survival = [analysis_df[analysis_df['cluster'] == i]['survival_time_days'].values for i in range(optimal_k)]\nbp = ax.boxplot(cluster_survival, patch_artist=True)\nfor patch, color in zip(bp['boxes'], cluster_colors[:optimal_k]):\n    patch.set_facecolor(color)\n    patch.set_alpha(0.7)\nax.set_xlabel('Cluster')\nax.set_ylabel('Survival Time (days)')\nax.set_title('Survival Time by Cluster', fontweight='bold')\nax.set_xticklabels([f'Cluster {i}' for i in range(optimal_k)])\nax.grid(True, alpha=0.3, axis='y')\nplt.tight_layout()\nplt.show()\n\n\nK-Means Cluster distribution:\ncluster\n0    756\n1    326\n2    183\nName: count, dtype: int64"
  },
  {
    "objectID": "technical-details/unsupervised-learning/main.html#hierarchical-clustering",
    "href": "technical-details/unsupervised-learning/main.html#hierarchical-clustering",
    "title": "Breast (BRCA) and Cervical (CESC) Cancer Patient Clustering and Mortality Analysis",
    "section": "Hierarchical Clustering",
    "text": "Hierarchical Clustering\n\nsample_size = min(500, len(X_scaled))\nnp.random.seed(42)\nsample_idx = np.random.choice(len(X_scaled), sample_size, replace=False)\nX_sample = X_scaled[sample_idx]\nlinkage_matrix = linkage(X_sample, method='ward')\nhc = AgglomerativeClustering(n_clusters=optimal_k, linkage='ward')\nhc_labels = hc.fit_predict(X_scaled)\nanalysis_df['hc_cluster'] = hc_labels\n\nprint(\"\\n--- HIERARCHICAL CLUSTER PROFILES ---\\n\")\nfor hc_id in sorted(analysis_df['hc_cluster'].unique()):\n    hc_data = analysis_df[analysis_df['hc_cluster'] == hc_id]\n    print(f\"HC Cluster {hc_id} (n={len(hc_data)}):\")\n    # Cancer type\n    cancer_dist = hc_data['cancer_type'].value_counts(normalize=True) * 100\n    cancer_str = \", \".join([f\"{c}: {p:.1f}%\" for c, p in cancer_dist.items()])\n    print(f\"  Cancer Type: {cancer_str}\")\n    # Mortality\n    mortality = hc_data['is_deceased'].mean() * 100\n    print(f\"  Mortality: {mortality:.1f}%\")\n    # Age\n    print(f\"  Mean Age: {hc_data['diagnoses.age_at_diagnosis'].mean():.1f} years\")\n    # Stage\n    stage_mode = hc_data['stage_severity'].mode().iloc[0]\n    print(f\"  Dominant Stage: {stage_labels.get(stage_mode, f'Stage {stage_mode}')}\")\n    print()\n\nprint(f\"\\nHierarchical Cluster distribution:\")\nprint(analysis_df['hc_cluster'].value_counts().sort_index())\n\nfig, ax = plt.subplots()\ndendrogram(linkage_matrix, ax=ax, truncate_mode='level', p=5, leaf_rotation=90, leaf_font_size=8, color_threshold=0.7*max(linkage_matrix[:,2]))\nax.set_title('Hierarchical Clustering Dendrogram (Ward Linkage)', fontweight='bold')\nax.set_xlabel('Sample Index')\nax.set_ylabel('Distance')\nplt.tight_layout()\nplt.show()\n\nfig, ax = plt.subplots()\nhc_colors = ['#E74C3C', '#3498DB', '#2ECC71', '#9B59B6', '#F39C12']\nfor i in sorted(analysis_df['hc_cluster'].unique()):\n    mask = hc_labels == i\n    ax.scatter(X_pca[mask, 0], X_pca[mask, 1], \n               c=hc_colors[i], label=f'HC Cluster {i}', alpha=0.5, s=30)\nax.set_xlabel(f'PC1 ({variance_explained[0]*100:.1f}%)')\nax.set_ylabel(f'PC2 ({variance_explained[1]*100:.1f}%)')\nax.set_title('Hierarchical Clusters', fontweight='bold')\nax.legend()\nax.grid(True, alpha=0.3)\nplt.tight_layout()\nplt.show()\n\n\n--- HIERARCHICAL CLUSTER PROFILES ---\n\nHC Cluster 0 (n=382):\n  Cancer Type: BRCA: 90.1%, CESC: 9.9%\n  Mortality: 14.7%\n  Mean Age: 57.9 years\n  Dominant Stage: Stage 2\n\nHC Cluster 1 (n=146):\n  Cancer Type: CESC: 100.0%\n  Mortality: 6.2%\n  Mean Age: 47.4 years\n  Dominant Stage: Stage 1\n\nHC Cluster 2 (n=737):\n  Cancer Type: BRCA: 100.0%\n  Mortality: 13.4%\n  Mean Age: 58.4 years\n  Dominant Stage: Stage 2\n\n\nHierarchical Cluster distribution:\nhc_cluster\n0    382\n1    146\n2    737\nName: count, dtype: int64"
  },
  {
    "objectID": "technical-details/unsupervised-learning/main.html#dbscan",
    "href": "technical-details/unsupervised-learning/main.html#dbscan",
    "title": "Breast (BRCA) and Cervical (CESC) Cancer Patient Clustering and Mortality Analysis",
    "section": "DBSCAN",
    "text": "DBSCAN\nKey hyperparameters: - eps: Maximum distance between neighbors - min_samples: Minimum points to form a dense region\n\nneighbors = NearestNeighbors(n_neighbors=5)\nneighbors_fit = neighbors.fit(X_scaled)\ndistances, indices = neighbors_fit.kneighbors(X_scaled)\ndistances = np.sort(distances[:, 4], axis=0)\n\nfig, ax = plt.subplots()\nax.plot(distances, color='steelblue', linewidth=2)\nax.set_xlabel('Data Points (sorted by distance)')\nax.set_ylabel('Distance to 5th Nearest Neighbor')\nax.set_title('K-Distance Graph for Epsilon Selection', fontweight='bold')\n\nfor eps_val, color in [(1.5, 'red'), (2.0, 'orange'), (2.5, 'green')]:\n    ax.axhline(y=eps_val, color=color, linestyle='--', alpha=0.7, label=f'eps = {eps_val}')\n\nax.legend()\nax.grid(True, alpha=0.3)\nplt.tight_layout()\nplt.show()\n\nparam_combinations = [\n    {'eps': 1.5, 'min_samples': 5},\n    {'eps': 2.0, 'min_samples': 5},\n    {'eps': 2.5, 'min_samples': 5},\n    {'eps': 2.0, 'min_samples': 10},\n    {'eps': 2.5, 'min_samples': 10},\n    {'eps': 3.0, 'min_samples': 10}\n]\n\ndbscan_results = []\n\nfor params in param_combinations:\n    dbscan = DBSCAN(eps=params['eps'], min_samples=params['min_samples'])\n    labels = dbscan.fit_predict(X_scaled)\n    \n    n_clusters = len(set(labels)) - (1 if -1 in labels else 0)\n    n_noise = list(labels).count(-1)\n    noise_pct = n_noise / len(X_scaled) * 100\n    \n    sil_score = np.nan\n    if n_clusters &gt; 1 and noise_pct &lt; 50:\n        valid_mask = labels != -1\n        if sum(valid_mask) &gt; 50:\n            sil_score = silhouette_score(X_scaled[valid_mask], labels[valid_mask])\n    \n    dbscan_results.append({\n        'eps': params['eps'],\n        'min_samples': params['min_samples'],\n        'n_clusters': n_clusters,\n        'n_noise': n_noise,\n        'noise_pct': noise_pct,\n        'silhouette': sil_score\n    })\n\ndbscan_df = pd.DataFrame(dbscan_results)\nprint(\"\\nDBSCAN Parameter Comparison:\")\nprint(dbscan_df.round(3).to_string(index=False))\n\nvalid_results = dbscan_df[(dbscan_df['n_clusters'] &gt;= 2) & (dbscan_df['noise_pct'] &lt; 30)]\n\nif len(valid_results) &gt; 0:\n    best_idx = valid_results['silhouette'].idxmax()\n    best_params = dbscan_df.loc[best_idx]\nelse:\n    best_idx = dbscan_df['n_clusters'].idxmax()\n    best_params = dbscan_df.loc[best_idx]\n\ndbscan_final = DBSCAN(eps=best_params['eps'], min_samples=int(best_params['min_samples']))\ndbscan_labels = dbscan_final.fit_predict(X_scaled)\nanalysis_df['dbscan_cluster'] = dbscan_labels\n\nprint(f\"\\nCluster Distribution:\")\nprint(pd.Series(dbscan_labels).value_counts().sort_index())\n\nunique_labels = sorted(set(dbscan_labels))\nn_clusters = len([l for l in unique_labels if l != -1])\ncolors_dbscan = plt.cm.tab10(np.linspace(0, 1, max(10, n_clusters + 1)))\n\nfig, ax = plt.subplots(figsize=(8, 6))\n\nfor label in unique_labels:\n    mask = dbscan_labels == label\n    if label == -1:\n        ax.scatter(X_tsne_final[mask, 0], X_tsne_final[mask, 1], c='gray', s=20, alpha=0.3, label='Noise')\n    else:\n        ax.scatter(X_tsne_final[mask, 0], X_tsne_final[mask, 1], c=[colors_dbscan[label]], s=40, alpha=0.6, label=f'Cluster {label}')\n\nax.set_xlabel('t-SNE 1')\nax.set_ylabel('t-SNE 2')\nax.set_title(f'DBSCAN Clustering (eps={best_params[\"eps\"]}, min_samples={int(best_params[\"min_samples\"])})', fontweight='bold')\nax.legend(loc='best', fontsize=7, ncol=2)\nax.grid(True, alpha=0.3)\nplt.tight_layout()\nplt.show()\n\n\n\n\n\n\n\n\n\nDBSCAN Parameter Comparison:\n eps  min_samples  n_clusters  n_noise  noise_pct  silhouette\n 1.5            5          25      111      8.775       0.582\n 2.0            5          26       94      7.431       0.579\n 2.5            5          25       81      6.403       0.479\n 2.0           10          21      135     10.672       0.584\n 2.5           10          21      107      8.458       0.480\n 3.0           10          20       93      7.352       0.466\n\nCluster Distribution:\n-1     135\n 0     218\n 1      64\n 2      54\n 3     279\n 4      91\n 5     108\n 6      14\n 7      20\n 8      24\n 9      15\n 10     24\n 11     47\n 12     17\n 13     16\n 14     13\n 15     15\n 16     11\n 17     20\n 18     53\n 19     13\n 20     14\nName: count, dtype: int64"
  },
  {
    "objectID": "technical-details/unsupervised-learning/main.html#method-comparison",
    "href": "technical-details/unsupervised-learning/main.html#method-comparison",
    "title": "Breast (BRCA) and Cervical (CESC) Cancer Patient Clustering and Mortality Analysis",
    "section": "Method Comparison",
    "text": "Method Comparison\n\nfig, axes = plt.subplots(1, 3, figsize=(18, 6))\n\n# K-Means\nax1 = axes[0]\nfor i in range(optimal_k):\n    mask = cluster_labels == i\n    ax1.scatter(X_tsne_final[mask, 0], X_tsne_final[mask, 1], c=cluster_colors[i], label=f'Cluster {i}', alpha=0.5, s=30)\nax1.set_xlabel('t-SNE 1')\nax1.set_ylabel('t-SNE 2')\nax1.set_title(f'K-Means (k={optimal_k})', fontweight='bold')\nax1.legend(loc='best')\nax1.grid(True, alpha=0.3)\n\n# DBSCAN\nax2 = axes[1]\nfor label in unique_labels:\n    mask = dbscan_labels == label\n    if label == -1:\n        ax2.scatter(X_tsne_final[mask, 0], X_tsne_final[mask, 1], c='gray', s=20, alpha=0.3, label='Noise')\n    else:\n        ax2.scatter(X_tsne_final[mask, 0], X_tsne_final[mask, 1], c=[colors_dbscan[label]], s=40, alpha=0.6, label=f'Cluster {label}')\nax2.set_xlabel('t-SNE 1')\nax2.set_ylabel('t-SNE 2')\nax2.set_title(f'DBSCAN (eps={best_params[\"eps\"]})', fontweight='bold')\nax2.legend(loc='best', fontsize=7, ncol=2)\nax2.grid(True, alpha=0.3)\n\n# Hierarchical\nax3 = axes[2]\nhc_colors = ['#E74C3C', '#3498DB', '#2ECC71', '#9B59B6', '#F39C12']\nfor i in sorted(analysis_df['hc_cluster'].unique()):\n    mask = hc_labels == i\n    ax3.scatter(X_tsne_final[mask, 0], X_tsne_final[mask, 1], c=hc_colors[i], label=f'HC Cluster {i}', alpha=0.5, s=30)\nax3.set_xlabel('t-SNE 1')\nax3.set_ylabel('t-SNE 2')\nax3.set_title(f'Hierarchical (k={optimal_k})', fontweight='bold')\nax3.legend(loc='best')\nax3.grid(True, alpha=0.3)\n\nplt.tight_layout()\nplt.show()\n\n# Method Comparison Table\nprint(\"\\nMethod Comparison:\")\nprint(f\"{'Method':&lt;15} {'Clusters':&lt;10} {'Noise':&lt;10} {'Silhouette':&lt;12}\")\nprint(\"-\" * 47)\nprint(f\"{'K-Means':&lt;15} {optimal_k:&lt;10} {'0':&lt;10} {silhouette_score(X_scaled, cluster_labels):.4f}\")\nprint(f\"{'Hierarchical':&lt;15} {optimal_k:&lt;10} {'0':&lt;10} {silhouette_score(X_scaled, hc_labels):.4f}\")\nif not np.isnan(best_params['silhouette']):\n    print(f\"{'DBSCAN':&lt;15} {int(best_params['n_clusters']):&lt;10} {int(best_params['n_noise']):&lt;10} {best_params['silhouette']:.4f}\")\n\n\n\n\n\n\n\n\n\nMethod Comparison:\nMethod          Clusters   Noise      Silhouette  \n-----------------------------------------------\nK-Means         3          0          0.1978\nHierarchical    3          0          0.2060\nDBSCAN          21         135        0.5837"
  },
  {
    "objectID": "technical-details/unsupervised-learning/main.html#cluster-profiling",
    "href": "technical-details/unsupervised-learning/main.html#cluster-profiling",
    "title": "Breast (BRCA) and Cervical (CESC) Cancer Patient Clustering and Mortality Analysis",
    "section": "Cluster Profiling",
    "text": "Cluster Profiling\n\nfor cluster_id in range(optimal_k):\n    cluster_data = analysis_df[analysis_df['cluster'] == cluster_id]\n    \n    print(f\"\\n{'='*40}\")\n    print(f\"CLUSTER {cluster_id} (n={len(cluster_data)})\")\n    print('='*40)\n    \n    cancer_dist = cluster_data['cancer_type'].value_counts(normalize=True) * 100\n    print(f\"\\nCancer Type Distribution:\")\n    for cancer, pct in cancer_dist.items():\n        print(f\"  {cancer}: {pct:.1f}%\")\n    \n    vital_dist = cluster_data['demographic.vital_status'].value_counts(normalize=True) * 100\n    print(f\"\\nVital Status:\")\n    for status, pct in vital_dist.items():\n        print(f\"  {status}: {pct:.1f}%\")\n    \n    mortality_rate = cluster_data['is_deceased'].mean() * 100\n    print(f\"\\nMortality Rate: {mortality_rate:.1f}%\")\n    \n    age_mean = cluster_data['diagnoses.age_at_diagnosis'].mean()\n    age_std = cluster_data['diagnoses.age_at_diagnosis'].std()\n    print(f\"\\nAge at Diagnosis: {age_mean:.1f} +/- {age_std:.1f} years\")\n    \n    surv_mean = cluster_data['survival_time_days'].mean()\n    surv_median = cluster_data['survival_time_days'].median()\n    print(f\"\\nSurvival Time: Mean={surv_mean:.0f} days, Median={surv_median:.0f} days\")\n    \n    stage_dist = cluster_data['stage_severity'].value_counts(normalize=True) * 100\n    print(f\"\\nStage Severity:\")\n    for stage, pct in stage_dist.items():\n        print(f\"  {stage_labels.get(stage, f'Stage {stage}')}: {pct:.1f}%\")\n\n\n========================================\nCLUSTER 0 (n=756)\n========================================\n\nCancer Type Distribution:\n  BRCA: 99.9%\n  CESC: 0.1%\n\nVital Status:\n  alive: 85.3%\n  dead: 14.7%\n\nMortality Rate: 14.7%\n\nAge at Diagnosis: 58.6 +/- 12.9 years\n\nSurvival Time: Mean=1338 days, Median=971 days\n\nStage Severity:\n  Stage 2: 55.4%\n  Stage 3: 23.3%\n  Stage 1: 20.5%\n  Unknown: 0.8%\n\n========================================\nCLUSTER 1 (n=326)\n========================================\n\nCancer Type Distribution:\n  BRCA: 100.0%\n\nVital Status:\n  alive: 87.7%\n  dead: 12.3%\n\nMortality Rate: 12.3%\n\nAge at Diagnosis: 58.6 +/- 13.7 years\n\nSurvival Time: Mean=1023 days, Median=628 days\n\nStage Severity:\n  Stage 2: 59.5%\n  Stage 3: 21.8%\n  Stage 1: 16.0%\n  Unknown: 2.8%\n\n========================================\nCLUSTER 2 (n=183)\n========================================\n\nCancer Type Distribution:\n  CESC: 100.0%\n\nVital Status:\n  alive: 92.9%\n  dead: 7.1%\n\nMortality Rate: 7.1%\n\nAge at Diagnosis: 47.4 +/- 12.1 years\n\nSurvival Time: Mean=1082 days, Median=761 days\n\nStage Severity:\n  Stage 1: 63.9%\n  Stage 2: 24.6%\n  Stage 3: 11.5%\n\n\n\nsummary_data = []\nfor cluster_id in range(optimal_k):\n    cluster_data = analysis_df[analysis_df['cluster'] == cluster_id]\n    cancer_mode = cluster_data['cancer_type'].mode().iloc[0]\n    cancer_pct = (cluster_data['cancer_type'] == cancer_mode).mean() * 100\n    stage_mode = cluster_data['stage_severity'].mode().iloc[0]\n    \n    summary_data.append({\n        'Cluster': cluster_id,\n        'n': len(cluster_data),\n        'Cancer': f\"{cancer_mode} ({cancer_pct:.0f}%)\",\n        'Mortality': f\"{cluster_data['is_deceased'].mean()*100:.1f}%\",\n        'Age': f\"{cluster_data['diagnoses.age_at_diagnosis'].mean():.1f}y\",\n        'Survival': f\"{cluster_data['survival_time_days'].mean():.0f}d\",\n        'Stage': stage_labels.get(stage_mode, f'Stage {stage_mode}')\n    })\n\nsummary_df = pd.DataFrame(summary_data)\nprint(summary_df.to_string(index=False))\n\n Cluster   n      Cancer Mortality   Age Survival   Stage\n       0 756 BRCA (100%)     14.7% 58.6y    1338d Stage 2\n       1 326 BRCA (100%)     12.3% 58.6y    1023d Stage 2\n       2 183 CESC (100%)      7.1% 47.4y    1082d Stage 1"
  },
  {
    "objectID": "technical-details/unsupervised-learning/main.html#feature-importance",
    "href": "technical-details/unsupervised-learning/main.html#feature-importance",
    "title": "Breast (BRCA) and Cervical (CESC) Cancer Patient Clustering and Mortality Analysis",
    "section": "Feature Importance",
    "text": "Feature Importance\n\ncluster_centers = kmeans.cluster_centers_\nfeature_importance = np.std(cluster_centers, axis=0)\n\ntop_n = 15\ntop_idx = np.argsort(feature_importance)[-top_n:][::-1]\n\nprint(f\"\\nTop {top_n} Features for Cluster Separation:\")\nfor i in top_idx:\n    print(f\"  {feature_names_short[i]}: {feature_importance[i]:.4f}\")\n    \nfig, ax = plt.subplots()\ntop_importance = feature_importance[top_idx]\ntop_names = [feature_names_short[i] for i in top_idx]\n\nax.barh(range(top_n), top_importance[::-1], color='steelblue')\nax.set_yticks(range(top_n))\nax.set_yticklabels(top_names[::-1])\nax.set_xlabel('Importance (Std across cluster centers)')\nax.set_title('Top 15 Feature Importance for Cluster Separation', fontweight='bold')\nax.grid(True, alpha=0.3, axis='x')\nplt.tight_layout()\nplt.show()\n\n\nTop 15 Features for Cluster Separation:\n  Treated:True: 1.3137\n  Treated:yes: 1.3100\n  Race:white: 0.9057\n  TxType:hysterectomy, nos: 0.8239\n  Race:black or african american: 0.6670\n  Race:not reported: 0.4692\n  Age: 0.3872\n  TxType:surgery, nos: 0.3828\n  Stage: 0.3510\n  Race:unknown: 0.3320\n  Race:asian: 0.2785\n  TxType:radiation, 3d conformal: 0.2758\n  TxType:radiation, internal: 0.2431\n  Treated:no: 0.2250\n  TxType:brachytherapy, high dose: 0.2053"
  },
  {
    "objectID": "technical-details/unsupervised-learning/main.html#statistical-validation",
    "href": "technical-details/unsupervised-learning/main.html#statistical-validation",
    "title": "Breast (BRCA) and Cervical (CESC) Cancer Patient Clustering and Mortality Analysis",
    "section": "Statistical Validation",
    "text": "Statistical Validation\n\nfor cancer in ['BRCA', 'CESC']:\n    cancer_data = analysis_df[analysis_df['cancer_type'] == cancer]\n    n_total = len(cancer_data)\n    n_deaths = cancer_data['is_deceased'].sum()\n    mortality = (n_deaths / n_total) * 100\n    print(f\"{cancer}: {n_deaths}/{n_total} deaths ({mortality:.1f}%)\")\n\ncontingency = pd.crosstab(analysis_df['cancer_type'], analysis_df['is_deceased'])\nprint(\"\\nContingency Table:\")\nprint(contingency)\n\nchi2, p_value, dof, expected = chi2_contingency(contingency)\nprint(f\"\\nChi-square: {chi2:.4f}\")\nprint(f\"P-value: {p_value:.6f}\")\nif p_value &lt; 0.05:\n    print(\"Result: Mortality difference IS statistically significant\")\nelse:\n    print(\"Result: Mortality difference is NOT statistically significant\")\n\nBRCA: 151/1081 deaths (14.0%)\nCESC: 13/184 deaths (7.1%)\n\nContingency Table:\nis_deceased    0    1\ncancer_type          \nBRCA         930  151\nCESC         171   13\n\nChi-square: 6.0431\nP-value: 0.013961\nResult: Mortality difference IS statistically significant\n\n\n\nbrca_survival = analysis_df[analysis_df['cancer_type'] == 'BRCA']['survival_time_days']\ncesc_survival = analysis_df[analysis_df['cancer_type'] == 'CESC']['survival_time_days']\n\nprint(f\"BRCA: Mean={brca_survival.mean():.0f}d, Median={brca_survival.median():.0f}d, n={len(brca_survival)}\")\nprint(f\"CESC: Mean={cesc_survival.mean():.0f}d, Median={cesc_survival.median():.0f}d, n={len(cesc_survival)}\")\n\nstat, p_value_surv = mannwhitneyu(brca_survival, cesc_survival, alternative='two-sided')\nprint(f\"\\nMann-Whitney U p-value: {p_value_surv:.6f}\")\nif p_value_surv &lt; 0.05:\n    print(\"Result: Survival time difference IS statistically significant\")\nelse:\n    print(\"Result: Survival time difference is NOT statistically significant\")\n\nBRCA: Mean=1244d, Median=856d, n=1081\nCESC: Mean=1076d, Median=758d, n=184\n\nMann-Whitney U p-value: 0.138011\nResult: Survival time difference is NOT statistically significant\n\n\n\ndeceased_df = analysis_df[analysis_df['is_deceased'] == 1].copy()\n\nprint(f\"Deceased patients:\")\nprint(f\"  BRCA: {len(deceased_df[deceased_df['cancer_type']=='BRCA'])} patients\")\nprint(f\"  CESC: {len(deceased_df[deceased_df['cancer_type']=='CESC'])} patients\")\n\nbrca_death_times = deceased_df[deceased_df['cancer_type']=='BRCA']['survival_time_days']\ncesc_death_times = deceased_df[deceased_df['cancer_type']=='CESC']['survival_time_days']\n\nprint(f\"\\nSurvival time among deceased patients:\")\nprint(f\"  BRCA deceased: Mean={brca_death_times.mean():.0f}d, Median={brca_death_times.median():.0f}d\")\nprint(f\"  CESC deceased: Mean={cesc_death_times.mean():.0f}d, Median={cesc_death_times.median():.0f}d\")\n\nstat_deceased, p_deceased = mannwhitneyu(brca_death_times, cesc_death_times, alternative='two-sided')\nprint(f\"\\nMann-Whitney U (deceased only): p={p_deceased:.4f}\")\nif p_deceased &lt; 0.05:\n    print(\"-&gt; CESC patients die significantly earlier when they do die\")\n\nDeceased patients:\n  BRCA: 151 patients\n  CESC: 13 patients\n\nSurvival time among deceased patients:\n  BRCA deceased: Mean=1585d, Median=1152d\n  CESC deceased: Mean=668d, Median=492d\n\nMann-Whitney U (deceased only): p=0.0032\n-&gt; CESC patients die significantly earlier when they do die\n\n\n\nfig, axes = plt.subplots(2, 2, figsize=(14, 10))\n\nax1 = axes[0, 0]\ncancer_stats = analysis_df.groupby('cancer_type').agg({'is_deceased': 'mean', 'survival_time_days': 'mean'}).reset_index()\nfor idx, row in cancer_stats.iterrows():\n    ax1.scatter(row['is_deceased']*100, row['survival_time_days'], s=300, alpha=0.7, color=colors_cancer[row['cancer_type']])\n    ax1.annotate(row['cancer_type'], (row['is_deceased']*100, row['survival_time_days']), xytext=(10, 10), textcoords='offset points', fontsize=12)\nax1.set_xlabel('Mortality Rate (%)')\nax1.set_ylabel('Mean Survival Time (days)')\nax1.set_title('The Paradox: Mortality vs Survival Time', fontweight='bold')\nax1.grid(True, alpha=0.3)\n\nax2 = axes[0, 1]\nage_data = []\nbox_labels = []\nbox_colors = []\nfor cancer in ['BRCA', 'CESC']:\n    for status in ['alive', 'dead']:\n        mask = (analysis_df['cancer_type'] == cancer) & (analysis_df['demographic.vital_status'].str.lower() == status)\n        age_data.append(analysis_df.loc[mask, 'diagnoses.age_at_diagnosis'].values)\n        box_labels.append(f'{cancer}\\n{status}')\n        box_colors.append(colors_cancer[cancer])\n\nbp = ax2.boxplot(age_data, patch_artist=True)\nfor patch, color in zip(bp['boxes'], box_colors):\n    patch.set_facecolor(color)\n    patch.set_alpha(0.7)\nax2.set_xticklabels(box_labels)\nax2.set_ylabel('Age at Diagnosis (years)')\nax2.set_title('Age Distribution by Cancer and Vital Status', fontweight='bold')\nax2.grid(True, alpha=0.3, axis='y')\n\nax3 = axes[1, 0]\nstage_comparison = pd.crosstab(analysis_df['cancer_type'], analysis_df['stage_severity'], normalize='index') * 100\nstage_comparison.plot(kind='bar', ax=ax3, color=[colors_stage[i] for i in stage_comparison.columns])\nax3.set_xlabel('Cancer Type')\nax3.set_ylabel('Percentage')\nax3.set_title('Stage Distribution by Cancer Type', fontweight='bold')\nax3.tick_params(axis='x', rotation=0)\nax3.legend(title='Stage', labels=[stage_labels.get(s, f'Stage {s}') for s in stage_comparison.columns])\n\nax4 = axes[1, 1]\nfor cancer in ['BRCA', 'CESC']:\n    cancer_data = analysis_df[analysis_df['cancer_type'] == cancer]['survival_time_days']\n    cancer_data_deceased = analysis_df[(analysis_df['cancer_type'] == cancer) & (analysis_df['is_deceased'] == 1)]['survival_time_days']\n    cancer_data.plot.kde(ax=ax4, label=f'{cancer} (all)', color=colors_cancer[cancer], linewidth=2)\n    if len(cancer_data_deceased) &gt; 1:\n        cancer_data_deceased.plot.kde(ax=ax4, label=f'{cancer} (deceased)', color=colors_cancer[cancer], linewidth=2, linestyle='--')\n\nax4.set_xlabel('Survival Time (days)')\nax4.set_ylabel('Density')\nax4.set_title('Survival Time Distribution', fontweight='bold')\nax4.legend()\nax4.grid(True, alpha=0.3)\nax4.set_xlim(0, analysis_df['survival_time_days'].quantile(0.95))\n\nplt.tight_layout()\nplt.show()"
  },
  {
    "objectID": "technical-details/eda/main.html",
    "href": "technical-details/eda/main.html",
    "title": "Exploratory Data Analysis",
    "section": "",
    "text": "Exploratory Data Analysis (EDA) serves as the critical foundation for understanding the complex clinical landscape of cancer patient data before building predictive models. Our analysis focuses on two major cancer types affecting women: Breast Invasive Carcinoma (BRCA) and Cervical Squamous Cell Carcinoma (CESC) from The Cancer Genome Atlas (TCGA).\n\n\nCancer datasets present unique analytical challenges that make thorough exploration crucial:\n\nMulti-dimensional Clinical Complexity: Cancer progression involves intricate relationships between patient demographics, tumor characteristics, staging systems (AJCC, FIGO), treatment modalities, and survival outcomes that required systematic investigation.\nData Quality Assessment: EDA was also a process enabling us to assess the effectiveness of our data cleaning stage.\nFeature Engineering Insights: Understanding distributions and relationships helped identify opportunities for creating meaningful derived features (e.g., ordinal encoding of cancer stages, treatments offered).\nModel Selection Guidance: EDA revealed whether relationships are linear or non-linear, helping inform appropriate algorithm choices for subsequent supervised and unsupervised learning tasks.\n\n\n\n\nOur EDA is designed to answer key questions that will inform our modeling strategy:\n\nSurvival Patterns: How do survival times vary between BRCA and CESC patients? What are the distributional characteristics of our regression target?\nStaging Relationships: How do different staging systems (AJCC pathologic staging, FIGO staging for cervical cancer) relate to patient outcomes?\nTreatment Impact: What treatment patterns exist, and how do they correlate with survival outcomes?\nFeature Relationships: Which clinical variables show the strongest associations with survival time and each other?\nData Completeness: Where are the gaps in our data, and how might they impact model performance?\n\n\n\n\nThrough systematic exploration, we aimed to:\n\nIdentify the most informative features for survival prediction\nDetect potential confounding variables or selection biases\nEstablish baseline expectations for model performance\nGenerate hypotheses about cancer survival mechanisms for validation in supervised learning"
  },
  {
    "objectID": "technical-details/eda/main.html#why-eda-is-essential-for-cancer-data",
    "href": "technical-details/eda/main.html#why-eda-is-essential-for-cancer-data",
    "title": "Exploratory Data Analysis",
    "section": "",
    "text": "Cancer datasets present unique analytical challenges that make thorough exploration crucial:\n\nMulti-dimensional Clinical Complexity: Cancer progression involves intricate relationships between patient demographics, tumor characteristics, staging systems (AJCC, FIGO), treatment modalities, and survival outcomes that required systematic investigation.\nData Quality Assessment: EDA was also a process enabling us to assess the effectiveness of our data cleaning stage.\nFeature Engineering Insights: Understanding distributions and relationships helped identify opportunities for creating meaningful derived features (e.g., ordinal encoding of cancer stages, treatments offered).\nModel Selection Guidance: EDA revealed whether relationships are linear or non-linear, helping inform appropriate algorithm choices for subsequent supervised and unsupervised learning tasks."
  },
  {
    "objectID": "technical-details/eda/main.html#research-questions-driving-our-analysis",
    "href": "technical-details/eda/main.html#research-questions-driving-our-analysis",
    "title": "Exploratory Data Analysis",
    "section": "",
    "text": "Our EDA is designed to answer key questions that will inform our modeling strategy:\n\nSurvival Patterns: How do survival times vary between BRCA and CESC patients? What are the distributional characteristics of our regression target?\nStaging Relationships: How do different staging systems (AJCC pathologic staging, FIGO staging for cervical cancer) relate to patient outcomes?\nTreatment Impact: What treatment patterns exist, and how do they correlate with survival outcomes?\nFeature Relationships: Which clinical variables show the strongest associations with survival time and each other?\nData Completeness: Where are the gaps in our data, and how might they impact model performance?"
  },
  {
    "objectID": "technical-details/eda/main.html#expected-outcomes",
    "href": "technical-details/eda/main.html#expected-outcomes",
    "title": "Exploratory Data Analysis",
    "section": "",
    "text": "Through systematic exploration, we aimed to:\n\nIdentify the most informative features for survival prediction\nDetect potential confounding variables or selection biases\nEstablish baseline expectations for model performance\nGenerate hypotheses about cancer survival mechanisms for validation in supervised learning"
  },
  {
    "objectID": "technical-details/eda/main.html#univariate-analysis-single-feature",
    "href": "technical-details/eda/main.html#univariate-analysis-single-feature",
    "title": "Exploratory Data Analysis",
    "section": "Univariate Analysis (Single Feature)",
    "text": "Univariate Analysis (Single Feature)\n\nFrequency Counts: For categorical features (e.g., vital_status, ajcc_pathological_stage, classification_of_tumor, treatment_type, laterality, diagnoses.behavior), visualize frequency distribution (bar charts).\nAge Distribution: Analyze the range and spread of age at diagnoses data (histograms, box plots).\nSurvival time distribution See the spread of survival_time_days (histograms, box plots).\nRace distribution\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nUnivariate Analysis Findings - Categorical - The breast cancer dataset is heavily imbalanced towards alive in the vital_status column, this makes sense as breast cancer has a high survival rate compared to many other cancers. - The behavior of the tumor is completely dominated by malignant tumors and for most patients, this is their first known malignant cancer diagnosis - Over 70% of the patients are white followed by almost 20% black/African American, this is reflective of the US population where breast cancer is most prevalent - As expected, most patients receive treatment with a majority receiving chemotherapy followed by surgery, and hormone therapy. - Last but not least, the disease type is ductal and lobular neoplasms and there is no difference in laterality (which breast)\n\n\n\n\n\n\n\n\n\nUnivariate Analysis Findings - Numerical - The average age at diagnoses is 56 years old with a minimum age of 26 and a maximum age of 89 years old. - The average survival time is 1324 days from diagnoses and ranges from 0 days to 8605 days"
  },
  {
    "objectID": "technical-details/eda/main.html#bivariate-analysis-two-features",
    "href": "technical-details/eda/main.html#bivariate-analysis-two-features",
    "title": "Exploratory Data Analysis",
    "section": "Bivariate Analysis (Two Features)",
    "text": "Bivariate Analysis (Two Features)\n\nvital_status vs. survival_time_days: Explore how survival time varies by vital_status, infer average survival_time_days (box plot or scatter plot).\nage_at_diagnoses vs. average survival_time_days: Analyze differences in average survival time by age_at_diagnoses .\ntreatment_type vs. survival_time_days: Check how treatment_type and survival_time_days are related.\ntreatment_type vs. vital_status: Check treatment_type s offered by vital_status.\najcc_pathological_stage vs. survival_time_days: Explore how survival time varies by ajcc_pathological_stage.\nSurvival_time_days vs. race: Analyze survival time across different races.\nDiagnoses behavior vs survival_time_days: Explore how survival time varies by diagnoses behavior.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBivariate Analysis Findings - The survival time is slightly higher for dead patients compared to alive patients, this is likely due to many alive patients being recently diagnosed and have not had enough time to accumulate survival days. - Older patients tend to have lower survival times compared to younger patients, this is expected as older patients tend to have more comorbidities and a weaker immune system. - Patients who received immunotherapy tend to have higher survival times compared to other treatment types, this is likely due to immunotherapy being a more aggressive treatment option. The next type of treatment that shows higher survival times is chemotherapy. - Patients who opted for treatment tend to have higher survival times compared to those who did not receive treatment, this is expected as treatment is designed to improve patient outcomes. - There is lower survical times for patients with stage iiib as it is one of the more severe stages of breast cancer before metastasis (stage iv). Stage i and ib have the highest survival times as they are the least severe stages."
  },
  {
    "objectID": "technical-details/eda/main.html#multivariate-analysis-multiple-features",
    "href": "technical-details/eda/main.html#multivariate-analysis-multiple-features",
    "title": "Exploratory Data Analysis",
    "section": "Multivariate Analysis (Multiple Features)",
    "text": "Multivariate Analysis (Multiple Features)\n\najcc_pathological_stage vs. age_at_diagnoses vs. survival_time_days : Analyze how survival time varies across different stages and age groups (3D scatter plot or heatmap).\ntreatment_type vs. age_at_diagnoses vs. survival_time_days: Explore trends across treatment types, age groups, and survival times (grouped bar plots).\nlaterality vs. age_at_diagnoses vs. survival_time_days: Check if tumor laterality impacts survival time at different age groups.\ndiagnoses.behavior vs. age_at_diagnoses vs. survival_time_days: Compare survival times across diagnoses behavior and age groups.\n\n\n\n\n\n\n\n\n\n\nMultivariate Analysis Findings - Generally, older patients tend to have lower survival times across all stages of breast cancer, with latter stages (stage iiib, iiic, iv)showing more pronounced decreases in survival time.\n- Younger patients generally have higher survival times, especially if the diagnoses is at an early stage (stage i, ib, ii). - Stage x is when the tumor could not be assessed, the patients tend to have a higher survival time - Overall, getting diagnoses at an earlier stage is associated with better survival outcomes, regardless of age. - Treatment or no treatment, there is no difference in survival times for older patients (&gt;70 years old). However, for younger patients (&lt; 70 years old), those who received treatment tend to have higher survival times compared to those who did not receive treatment."
  },
  {
    "objectID": "technical-details/eda/main.html#text-analysis",
    "href": "technical-details/eda/main.html#text-analysis",
    "title": "Exploratory Data Analysis",
    "section": "Text Analysis",
    "text": "Text Analysis\n\nSites of involvement: Word cloud or frequency distribution of common sites mentioned.\n\n\n\n\n\n\n\n\n\n\nText Analysis Findings - Text Analysis Findings reveal not difference in breast side and a slightly higher frequency for the upper outer region."
  },
  {
    "objectID": "technical-details/eda/main.html#correlations-and-associations",
    "href": "technical-details/eda/main.html#correlations-and-associations",
    "title": "Exploratory Data Analysis",
    "section": "Correlations and Associations",
    "text": "Correlations and Associations\n\nCorrelation Matrix: Compute correlations between numerical features (e.g., age_at_diagnoses and survival_time_Days) to find relationships.\n\n\n\nCorrelation between Age at Diagnosis and Survival Time: -0.1989\n\n\n\nThere is a negative correlation between age at diagnoses and survival time days, indicating that as age at diagnoses increases, survival time days tends to decrease. This suggests that older patients may have poorer survival outcomes compared to younger patients.\n\n\ncesc_df.head(1)\n\n\n\n\n\n\n\n\nproject.project_id\ncases.case_id\ncases.disease_type\ncases.index_date\ncases.lost_to_followup\ncases.primary_site\ncases.submitter_id\ndemographic.days_to_death\ndemographic.ethnicity\ndemographic.gender\ndemographic.race\ndemographic.submitter_id\ndemographic.vital_status\ndiagnoses.age_at_diagnosis\ndiagnoses.ajcc_pathologic_m\ndiagnoses.ajcc_pathologic_n\ndiagnoses.ajcc_pathologic_t\ndiagnoses.classification_of_tumor\ndiagnoses.days_to_diagnosis\ndiagnoses.days_to_last_follow_up\ndiagnoses.figo_stage\ndiagnoses.figo_staging_edition_year\ndiagnoses.method_of_diagnosis\ndiagnoses.morphology\ndiagnoses.primary_diagnosis\ndiagnoses.prior_malignancy\ndiagnoses.prior_treatment\ndiagnoses.site_of_resection_or_biopsy\ndiagnoses.submitter_id\ndiagnoses.synchronous_malignancy\ndiagnoses.tissue_or_organ_of_origin\ndiagnoses.tumor_grade\ntreatments.submitter_id\ntreatments.treatment_or_therapy\ntreatments.treatment_type\nsurvival_time_days\ndiagnoses.behavior\nexposures.tobacco_smoking_status\n\n\n\n\n0\ntcga-cesc\n00bca18c-b3d4-45a3-8f19-034cc40449a4\nsquamous cell neoplasms\ndiagnosis\nyes\ncervix uteri\ntcga-c5-a2lv\nNaN\nnot hispanic or latino\nfemale\nblack or african american\ntcga-c5-a2lv_demographic\nalive\n36.0\nmx\nn1\nt1b\nprimary\n0\n2234.0\nstage ib\n1995\nbiopsy\n8070/3\nsquamous cell carcinoma, nos\nFalse\nFalse\ncervix uteri\ntcga-c5-a2lv_diagnosis\nFalse\ncervix uteri\ng3\ntcga-c5-a2lv_treatment3\nyes\nhysterectomy, nos\n2234.0\nmalignant\ncurrent smoker"
  },
  {
    "objectID": "technical-details/eda/main.html#univariate-analysis-single-feature-1",
    "href": "technical-details/eda/main.html#univariate-analysis-single-feature-1",
    "title": "Exploratory Data Analysis",
    "section": "Univariate Analysis (Single Feature)",
    "text": "Univariate Analysis (Single Feature)\n\nFrequency Counts: For categorical features (e.g., vital_status, figo_stage, tumor_grade, treatment_type, diagnoses.behavior), visualize frequency distribution (bar charts).\nAge Distribution: Analyze the range and spread of age at diagnoses data (histograms, box plots).\nSurvival time distribution See the spread of survival_time_days (histograms, box plots).\nRace distribution\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nUnivariate Analysis Findings - Categorical - The cervical cancer dataset is heavily imbalanced towards alive in the vital_status column, this makes sense as cervical cancer also has a high survival rate compared to many other cancers. - The tumor grade is mostly dominated by grade ii and grade iii tumors, with very few patients having grade i tumors. - The stage is domniated by ib1 followed by iib and ib2, which are some of the less severe stages of cervical cancer. - Almost 70% of the patients are white followed by an approximately equal distribution of the rest of the other races, which is not reflective of the US population - As expected, most patients receive treatment with a majority receiving pharmaceutical therapy followed by radiation therapy. - Last but not least, the disease type is squamous cell neoplasm. All of the patients have malignant tumors and no prior malignant cancer diagnoses.\n\n\n\n\n\n\n\n\n\nUnivariate Analysis Findings - Numerical - The average age at diagnoses is 48 years old with a minimum age of 25 and a maximum age of 80 years old. - The average survival time is 1036 days from diagnoses and ranges from 2 days to 6408 days"
  },
  {
    "objectID": "technical-details/eda/main.html#bivariate-analysis-two-features-1",
    "href": "technical-details/eda/main.html#bivariate-analysis-two-features-1",
    "title": "Exploratory Data Analysis",
    "section": "Bivariate Analysis (Two Features)",
    "text": "Bivariate Analysis (Two Features)\n\nvital_status vs. survival_time_days: Explore how survival time varies by vital_status, infer average survival_time_days (box plot or scatter plot).\nage_at_diagnoses vs. average survival_time_days: Analyze differences in average survival time by age_at_diagnoses .\ntreatment_type vs. survival_time_days: Check how treatment_type and survival_time_days are related.\ntreatment_type vs. vital_status: Check treatment_type s offered by vital_status.\nfigo_stage vs. survival_time_days: Explore how survival time varies by ajcc_pathological_stage.\nSurvival_time_days vs. race: Analyze survival time across different races.\nTumor_grade vs. survival_time_days: Explore how survival time varies by tumor_grade.\nDiagnoses behavior vs survival_time_days: Explore how survival time varies by diagnoses behavior.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBivariate Analysis Findings - The survival time is slightly higher for alive patients which is expected as alive patients have had more time to accumulate survival days, unlike breast cancer where many alive patients are recently diagnosed. - Older patients tend to have higher survival times compared to younger patients, this is unexpected as older patients tend to have more comorbidities and a weaker immune system. - Patients who received radiation combination therapy tend to have higher survival times compared to other treatment types, this is likely due to combination therapy being a more aggressive treatment option. The next type of treatment that shows higher survival times is pharmaceutical therapy. - There is no difference in survival times for patients who opted for treatment compared to those who did not receive treatment, which is unexpected as treatment is designed to improve patient outcomes. - There is lower survical times for patients with stage iiib, which is one of the more severe stages of cervical cancer before metastasis (stage iv). Stage ib has the highest survival times as it is one of the least severe stages. - Stage ia2, ia1 have small sample size which might indicate need for earlier testing to catch cancer at these stages. There is no data for stage iii which might also suggest a need to shift in diagnoses to earlier stages."
  },
  {
    "objectID": "technical-details/eda/main.html#multivariate-analysis-multiple-features-1",
    "href": "technical-details/eda/main.html#multivariate-analysis-multiple-features-1",
    "title": "Exploratory Data Analysis",
    "section": "Multivariate Analysis (Multiple Features)",
    "text": "Multivariate Analysis (Multiple Features)\n\nTumor_stage vs. age_at_diagnoses vs. survival_time_days : Analyze how survival time varies across different stages and age groups (3D scatter plot or heatmap).\ntreatment_type vs. age_at_diagnoses vs. survival_time_days: Explore trends across treatment types, age groups, and survival times (grouped bar plots).\nfigo_stage vs. age_at_diagnoses vs. survival_time_days: Check if stage impacts survival time at different age groups.\ndiagnoses.behavior vs. age_at_diagnoses vs. survival_time_days: Compare survival times across diagnoses behavior and age groups.\n\n\n\n\n\n\n\n\n\n\nMultivariate Analysis Findings - Generally, earlier stages show higher survival times across all age groups. - The heatmap plot interpretation is obfuscated by missing data at stages but also younger patients will have lower survival times due to less time to accumulate survival days."
  },
  {
    "objectID": "technical-details/eda/main.html#correlations-and-associations-1",
    "href": "technical-details/eda/main.html#correlations-and-associations-1",
    "title": "Exploratory Data Analysis",
    "section": "Correlations and Associations",
    "text": "Correlations and Associations\n\nCorrelation Matrix: Compute correlations between numerical features (e.g., age_at_diagnoses and survival_time_Days) to find relationships.\n\n\n\nCorrelation between Age at Diagnosis and Survival Time: 0.1390\n\n\nThere is a positive correlation between age at diagnoses and survival time days, indicating that as age at diagnoses increases, survival time days tends to increase. This suggests that older patients may have better survival outcomes compared to younger patients but this is unexpected, potentially due to less survival days accumulated by younger patients."
  },
  {
    "objectID": "technical-details/eda/main.html#smoking-exposure-effect-on-survival-time-for-cesc-patients",
    "href": "technical-details/eda/main.html#smoking-exposure-effect-on-survival-time-for-cesc-patients",
    "title": "Exploratory Data Analysis",
    "section": "Smoking Exposure Effect on survival time for CESC patients",
    "text": "Smoking Exposure Effect on survival time for CESC patients\n\nsmoking_exposure vs. survival_time_days: Analyze how smoking exposure impacts survival time (box plots or histograms).\n\n\n\nSmoking Status Distribution in CESC Dataset:\nexposures.tobacco_smoking_status\nlifelong non-smoker                                553\ncurrent smoker                                     142\ncurrent reformed smoker for &lt; or = 15 yrs           94\nnot reported                                        29\nunknown                                             23\ncurrent reformed smoker for &gt; 15 yrs                20\ncurrent reformed smoker, duration not specified     11\nName: count, dtype: int64\n\nTotal patients with smoking data: 872\n\n\n\n\n\n\n\n\n\n\n============================================================\nSMOKING EXPOSURE SURVIVAL ANALYSIS SUMMARY\n============================================================\n\nInsufficient data for statistical comparison between never smokers and current smokers\n\n============================================================\n\n\nThere is a heavy imbalance towards lifelong non-smoker in the tobacco smoking status column which might indicate underreporting or misclassification of smoking status among cervical cancer patients. This results suggests that smoking status may not be a reliable indicator of cervical cancer risk in this dataset. From survival time by smoking status, lifelong non-smokers and unknowen tend to have higher survival times compared to current smokers and former smokers. However, there is insufficient data to draw definitive conclusions about the impact of smoking status on survival time in cervical cancer patients."
  },
  {
    "objectID": "technical-details/data-cleaning/main.html",
    "href": "technical-details/data-cleaning/main.html",
    "title": "Data Cleaning",
    "section": "",
    "text": "Our data cleaning methods were comparable for both the cervical (cesc) and breast (brca) cancer datasets due to the dataset having similar columns due to both diseases being cancer. The clinical breast cancer dataset originally has 5546 rows and 210 columns representing 1098 patients. The clinical cervical cancer dataset originally has 1535 rows and 210 columns representing 307 patients.\nOur data cleaning was focused on three key areas:\n\nManaging missing data\nData type correction and formatting\nData engineering\n\nVisualizations below will be centered on the brca dataset due to the larger number of samples. However, the similar process for cleaning the cesc dataset can be found here along with the data cleaning code for the brca dataset.\n\n\n#| echo: false\n#| warning: false\n#| tbl-cap: Rows showing a unique patient (cases.submitter_id) and their different treatments for breast cancer\n\n# Import relevant libraries\nimport pandas as pd\nimport numpy as np\nimport matplotlib.pyplot as plt\nimport seaborn as sns\n%matplotlib inline\nimport plotly.express as px\nimport plotly.graph_objects as go\nimport plotly.io as pio\npio.renderers.default = \"notebook_connected\"\nimport missingno as msno\nimport warnings\nwarnings.filterwarnings('ignore')\nfrom scipy import stats\nfrom scipy.stats import norm, skew\n\n# Import dataset\nbrca_df_original = pd.read_csv(\"../../data/raw-data/brca/brca-clinical.tsv\", sep=\"\\t\")\n\n# Create a copy of the original dataframe to work on\nbrca_df = brca_df_original.copy()\n\n# Display first few rows of the dataset\nbrca_df.head()\nMissing data: From viewing both datasets, the missing data was represented as ’— and required replacing the placeholder string with numpy nontype in order to handle missing values efficiently.\nThe missing values per columns ranged from 0% to 100%, this was a limitation of the datasets especially due to a lot of demographic columns having a large percentage of missing values, as these columns might have been potential social determinants of survival days depending on the type of cancer,\n#| echo: false\n#| warning: false\n#| tbl-cap: Distribution of missing values in key demographic columns\n\ncols_to_check = [\n    'demographic.year_of_birth',\n    'demographic.age_at_index',\n    'demographic.cause_of_death',\n    'demographic.year_of_death',\n    'demographic.vital_status',\n    'demographic.cause_of_death',\n    'demographic.education_level',\n    'demographic.days_to_death'\n]\nfor col in cols_to_check:\n    missing_percentage = brca_df[col].isnull().mean() * 100\n    print(f\"{col}: {missing_percentage:.2f}% missing values\")\nHowever, the demographic.vital_status column has fewer missing values, which still allowed for some analysis regarding survival status. Despite a large number of missing values in demographic.days_to_death, we reasonable assummed it is because the patient is alive since the missing values corresponded to alive in the vital_status column. In addition, days_to_last_follow_up also has fewer missing values (11% in the brca dataset, and 12% in the cesc dataset), which enabled inferring survival time in feature engineering.\nThe datasets had a lot of columns with missing data. The overall original view of missing data in the brca dataset is showed below:\n#| echo: false\n#| warning: false\n#| tbl-cap: Distribution of missing values in breast cancer dataset\n\n# Replace \"'--\" as NA\nbrca_df_original.replace('\\'--', np.nan, inplace=True)\nbrca_df.replace('\\'--', np.nan, inplace=True)\n\nplt.figure(figsize=(15, 8))\nmsno.matrix(brca_df)\nplt.title(\"Missing Data Matrix - Breast Cancer Dataset\", fontsize=14, fontweight='bold')\nplt.show()\nMost of the missing values were initially dropped through the following logic:\n\nDrop of columns with more than 30% data missing (except days_to_death as it is a key column for analysis). This reduced the number of columns by ~75% (e.g., to 46 columns for brca)\nDrop of columns irrelevant to the task of analysing survival time for the two different types of cancers e.g., data consent - not a predictor of how someone will survive a cancer, year of diagnoses - age at diagnoses captures the effect\nDrop of duplicate rows and rows with greater than 30% of the data missing i.e., 30% of information on that patient missing\n\nThe above resulted in a cleaner dataset as shown below:\n\n\n\nDistribution of missing data after dropping missing values as described above\n\n\nAfterwards, missing data was cleaned as follows\n\nFor most of the columns, the missing values were replaced with the mode/most frequent value e.g., diasease_is_primary diasease as True, site_of_involvement as breast, pathologic n (lymph node component of cancer staging) as N0 (no regional lymph node metastasis) due to heavy imbalance towards specific classes\nOverall stage infered from pathologic n, pathologic t (size and extent of primary tumor), and pathologic m (distant metastasis - whether the cancer has spread to distant organs)\nHandling of missing data in days_to_death was handled in the supervised learning section, this was due to the patients still being alive\n\n\n\n\n\nData Types: All columns in the dataset are originally stored as object datatype\nTransformation: Columns were changed to numeric, boolean, and strings as needed in the dataset\n\nNumeric: days_to_death and days_to_last_follow_up were changed to numeric integers. age_at_diagnoses was changed from days to years for easier analysis during exploratory data analysis\nBoolean: Boolean columns were primarily coded as yes/no and these values were changed to True/False respectively\nStrings: Object columns were changed to lowercase strings and leading/trailing whitespace trimmed\n\nImpact of changes: These changes were primarily made with exploratory data analysis in mind and a longer term view towards survival time prediction. Changing age at diagnoses to years enabled better synthesis of multivariate analysis and while preserving days_to_death and days_to_last_follow_up preserved information as the columns are a measure of survival time. Boolean columns enabled efficient filtering and subseeting and the string columns were optimal for wordcloud analysis.\n\n\n\n\nAfter validating the range and distribution of age_at_diagnosis (min of 26 years and max of 89 years), and handling negative values for days_to_last_follow_up by replacing them with the mean, our data engineering process involved extracting more data from columns. Primarily the two columns below were derived:\n\ndiagnosis.behavior: Tumor behavior was derived from the diagnoses.morphology field using the International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Morphology codes follow the format ####/B, where the digit following the slash encodes tumor behavior (e.g., /3 indicates malignant primary disease). For example, morphology code 8500/3 corresponds to infiltrating duct carcinoma with malignant primary behavior. Behavior values were extracted and mapped to ordinal numeric representations following ICD-O-3 guidelines.1\nsurvival_time_days: Survival time was derived using clinical time-to-event variables provided by the Genomic Data Commons (GDC).2 For patients with a recorded death event, survival time was calculated as the difference between demographic.days_to_death and diagnoses.days_to_diagnosis, yielding the number of days survived following cancer diagnosis. For patients without a recorded death event (i.e., alive at last contact), survival time was defined as diagnoses.days_to_last_follow_up, representing the number of days from diagnosis to the most recent clinical follow-up. This approach follows standard survival analysis practice by treating deaths as observed events and living patients as right-censored observations. Missing values in days_to_death were therefore interpreted as censored outcomes rather than zero survival time. No additional adjustments or imputation were applied to survival duration to preserve the temporal integrity of the observed clinical timelines.\n\nFurther data engineering e.g., handling of multiple rows per patient due to multiple treatment types, were handled in feature engineering before machine learning in order to analyse variables in depth e.g., number of treatments. Additional columns are also dropped and some created after exploratory data analysis (EDA) continuing the process of data engineering.\nFor cervical cancer, data cleaning also included extracting the tobacco smoking status and unique ID from the exposure dataset. Unfortunately, the breast cancer exposure file contained only missing values, limiting our analysis. However, examining tobacco exposure in the cervical cancer dataset and not in the breast cancer dataset is epidemiologically justified as cigarette smoking is a recognized co-factor in cervical carcinogenesis while it is not considered a primary risk factor for breast cancer onset or progression, with prior research indicating weak, inconsistent, or indirect associations compared to dominant hormonal, genetic, and reproductive factors3"
  },
  {
    "objectID": "technical-details/data-cleaning/main.html#managing-missing-data",
    "href": "technical-details/data-cleaning/main.html#managing-missing-data",
    "title": "Data Cleaning",
    "section": "",
    "text": "#| echo: false\n#| warning: false\n#| tbl-cap: Rows showing a unique patient (cases.submitter_id) and their different treatments for breast cancer\n\n# Import relevant libraries\nimport pandas as pd\nimport numpy as np\nimport matplotlib.pyplot as plt\nimport seaborn as sns\n%matplotlib inline\nimport plotly.express as px\nimport plotly.graph_objects as go\nimport plotly.io as pio\npio.renderers.default = \"notebook_connected\"\nimport missingno as msno\nimport warnings\nwarnings.filterwarnings('ignore')\nfrom scipy import stats\nfrom scipy.stats import norm, skew\n\n# Import dataset\nbrca_df_original = pd.read_csv(\"../../data/raw-data/brca/brca-clinical.tsv\", sep=\"\\t\")\n\n# Create a copy of the original dataframe to work on\nbrca_df = brca_df_original.copy()\n\n# Display first few rows of the dataset\nbrca_df.head()\nMissing data: From viewing both datasets, the missing data was represented as ’— and required replacing the placeholder string with numpy nontype in order to handle missing values efficiently.\nThe missing values per columns ranged from 0% to 100%, this was a limitation of the datasets especially due to a lot of demographic columns having a large percentage of missing values, as these columns might have been potential social determinants of survival days depending on the type of cancer,\n#| echo: false\n#| warning: false\n#| tbl-cap: Distribution of missing values in key demographic columns\n\ncols_to_check = [\n    'demographic.year_of_birth',\n    'demographic.age_at_index',\n    'demographic.cause_of_death',\n    'demographic.year_of_death',\n    'demographic.vital_status',\n    'demographic.cause_of_death',\n    'demographic.education_level',\n    'demographic.days_to_death'\n]\nfor col in cols_to_check:\n    missing_percentage = brca_df[col].isnull().mean() * 100\n    print(f\"{col}: {missing_percentage:.2f}% missing values\")\nHowever, the demographic.vital_status column has fewer missing values, which still allowed for some analysis regarding survival status. Despite a large number of missing values in demographic.days_to_death, we reasonable assummed it is because the patient is alive since the missing values corresponded to alive in the vital_status column. In addition, days_to_last_follow_up also has fewer missing values (11% in the brca dataset, and 12% in the cesc dataset), which enabled inferring survival time in feature engineering.\nThe datasets had a lot of columns with missing data. The overall original view of missing data in the brca dataset is showed below:\n#| echo: false\n#| warning: false\n#| tbl-cap: Distribution of missing values in breast cancer dataset\n\n# Replace \"'--\" as NA\nbrca_df_original.replace('\\'--', np.nan, inplace=True)\nbrca_df.replace('\\'--', np.nan, inplace=True)\n\nplt.figure(figsize=(15, 8))\nmsno.matrix(brca_df)\nplt.title(\"Missing Data Matrix - Breast Cancer Dataset\", fontsize=14, fontweight='bold')\nplt.show()\nMost of the missing values were initially dropped through the following logic:\n\nDrop of columns with more than 30% data missing (except days_to_death as it is a key column for analysis). This reduced the number of columns by ~75% (e.g., to 46 columns for brca)\nDrop of columns irrelevant to the task of analysing survival time for the two different types of cancers e.g., data consent - not a predictor of how someone will survive a cancer, year of diagnoses - age at diagnoses captures the effect\nDrop of duplicate rows and rows with greater than 30% of the data missing i.e., 30% of information on that patient missing\n\nThe above resulted in a cleaner dataset as shown below:\n\n\n\nDistribution of missing data after dropping missing values as described above\n\n\nAfterwards, missing data was cleaned as follows\n\nFor most of the columns, the missing values were replaced with the mode/most frequent value e.g., diasease_is_primary diasease as True, site_of_involvement as breast, pathologic n (lymph node component of cancer staging) as N0 (no regional lymph node metastasis) due to heavy imbalance towards specific classes\nOverall stage infered from pathologic n, pathologic t (size and extent of primary tumor), and pathologic m (distant metastasis - whether the cancer has spread to distant organs)\nHandling of missing data in days_to_death was handled in the supervised learning section, this was due to the patients still being alive"
  },
  {
    "objectID": "technical-details/data-cleaning/main.html#data-type-correction-and-formatting",
    "href": "technical-details/data-cleaning/main.html#data-type-correction-and-formatting",
    "title": "Data Cleaning",
    "section": "",
    "text": "Data Types: All columns in the dataset are originally stored as object datatype\nTransformation: Columns were changed to numeric, boolean, and strings as needed in the dataset\n\nNumeric: days_to_death and days_to_last_follow_up were changed to numeric integers. age_at_diagnoses was changed from days to years for easier analysis during exploratory data analysis\nBoolean: Boolean columns were primarily coded as yes/no and these values were changed to True/False respectively\nStrings: Object columns were changed to lowercase strings and leading/trailing whitespace trimmed\n\nImpact of changes: These changes were primarily made with exploratory data analysis in mind and a longer term view towards survival time prediction. Changing age at diagnoses to years enabled better synthesis of multivariate analysis and while preserving days_to_death and days_to_last_follow_up preserved information as the columns are a measure of survival time. Boolean columns enabled efficient filtering and subseeting and the string columns were optimal for wordcloud analysis."
  },
  {
    "objectID": "technical-details/data-cleaning/main.html#data-engineering",
    "href": "technical-details/data-cleaning/main.html#data-engineering",
    "title": "Data Cleaning",
    "section": "",
    "text": "After validating the range and distribution of age_at_diagnosis (min of 26 years and max of 89 years), and handling negative values for days_to_last_follow_up by replacing them with the mean, our data engineering process involved extracting more data from columns. Primarily the two columns below were derived:\n\ndiagnosis.behavior: Tumor behavior was derived from the diagnoses.morphology field using the International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Morphology codes follow the format ####/B, where the digit following the slash encodes tumor behavior (e.g., /3 indicates malignant primary disease). For example, morphology code 8500/3 corresponds to infiltrating duct carcinoma with malignant primary behavior. Behavior values were extracted and mapped to ordinal numeric representations following ICD-O-3 guidelines.1\nsurvival_time_days: Survival time was derived using clinical time-to-event variables provided by the Genomic Data Commons (GDC).2 For patients with a recorded death event, survival time was calculated as the difference between demographic.days_to_death and diagnoses.days_to_diagnosis, yielding the number of days survived following cancer diagnosis. For patients without a recorded death event (i.e., alive at last contact), survival time was defined as diagnoses.days_to_last_follow_up, representing the number of days from diagnosis to the most recent clinical follow-up. This approach follows standard survival analysis practice by treating deaths as observed events and living patients as right-censored observations. Missing values in days_to_death were therefore interpreted as censored outcomes rather than zero survival time. No additional adjustments or imputation were applied to survival duration to preserve the temporal integrity of the observed clinical timelines.\n\nFurther data engineering e.g., handling of multiple rows per patient due to multiple treatment types, were handled in feature engineering before machine learning in order to analyse variables in depth e.g., number of treatments. Additional columns are also dropped and some created after exploratory data analysis (EDA) continuing the process of data engineering.\nFor cervical cancer, data cleaning also included extracting the tobacco smoking status and unique ID from the exposure dataset. Unfortunately, the breast cancer exposure file contained only missing values, limiting our analysis. However, examining tobacco exposure in the cervical cancer dataset and not in the breast cancer dataset is epidemiologically justified as cigarette smoking is a recognized co-factor in cervical carcinogenesis while it is not considered a primary risk factor for breast cancer onset or progression, with prior research indicating weak, inconsistent, or indirect associations compared to dominant hormonal, genetic, and reproductive factors3"
  },
  {
    "objectID": "technical-details/data-cleaning/brca-cleaning.html",
    "href": "technical-details/data-cleaning/brca-cleaning.html",
    "title": "EDA for breast cancer dataset",
    "section": "",
    "text": "# Import relevant libraries\nimport pandas as pd\nimport numpy as np\nimport matplotlib.pyplot as plt\nimport seaborn as sns\n%matplotlib inline\nimport plotly.express as px\nimport plotly.graph_objects as go\nimport plotly.io as pio\npio.renderers.default = \"notebook_connected\"\nimport missingno as msno\nimport warnings\nwarnings.filterwarnings('ignore')\nfrom scipy import stats\nfrom scipy.stats import norm, skew\n\n\n# Import dataset\nbrca_df_original = pd.read_csv(\"../../data/raw-data/brca/brca-clinical.tsv\", sep=\"\\t\")\n\n# Create a copy of the original dataframe to work on\nbrca_df = brca_df_original.copy()\n\n# Display first few rows of the dataset\nbrca_df.head()\n\n\n\n\n\n\n\n\nproject.project_id\ncases.case_id\ncases.consent_type\ncases.days_to_consent\ncases.days_to_lost_to_followup\ncases.disease_type\ncases.index_date\ncases.lost_to_followup\ncases.primary_site\ncases.submitter_id\n...\ntreatments.treatment_duration\ntreatments.treatment_effect\ntreatments.treatment_effect_indicator\ntreatments.treatment_frequency\ntreatments.treatment_id\ntreatments.treatment_intent_type\ntreatments.treatment_or_therapy\ntreatments.treatment_outcome\ntreatments.treatment_outcome_duration\ntreatments.treatment_type\n\n\n\n\n0\nTCGA-BRCA\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nInformed Consent\n-34\n'--\nDuctal and Lobular Neoplasms\nDiagnosis\n'--\nBreast\nTCGA-E2-A1IU\n...\n'--\n'--\n'--\n'--\n1b884f21-eb24-467f-aba2-208af17070b9\nAdjuvant\nno\n'--\n'--\nRadiation Therapy, NOS\n\n\n1\nTCGA-BRCA\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nInformed Consent\n-34\n'--\nDuctal and Lobular Neoplasms\nDiagnosis\n'--\nBreast\nTCGA-E2-A1IU\n...\n'--\n'--\n'--\n'--\n27868bc3-23c8-5e85-a0e2-314e6cdf9b2a\nAdjuvant\nyes\nTreatment Ongoing\n'--\nHormone Therapy\n\n\n2\nTCGA-BRCA\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nInformed Consent\n-34\n'--\nDuctal and Lobular Neoplasms\nDiagnosis\n'--\nBreast\nTCGA-E2-A1IU\n...\n'--\n'--\n'--\n'--\naedf144c-6b7b-4d76-a3cb-4271aef10f1d\nFirst-Line Therapy\nyes\n'--\n'--\nSurgery, NOS\n\n\n3\nTCGA-BRCA\n0045349c-69d9-4306-a403-c9c1fa836644\nInformed Consent\n76\n'--\nAdenomas and Adenocarcinomas\nDiagnosis\n'--\nBreast\nTCGA-A1-A0SB\n...\n'--\n'--\n'--\n'--\n0a534cae-de91-5e77-a3e7-b52d46bd3966\nFirst-Line Therapy\nyes\n'--\n'--\nSurgery, NOS\n\n\n4\nTCGA-BRCA\n00807dae-9f4a-4fd1-aac2-82eb11bf2afb\nInformed Consent\n19\n'--\nAdnexal and Skin Appendage Neoplasms\nDiagnosis\nNo\nBreast\nTCGA-A2-A04W\n...\n'--\n'--\n'--\n'--\n024faa94-ec57-4d14-b919-62dcab409958\nAdjuvant\nyes\nTreatment Ongoing\n'--\nBisphosphonate Therapy\n\n\n\n\n5 rows × 210 columns\n\n\n\n\n# Check the shape of the dataset\nbrca_df.shape\n\n(5546, 210)\n\n\nFrom the first rows, we can see that there are several columns with missing values, represented as ’– . These values will be turned to NA for easier handling\n\n# Replace \"'--\" as NA\nbrca_df_original.replace('\\'--', np.nan, inplace=True)\nbrca_df.replace('\\'--', np.nan, inplace=True)\n\n\nInspect key columns for survival analysis\n\n# List all cols starting with 'demographic'\ndemographic_cols = [col for col in brca_df.columns if col.startswith('demographic')]\nprint(\"Columns starting with 'demographic':\")\nfor col in demographic_cols:\n    print(f\"  - {col}\")\nprint(f\"\\nTotal demographic columns: {len(demographic_cols)}\")\n\n\nColumns starting with 'demographic':\n  - demographic.age_at_index\n  - demographic.age_is_obfuscated\n  - demographic.cause_of_death\n  - demographic.cause_of_death_source\n  - demographic.country_of_birth\n  - demographic.country_of_residence_at_enrollment\n  - demographic.days_to_birth\n  - demographic.days_to_death\n  - demographic.demographic_id\n  - demographic.education_level\n  - demographic.ethnicity\n  - demographic.gender\n  - demographic.marital_status\n  - demographic.occupation_duration_years\n  - demographic.population_group\n  - demographic.premature_at_birth\n  - demographic.race\n  - demographic.submitter_id\n  - demographic.vital_status\n  - demographic.weeks_gestation_at_birth\n  - demographic.year_of_birth\n  - demographic.year_of_death\n\nTotal demographic columns: 22\n\n\n\n# Check unique values in 'demographic.days_to_death'\nbrca_df[\"demographic.days_to_death\"].unique()\n\narray([nan, '991', '571', '2534', '1793', '538', '320', '2483', '1812',\n       '255', '3926', '723', '1673', '2373', '3941', '2573', '1034',\n       '7455', '584', '2965', '1649', '266', '3945', '785', '1563', '426',\n       '1275', '2911', '224', '3409', '158', '4456', '239', '616', '302',\n       '322', '1009', '227', '1993', '365', '2009', '362', '116', '2798',\n       '3126', '904', '2273', '1272', '860', '2097', '2763', '3462',\n       '3959', '573', '1439', '2469', '921', '336', '3873', '1781',\n       '2361', '295', '1900', '1920', '786', '468', '1127', '959', '1556',\n       '883', '2192', '749', '943', '879', '2417', '1430', '1508', '0',\n       '1388', '2127', '2520', '30', '614', '1884', '1468', '3063',\n       '1152', '976', '678', '1365', '2551', '1694', '811', '1286', '639',\n       '967', '1032', '385', '1072', '912', '825', '1174', '792', '3472',\n       '1642', '6593', '6456', '1688', '1104', '3262', '4267', '612',\n       '548', '2348', '172', '1411', '160', '2854', '577', '348', '563',\n       '446', '1699', '1692', '1004', '1048', '1759', '2866', '1093',\n       '2712', '1324', '754', '3669', '524', '377', '1', '558', '821',\n       '2296', '3461', '2207', '1927', '1142', '2636', '197'],\n      dtype=object)\n\n\n\n# Check for percentage of missing values in 'demographic.days_to_death'\nmissing_percentage = brca_df[\"demographic.days_to_death\"].isnull().mean()\nprint(f\"'Percentage of missing values in 'demographic.days_to_death' {missing_percentage:.2f}\")\n\n'Percentage of missing values in 'demographic.days_to_death' 0.85\n\n\n\n# Check to see if status is 'alive' where days_to_death is missing\nmissing_death_status = brca_df[brca_df[\"demographic.days_to_death\"].isnull()][\"demographic.vital_status\"].value_counts()\nmissing_death_status\n\ndemographic.vital_status\nAlive    4697\nDead        3\nName: count, dtype: int64\n\n\nWe can assume that the demographic.days_to_death column is crucial for survival analysis, as it indicates the time until death for each patient. Despite a significant number of missing values in this column, these are for patients who are still alive, as indicated by the demographic.vital_status column. Therefore, we can retain this column for analysis, treating missing values as censored data.\n\n# Drop rows where days_to_death is missing and vital_status is 'Dead'\nbrca_df = brca_df[~((brca_df[\"demographic.days_to_death\"].isnull()) & (brca_df[\"demographic.vital_status\"] == 'Dead'))]\n\n\n# Check for percentage of missing values in diagnoses.days_to_last_follow_up\nmissing_percentage = brca_df[\"diagnoses.days_to_last_follow_up\"].isnull().mean()\nprint(f\"'Percentage of missing values in 'diagnoses.days_to_last_follow_up' {missing_percentage:.2f}\")\n\n'Percentage of missing values in 'diagnoses.days_to_last_follow_up' 0.11\n\n\n\n# Check the distribution of vital_status when days_to_last_follow_up is missing\nmissing_followup_status = brca_df[brca_df[\"diagnoses.days_to_last_follow_up\"].isnull()][\"demographic.vital_status\"].value_counts()\nmissing_followup_status\n\ndemographic.vital_status\nAlive    337\nDead     260\nName: count, dtype: int64\n\n\n\n# Check the percentage of missing values for the following columns:\n# - demographic.year_of_birth\n# - demographic.year_of_death\n# - demographic.vital_status\n# - demographic.cause_of_death\n# - demographic.education_level\ncols_to_check = [\n    'demographic.year_of_birth',\n    'demographic.age_at_index',\n    'demographic.cause_of_death',\n    'demographic.year_of_death',\n    'demographic.vital_status',\n    'demographic.cause_of_death',\n    'demographic.education_level',\n    'demographic.days_to_death'\n]\nfor col in cols_to_check:\n    missing_percentage = brca_df[col].isnull().mean() * 100\n    print(f\"{col}: {missing_percentage:.2f}% missing values\")\n\ndemographic.year_of_birth: 99.96% missing values\ndemographic.age_at_index: 0.02% missing values\ndemographic.cause_of_death: 100.00% missing values\ndemographic.year_of_death: 100.00% missing values\ndemographic.vital_status: 0.02% missing values\ndemographic.cause_of_death: 100.00% missing values\ndemographic.education_level: 100.00% missing values\ndemographic.days_to_death: 84.76% missing values\n\n\nA lot of missing values in key demographic columns, especially in cause of death become a limiting factor for analysis.\n\n# Distribution of demographic.vital_status\nvital_status_counts = brca_df['demographic.vital_status'].value_counts(dropna=False)\nprint(\"\\ndemographic.vital_status distribution:\")\nprint(vital_status_counts)\n\n\ndemographic.vital_status distribution:\ndemographic.vital_status\nAlive    4697\nDead      845\nNaN         1\nName: count, dtype: int64\n\n\nHowever, the demographic.vital_status column has fewer missing values, which may still allow for some analysis regarding survival status. Despite large number of missing values in demographic.days_to_death, we can assume it is because the patient is alive since the missing values correspond to alive in the vital_status column. In addition, days_to_last_follow_up in the diagnoses table also has fewer missing values, which may be useful for survival time analysis.\n\n\nCheck for missing values\n\n# Missing data visualization\nplt.figure(figsize=(15, 8))\nmsno.matrix(brca_df)\nplt.title(\"Missing Data Matrix - Breast Cancer Dataset\", fontsize=14, fontweight='bold')\nplt.show()\n\n&lt;Figure size 1500x800 with 0 Axes&gt;\n\n\n\n\n\n\n\n\n\n\n# Drop columns with more than 30% missing values except for demographic.days_to_death and diagnoses.days_to_last_follow_up\n\n# Calculate missing percentage for each column\nmissing_percentages = brca_df.isnull().mean()\n\n# Identify columns to drop (more than 30% missing, excluding the exceptions)\nexceptions = ['demographic.days_to_death', 'diagnoses.days_to_last_follow_up']\ncolumns_to_drop = []\n\nfor col in brca_df.columns:\n    if col not in exceptions and missing_percentages[col] &gt; 0.3:\n        columns_to_drop.append(col)\n\nprint(f\"Columns to be dropped due to &gt;30% missing values: {columns_to_drop}\")\n\n# Drop the identified columns\nbrca_df = brca_df.drop(columns=columns_to_drop)\n\n# Display the shape of the cleaned dataset\nbrca_df.shape\n\nColumns to be dropped due to &gt;30% missing values: ['cases.days_to_lost_to_followup', 'cases.lost_to_followup', 'demographic.cause_of_death', 'demographic.cause_of_death_source', 'demographic.country_of_birth', 'demographic.country_of_residence_at_enrollment', 'demographic.education_level', 'demographic.marital_status', 'demographic.occupation_duration_years', 'demographic.population_group', 'demographic.premature_at_birth', 'demographic.weeks_gestation_at_birth', 'demographic.year_of_birth', 'demographic.year_of_death', 'diagnoses.adrenal_hormone', 'diagnoses.ajcc_clinical_m', 'diagnoses.ajcc_clinical_n', 'diagnoses.ajcc_clinical_stage', 'diagnoses.ajcc_clinical_t', 'diagnoses.ajcc_serum_tumor_markers', 'diagnoses.ann_arbor_b_symptoms', 'diagnoses.ann_arbor_b_symptoms_described', 'diagnoses.ann_arbor_clinical_stage', 'diagnoses.ann_arbor_extranodal_involvement', 'diagnoses.ann_arbor_pathologic_stage', 'diagnoses.best_overall_response', 'diagnoses.burkitt_lymphoma_clinical_variant', 'diagnoses.calgb_risk_group', 'diagnoses.cancer_detection_method', 'diagnoses.child_pugh_classification', 'diagnoses.clark_level', 'diagnoses.cog_liver_stage', 'diagnoses.cog_neuroblastoma_risk_group', 'diagnoses.cog_renal_stage', 'diagnoses.cog_rhabdomyosarcoma_risk_group', 'diagnoses.contiguous_organ_invaded', 'diagnoses.days_to_best_overall_response', 'diagnoses.days_to_last_known_disease_status', 'diagnoses.days_to_recurrence', 'diagnoses.double_expressor_lymphoma', 'diagnoses.double_hit_lymphoma', 'diagnoses.eln_risk_classification', 'diagnoses.enneking_msts_grade', 'diagnoses.enneking_msts_metastasis', 'diagnoses.enneking_msts_stage', 'diagnoses.enneking_msts_tumor_site', 'diagnoses.ensat_clinical_m', 'diagnoses.ensat_pathologic_n', 'diagnoses.ensat_pathologic_stage', 'diagnoses.ensat_pathologic_t', 'diagnoses.esophageal_columnar_dysplasia_degree', 'diagnoses.esophageal_columnar_metaplasia_present', 'diagnoses.fab_morphology_code', 'diagnoses.figo_stage', 'diagnoses.figo_staging_edition_year', 'diagnoses.first_symptom_longest_duration', 'diagnoses.first_symptom_prior_to_diagnosis', 'diagnoses.gastric_esophageal_junction_involvement', 'diagnoses.gleason_grade_group', 'diagnoses.gleason_grade_tertiary', 'diagnoses.gleason_patterns_percent', 'diagnoses.gleason_score', 'diagnoses.goblet_cells_columnar_mucosa_present', 'diagnoses.igcccg_stage', 'diagnoses.inpc_grade', 'diagnoses.inpc_histologic_group', 'diagnoses.inrg_stage', 'diagnoses.inss_stage', 'diagnoses.international_prognostic_index', 'diagnoses.irs_group', 'diagnoses.irs_stage', 'diagnoses.ishak_fibrosis_score', 'diagnoses.iss_stage', 'diagnoses.last_known_disease_status', 'diagnoses.margin_distance', 'diagnoses.margins_involved_site', 'diagnoses.masaoka_stage', 'diagnoses.max_tumor_bulk_site', 'diagnoses.medulloblastoma_molecular_classification', 'diagnoses.melanoma_known_primary', 'diagnoses.metastasis_at_diagnosis', 'diagnoses.metastasis_at_diagnosis_site', 'diagnoses.micropapillary_features', 'diagnoses.mitosis_karyorrhexis_index', 'diagnoses.mitotic_count', 'diagnoses.ovarian_specimen_status', 'diagnoses.ovarian_surface_involvement', 'diagnoses.papillary_renal_cell_type', 'diagnoses.pediatric_kidney_staging', 'diagnoses.peritoneal_fluid_cytological_status', 'diagnoses.pregnant_at_diagnosis', 'diagnoses.primary_disease', 'diagnoses.primary_gleason_grade', 'diagnoses.progression_or_recurrence', 'diagnoses.residual_disease', 'diagnoses.satellite_nodule_present', 'diagnoses.secondary_gleason_grade', 'diagnoses.sites_of_involvement_count', 'diagnoses.supratentorial_localization', 'diagnoses.tumor_burden', 'diagnoses.tumor_confined_to_organ_of_origin', 'diagnoses.tumor_depth', 'diagnoses.tumor_focality', 'diagnoses.tumor_grade', 'diagnoses.tumor_grade_category', 'diagnoses.tumor_of_origin', 'diagnoses.tumor_regression_grade', 'diagnoses.uicc_clinical_m', 'diagnoses.uicc_clinical_n', 'diagnoses.uicc_clinical_stage', 'diagnoses.uicc_clinical_t', 'diagnoses.uicc_pathologic_m', 'diagnoses.uicc_pathologic_n', 'diagnoses.uicc_pathologic_stage', 'diagnoses.uicc_pathologic_t', 'diagnoses.uicc_staging_system_edition', 'diagnoses.ulceration_indicator', 'diagnoses.weiss_assessment_findings', 'diagnoses.weiss_assessment_score', 'diagnoses.who_cns_grade', 'diagnoses.who_nte_grade', 'diagnoses.wilms_tumor_histologic_subtype', 'treatments.chemo_concurrent_to_radiation', 'treatments.clinical_trial_indicator', 'treatments.course_number', 'treatments.days_to_treatment_end', 'treatments.days_to_treatment_start', 'treatments.drug_category', 'treatments.embolic_agent', 'treatments.initial_disease_status', 'treatments.lesions_treated_number', 'treatments.margin_distance', 'treatments.margin_status', 'treatments.margins_involved_site', 'treatments.number_of_cycles', 'treatments.number_of_fractions', 'treatments.prescribed_dose', 'treatments.prescribed_dose_units', 'treatments.pretreatment', 'treatments.protocol_identifier', 'treatments.radiosensitizing_agent', 'treatments.reason_treatment_ended', 'treatments.reason_treatment_not_given', 'treatments.regimen_or_line_of_therapy', 'treatments.residual_disease', 'treatments.route_of_administration', 'treatments.therapeutic_agents', 'treatments.therapeutic_level_achieved', 'treatments.therapeutic_levels_achieved', 'treatments.therapeutic_target_level', 'treatments.timepoint_category', 'treatments.treatment_anatomic_site', 'treatments.treatment_anatomic_sites', 'treatments.treatment_arm', 'treatments.treatment_dose', 'treatments.treatment_dose_max', 'treatments.treatment_dose_units', 'treatments.treatment_duration', 'treatments.treatment_effect', 'treatments.treatment_effect_indicator', 'treatments.treatment_frequency', 'treatments.treatment_intent_type', 'treatments.treatment_outcome', 'treatments.treatment_outcome_duration']\n\n\n(5543, 46)\n\n\n\n# Check distribution na values after dropping columns\nplt.figure(figsize=(15, 8))\nmsno.matrix(brca_df)\nplt.title(\"Missing Data Matrix After Dropping Columns - BRCA Clinical Dataset\", fontsize=14, fontweight='bold')\nplt.show()\n\n&lt;Figure size 1500x800 with 0 Axes&gt;\n\n\n\n\n\n\n\n\n\n\n\nCheck for duplicate IDs\n\n# Count unique IDs (cases.submitter_id)\n\nunique_ids = brca_df['cases.submitter_id'].nunique()\nprint(f\"Number of unique IDs: {unique_ids}\")\n\nNumber of unique IDs: 1097\n\n\nThe TGCA BRCA dataset contains 1,082 unique patient IDs (cases.submitter_id) but 3554 rows in total. This is because the TCGA Schema is designed to have multiple samples per patient, capturing different aspects of the tumor biology. Each patient may have multiple entries corresponding to different sample types, such as primary tumor, metastatic tumor, or normal tissue adjacent to the tumor. This allows for a more comprehensive analysis of the cancer’s characteristics and progression within the same individual.\nThe tcga schema is hierarchical as follows:\nCase (BRCA) -&gt; Diagnosis -&gt; Follow-up -&gt; Treatment -&gt; Biospecimens\nMost BRCA patients have: - 1 diagnosis - 1 - 5 follow-up entries - 1 - 3 treatments - 2 - 4 tissue samples (tumor and normal)\n\n# Drop completely duplicate rows\nbrca_df = brca_df.drop_duplicates()\n\n\n\nFilter columns based on task\nColumns that are not relevant to the predictive modeling task will be dropped. These include identifiers, dates, and other metadata that do not contribute to the prediction of breast cancer outcomes such as the following:\n\ncases.consent_type\ncases.days_to_consent\ndemographic.days_to_birth\ndemographic.age_at_index (will preserve diagnosis.age_at_diagnosis instead for age at diagnosis)\ndiagnoses.ajcc_staging_system_edition\ndiagnoses.diagnosis_id (captured in disease_type)\ndiagnoses.icd_10_code (captured in disease_type)\ndiagnoses.year_of_diagnosis (interested in age at diagnosis instead)\ntreatments.treatment_id\n\n\n# Drop irrelevant columns\ncolumns_to_drop = [\n    'cases.consent_type',\n    'cases.days_to_consent',\n    'demographic.days_to_birth',\n    'demographic.age_at_index',\n    'demographic.demographic_id',\n    'diagnoses.ajcc_staging_system_edition',\n    'diagnoses.diagnosis_id',\n    'diagnoses.icd_10_code',\n    'diagnoses.year_of_diagnosis',\n    'treatments.treatment_id'\n]\n\n# Drop the existing columns\nbrca_df = brca_df.drop(columns=columns_to_drop)\n\nprint(f\"Dataset shape after dropping columns: {brca_df.shape}\")\n\nDataset shape after dropping columns: (5543, 36)\n\n\n\n# Using msno to visualize missing data in remaining columns\nplt.figure(figsize=(15, 8))\nmsno.matrix(brca_df)\nplt.title(\"Missing Data Matrix After Dropping irrelevant columns - BRCA Clinical Dataset\", fontsize=14, fontweight='bold')\nplt.show()\n\n&lt;Figure size 1500x800 with 0 Axes&gt;\n\n\n\n\n\n\n\n\n\n\n# Check missing value percentages again\n\nfor col in brca_df.columns:\n    missing_percentage = brca_df[col].isnull().mean() * 100\n    print(f\"{col}: {missing_percentage:.2f}% missing values\")\n\nproject.project_id: 0.00% missing values\ncases.case_id: 0.00% missing values\ncases.disease_type: 0.00% missing values\ncases.index_date: 0.05% missing values\ncases.primary_site: 0.00% missing values\ncases.submitter_id: 0.00% missing values\ndemographic.age_is_obfuscated: 0.05% missing values\ndemographic.days_to_death: 84.76% missing values\ndemographic.ethnicity: 0.02% missing values\ndemographic.gender: 0.02% missing values\ndemographic.race: 0.02% missing values\ndemographic.submitter_id: 0.02% missing values\ndemographic.vital_status: 0.02% missing values\ndiagnoses.age_at_diagnosis: 3.50% missing values\ndiagnoses.ajcc_pathologic_m: 9.44% missing values\ndiagnoses.ajcc_pathologic_n: 9.44% missing values\ndiagnoses.ajcc_pathologic_stage: 10.25% missing values\ndiagnoses.ajcc_pathologic_t: 9.40% missing values\ndiagnoses.classification_of_tumor: 0.02% missing values\ndiagnoses.days_to_diagnosis: 2.62% missing values\ndiagnoses.days_to_last_follow_up: 10.79% missing values\ndiagnoses.diagnosis_is_primary_disease: 0.05% missing values\ndiagnoses.laterality: 8.44% missing values\ndiagnoses.method_of_diagnosis: 17.54% missing values\ndiagnoses.morphology: 0.02% missing values\ndiagnoses.primary_diagnosis: 0.02% missing values\ndiagnoses.prior_malignancy: 10.79% missing values\ndiagnoses.prior_treatment: 3.63% missing values\ndiagnoses.site_of_resection_or_biopsy: 0.02% missing values\ndiagnoses.sites_of_involvement: 10.82% missing values\ndiagnoses.submitter_id: 0.02% missing values\ndiagnoses.synchronous_malignancy: 10.79% missing values\ndiagnoses.tissue_or_organ_of_origin: 0.02% missing values\ntreatments.submitter_id: 0.67% missing values\ntreatments.treatment_or_therapy: 0.67% missing values\ntreatments.treatment_type: 0.67% missing values\n\n\n\n# Check distribution of rows that have a lot of missing values\nbrca_df[\"na_count\"] = brca_df.isna().sum(axis=1)\nna_count_distribution = brca_df['na_count'].value_counts().sort_index()\nprint(\"\\nDistribution of rows by number of missing values:\")\nprint(na_count_distribution)\n\n\nDistribution of rows by number of missing values:\nna_count\n0      543\n1     3981\n2      415\n3        4\n7       20\n8       15\n9       37\n10     218\n11     172\n12      27\n13      51\n14      56\n15       1\n16       1\n17       1\n31       1\nName: count, dtype: int64\n\n\n\n# Delete rows that have 9 or more missing values (representing over 30% of that entity info missing)\nbrca_df = brca_df[brca_df['na_count'] &lt; 9].drop(columns=['na_count'])\n\n\n# Delete rows that have missing age_at_diagnosis info since this is a critical variable for our analysis\nbrca_df = brca_df[brca_df['diagnoses.age_at_diagnosis'].notna()]\n\n\n# Check missing value percentages again\n\nfor col in brca_df.columns:\n    missing_percentage = brca_df[col].isnull().mean() * 100\n    print(f\"{col}: {missing_percentage:.2f}% missing values\")\n\nproject.project_id: 0.00% missing values\ncases.case_id: 0.00% missing values\ncases.disease_type: 0.00% missing values\ncases.index_date: 0.04% missing values\ncases.primary_site: 0.00% missing values\ncases.submitter_id: 0.00% missing values\ndemographic.age_is_obfuscated: 0.04% missing values\ndemographic.days_to_death: 88.11% missing values\ndemographic.ethnicity: 0.00% missing values\ndemographic.gender: 0.00% missing values\ndemographic.race: 0.00% missing values\ndemographic.submitter_id: 0.00% missing values\ndemographic.vital_status: 0.00% missing values\ndiagnoses.age_at_diagnosis: 0.00% missing values\ndiagnoses.ajcc_pathologic_m: 0.00% missing values\ndiagnoses.ajcc_pathologic_n: 0.00% missing values\ndiagnoses.ajcc_pathologic_stage: 0.89% missing values\ndiagnoses.ajcc_pathologic_t: 0.06% missing values\ndiagnoses.classification_of_tumor: 0.00% missing values\ndiagnoses.days_to_diagnosis: 0.00% missing values\ndiagnoses.days_to_last_follow_up: 0.49% missing values\ndiagnoses.diagnosis_is_primary_disease: 0.04% missing values\ndiagnoses.laterality: 0.10% missing values\ndiagnoses.method_of_diagnosis: 8.09% missing values\ndiagnoses.morphology: 0.00% missing values\ndiagnoses.primary_diagnosis: 0.00% missing values\ndiagnoses.prior_malignancy: 0.49% missing values\ndiagnoses.prior_treatment: 0.49% missing values\ndiagnoses.site_of_resection_or_biopsy: 0.00% missing values\ndiagnoses.sites_of_involvement: 0.53% missing values\ndiagnoses.submitter_id: 0.00% missing values\ndiagnoses.synchronous_malignancy: 0.49% missing values\ndiagnoses.tissue_or_organ_of_origin: 0.00% missing values\ntreatments.submitter_id: 0.00% missing values\ntreatments.treatment_or_therapy: 0.00% missing values\ntreatments.treatment_type: 0.00% missing values\n\n\n\n# Using msno to visualize missing data in remaining columns\nplt.figure(figsize=(15, 8))\nmsno.matrix(brca_df)\nplt.title(\"Missing Data Matrix After Dropping irrelevant columns - BRCA Clinical Dataset\", fontsize=14, fontweight='bold')\nplt.show()\n\n&lt;Figure size 1500x800 with 0 Axes&gt;\n\n\n\n\n\n\n\n\n\n\n# Check the distribution of the method_of_diagnosis since it has a significantly higher missing value percentage\nmethod_of_diagnosis_counts = brca_df['diagnoses.method_of_diagnosis'].value_counts(dropna=False)\nprint(\"\\ndiagnoses.method_of_diagnosis distribution:\")\nprint(method_of_diagnosis_counts)\n\n\ndiagnoses.method_of_diagnosis distribution:\ndiagnoses.method_of_diagnosis\nCore Biopsy                 2932\nSurgical Resection           797\nNaN                          398\nFine Needle Aspiration       380\nExcisional Biopsy            143\nCytology                     124\nBiopsy                        67\nIncisional Biopsy             66\nUltrasound Guided Biopsy       7\nUnknown                        6\nName: count, dtype: int64\n\n\nDue to the heavy imbalance leaning towards Core Biopsy for the diagnoses.method_of_diagnosis column, we can replace missing values with ‘Core Biopsy’ to retain more rows for analysis.\n\n# Distribution of cases.index_date\nindex_date_counts = brca_df['cases.index_date'].value_counts(dropna=False)\nprint(\"\\ncases.index_date distribution:\")\nprint(index_date_counts)\n\n\ncases.index_date distribution:\ncases.index_date\nDiagnosis    4918\nNaN             2\nName: count, dtype: int64\n\n\nDue to the heavy imbalance leaning towards Diagnosis for the cases.index_date column, we can replace missing values with ‘Diagnosis’ to retain more rows for analysis.\n\n# Set pandas options to display all columns\npd.set_option('display.max_columns', None)\npd.set_option('display.width', None)\npd.set_option('display.max_colwidth', None)\n\n\n# Check rows that have missing age_is_obfuscated \nbrca_df[brca_df['demographic.age_is_obfuscated'].isna()].head()\n\n\n\n\n\n\n\n\nproject.project_id\ncases.case_id\ncases.disease_type\ncases.index_date\ncases.primary_site\ncases.submitter_id\ndemographic.age_is_obfuscated\ndemographic.days_to_death\ndemographic.ethnicity\ndemographic.gender\ndemographic.race\ndemographic.submitter_id\ndemographic.vital_status\ndiagnoses.age_at_diagnosis\ndiagnoses.ajcc_pathologic_m\ndiagnoses.ajcc_pathologic_n\ndiagnoses.ajcc_pathologic_stage\ndiagnoses.ajcc_pathologic_t\ndiagnoses.classification_of_tumor\ndiagnoses.days_to_diagnosis\ndiagnoses.days_to_last_follow_up\ndiagnoses.diagnosis_is_primary_disease\ndiagnoses.laterality\ndiagnoses.method_of_diagnosis\ndiagnoses.morphology\ndiagnoses.primary_diagnosis\ndiagnoses.prior_malignancy\ndiagnoses.prior_treatment\ndiagnoses.site_of_resection_or_biopsy\ndiagnoses.sites_of_involvement\ndiagnoses.submitter_id\ndiagnoses.synchronous_malignancy\ndiagnoses.tissue_or_organ_of_origin\ntreatments.submitter_id\ntreatments.treatment_or_therapy\ntreatments.treatment_type\n\n\n\n\n4368\nTCGA-BRCA\ncb9f5e50-f49d-4899-8895-9367afcc1015\nDuctal and Lobular Neoplasms\nNaN\nBreast\nTCGA-A7-A0DC\nNaN\nNaN\nnot hispanic or latino\nfemale\nwhite\nTCGA-A7-A0DC_demographic\nAlive\n23294\nM0\nN0 (i-)\nStage IA\nT1c\nnot reported\n0\n906.0\nNaN\nNaN\nNaN\n8500/3\nInfiltrating duct carcinoma, NOS\nno\nNo\nBreast, NOS\nNaN\nTCGA-A7-A0DC_diagnosis\nNo\nBreast, NOS\nTCGA-A7-A0DC_treatment_1\nyes\nPharmaceutical Therapy, NOS\n\n\n4369\nTCGA-BRCA\ncb9f5e50-f49d-4899-8895-9367afcc1015\nDuctal and Lobular Neoplasms\nNaN\nBreast\nTCGA-A7-A0DC\nNaN\nNaN\nnot hispanic or latino\nfemale\nwhite\nTCGA-A7-A0DC_demographic\nAlive\n23294\nM0\nN0 (i-)\nStage IA\nT1c\nnot reported\n0\n906.0\nNaN\nNaN\nNaN\n8500/3\nInfiltrating duct carcinoma, NOS\nno\nNo\nBreast, NOS\nNaN\nTCGA-A7-A0DC_diagnosis\nNo\nBreast, NOS\nTCGA-A7-A0DC_treatment\nyes\nRadiation Therapy, NOS\n\n\n\n\n\n\n\nIt seems that when age is obfuscated is NaN, age_at_diagnosis exists, therefore we can replace these with False\n\n# Check distribution of diagnoses.ajcc_pathologic_n \najcc_pathologic_stage_counts = brca_df['diagnoses.ajcc_pathologic_n'].value_counts(dropna=False)\nprint(\"\\ndiagnoses.ajcc_pathologic_n distribution:\")\nprint(ajcc_pathologic_stage_counts)\n\n\ndiagnoses.ajcc_pathologic_n distribution:\ndiagnoses.ajcc_pathologic_n\nN0           1289\nN1a           839\nN0 (i-)       682\nN1            579\nN2a           352\nN2            267\nN3a           247\nN1mi          178\nN0 (i+)       138\nN3            130\nN1b           104\nNX             77\nN3b            16\nN3c            13\nN1c             6\nN0 (mol+)       3\nName: count, dtype: int64\n\n\n\n# Check distribution of diagnoses.ajcc_pathologic_m \najcc_pathologic_stage_counts = brca_df['diagnoses.ajcc_pathologic_m'].value_counts(dropna=False)\nprint(\"\\ndiagnoses.ajcc_pathologic_m distribution:\")\nprint(ajcc_pathologic_stage_counts)\n\n\ndiagnoses.ajcc_pathologic_m distribution:\ndiagnoses.ajcc_pathologic_m\nM0          4095\nMX           703\nM1            87\ncM0 (i+)      35\nName: count, dtype: int64\n\n\n\n# Check distribution of diagnoses.ajcc_pathologic_t \najcc_pathologic_stage_counts = brca_df['diagnoses.ajcc_pathologic_t'].value_counts(dropna=False)\nprint(\"\\ndiagnoses.ajcc_pathologic_t distribution:\")\nprint(ajcc_pathologic_stage_counts)\n\n\ndiagnoses.ajcc_pathologic_t distribution:\ndiagnoses.ajcc_pathologic_t\nT2            2908\nT1c            941\nT3             649\nT1             178\nT4b             94\nT1b             76\nT4              31\nT4d             12\nTX               9\nTis (DCIS)       6\nT3a              4\nT2a              4\nTis              3\nNaN              3\nT1a              1\nT2b              1\nName: count, dtype: int64\n\n\n\n# Check distribution of diagnoses.ajcc_pathologic_stage \najcc_pathologic_stage_counts = brca_df['diagnoses.ajcc_pathologic_stage'].value_counts(dropna=False)\nprint(\"\\ndiagnoses.ajcc_pathologic_stage distribution:\")\nprint(ajcc_pathologic_stage_counts)\n\n\ndiagnoses.ajcc_pathologic_stage distribution:\ndiagnoses.ajcc_pathologic_stage\nStage IIA     1532\nStage IIB     1227\nStage IIIA     787\nStage IIIC     364\nStage I        341\nStage IA       338\nStage IIIB      89\nStage IV        77\nNaN             44\nStage X         42\nStage IB        33\nStage II        25\nStage III       12\nStage 0          6\nStage 0is        3\nName: count, dtype: int64\n\n\nThe missing values in the diagnoses.ajcc_pathologic_t, diagnoses.ajcc_pathologic_n, and diagnoses.ajcc_pathologic_m columns will be replaced by the mode of each column respectively and the state (diagnoses.ajcc_pathologic_stage) will be derived from these three columns using the AJCC staging guidelines.\n\n# Check rows with missing diagnoses.ajcc_pathologic_stage\nbrca_df[brca_df['diagnoses.ajcc_pathologic_stage'].isna()].head()\n\n\n\n\n\n\n\n\nproject.project_id\ncases.case_id\ncases.disease_type\ncases.index_date\ncases.primary_site\ncases.submitter_id\ndemographic.age_is_obfuscated\ndemographic.days_to_death\ndemographic.ethnicity\ndemographic.gender\ndemographic.race\ndemographic.submitter_id\ndemographic.vital_status\ndiagnoses.age_at_diagnosis\ndiagnoses.ajcc_pathologic_m\ndiagnoses.ajcc_pathologic_n\ndiagnoses.ajcc_pathologic_stage\ndiagnoses.ajcc_pathologic_t\ndiagnoses.classification_of_tumor\ndiagnoses.days_to_diagnosis\ndiagnoses.days_to_last_follow_up\ndiagnoses.diagnosis_is_primary_disease\ndiagnoses.laterality\ndiagnoses.method_of_diagnosis\ndiagnoses.morphology\ndiagnoses.primary_diagnosis\ndiagnoses.prior_malignancy\ndiagnoses.prior_treatment\ndiagnoses.site_of_resection_or_biopsy\ndiagnoses.sites_of_involvement\ndiagnoses.submitter_id\ndiagnoses.synchronous_malignancy\ndiagnoses.tissue_or_organ_of_origin\ntreatments.submitter_id\ntreatments.treatment_or_therapy\ntreatments.treatment_type\n\n\n\n\n276\nTCGA-BRCA\n0adf59c6-581a-475d-a2f4-40aa40060b5b\nDuctal and Lobular Neoplasms\nDiagnosis\nBreast\nTCGA-A8-A09T\nfalse\nNaN\nnot reported\nfemale\nnot reported\nTCGA-A8-A09T_demographic\nAlive\n25110\nMX\nN0\nNaN\nT1c\nprimary\n0\n579.0\ntrue\nLeft\nNaN\n8520/3\nLobular carcinoma, NOS\nno\nNo\nBreast, NOS\nBreast, NOS\nTCGA-A8-A09T_diagnosis\nNo\nBreast, NOS\nTCGA-A8-A09T_treatment2\nyes\nHormone Therapy\n\n\n277\nTCGA-BRCA\n0adf59c6-581a-475d-a2f4-40aa40060b5b\nDuctal and Lobular Neoplasms\nDiagnosis\nBreast\nTCGA-A8-A09T\nfalse\nNaN\nnot reported\nfemale\nnot reported\nTCGA-A8-A09T_demographic\nAlive\n25110\nMX\nN0\nNaN\nT1c\nprimary\n0\n579.0\ntrue\nLeft\nNaN\n8520/3\nLobular carcinoma, NOS\nno\nNo\nBreast, NOS\nBreast, NOS\nTCGA-A8-A09T_diagnosis\nNo\nBreast, NOS\nTCGA-A8-A09T_treatment3\nyes\nSurgery, NOS\n\n\n278\nTCGA-BRCA\n0adf59c6-581a-475d-a2f4-40aa40060b5b\nDuctal and Lobular Neoplasms\nDiagnosis\nBreast\nTCGA-A8-A09T\nfalse\nNaN\nnot reported\nfemale\nnot reported\nTCGA-A8-A09T_demographic\nAlive\n25110\nMX\nN0\nNaN\nT1c\nprimary\n0\n579.0\ntrue\nLeft\nNaN\n8520/3\nLobular carcinoma, NOS\nno\nNo\nBreast, NOS\nBreast, NOS\nTCGA-A8-A09T_diagnosis\nNo\nBreast, NOS\nTCGA-A8-A09T_treatment\nyes\nRadiation, External Beam\n\n\n508\nTCGA-BRCA\n178b2c48-c07d-422e-ae17-8bcfd996ad51\nDuctal and Lobular Neoplasms\nDiagnosis\nBreast\nTCGA-B6-A0X1\nfalse\n7455\nnot hispanic or latino\nfemale\nwhite\nTCGA-B6-A0X1_demographic\nDead\n17624\nM1\nN1\nNaN\nT2\nprimary\n0\n7455.0\ntrue\nLeft\nFine Needle Aspiration\n8500/3\nInfiltrating duct carcinoma, NOS\nno\nNo\nBreast, NOS\nBreast, NOS\nTCGA-B6-A0X1_diagnosis\nNo\nBreast, NOS\nTCGA-B6-A0X1_treatment3\nyes\nSurgery, NOS\n\n\n509\nTCGA-BRCA\n178b2c48-c07d-422e-ae17-8bcfd996ad51\nDuctal and Lobular Neoplasms\nDiagnosis\nBreast\nTCGA-B6-A0X1\nfalse\n7455\nnot hispanic or latino\nfemale\nwhite\nTCGA-B6-A0X1_demographic\nDead\n17624\nM1\nN1\nNaN\nT2\nprimary\n0\n7455.0\ntrue\nLeft\nFine Needle Aspiration\n8500/3\nInfiltrating duct carcinoma, NOS\nno\nNo\nBreast, NOS\nBreast, NOS\nTCGA-B6-A0X1_diagnosis\nNo\nBreast, NOS\nTCGA-B6-A0X1_treatment\nyes\nPharmaceutical Therapy, NOS\n\n\n\n\n\n\n\n\n# Percentage of missing values in each column\nmissing_percentages = brca_df.isnull().mean() * 100\nprint(\"\\nPercentage of missing values in each column:\")\nprint(missing_percentages)\n\n\nPercentage of missing values in each column:\nproject.project_id                         0.000000\ncases.case_id                              0.000000\ncases.disease_type                         0.000000\ncases.index_date                           0.040650\ncases.primary_site                         0.000000\ncases.submitter_id                         0.000000\ndemographic.age_is_obfuscated              0.040650\ndemographic.days_to_death                 88.109756\ndemographic.ethnicity                      0.000000\ndemographic.gender                         0.000000\ndemographic.race                           0.000000\ndemographic.submitter_id                   0.000000\ndemographic.vital_status                   0.000000\ndiagnoses.age_at_diagnosis                 0.000000\ndiagnoses.ajcc_pathologic_m                0.000000\ndiagnoses.ajcc_pathologic_n                0.000000\ndiagnoses.ajcc_pathologic_stage            0.894309\ndiagnoses.ajcc_pathologic_t                0.060976\ndiagnoses.classification_of_tumor          0.000000\ndiagnoses.days_to_diagnosis                0.000000\ndiagnoses.days_to_last_follow_up           0.487805\ndiagnoses.diagnosis_is_primary_disease     0.040650\ndiagnoses.laterality                       0.101626\ndiagnoses.method_of_diagnosis              8.089431\ndiagnoses.morphology                       0.000000\ndiagnoses.primary_diagnosis                0.000000\ndiagnoses.prior_malignancy                 0.487805\ndiagnoses.prior_treatment                  0.487805\ndiagnoses.site_of_resection_or_biopsy      0.000000\ndiagnoses.sites_of_involvement             0.528455\ndiagnoses.submitter_id                     0.000000\ndiagnoses.synchronous_malignancy           0.487805\ndiagnoses.tissue_or_organ_of_origin        0.000000\ntreatments.submitter_id                    0.000000\ntreatments.treatment_or_therapy            0.000000\ntreatments.treatment_type                  0.000000\ndtype: float64\n\n\n\n# Check distribution of diagnoses.treatment_or_therapy\ntreatment_or_therapy_counts = brca_df['treatments.treatment_or_therapy'].value_counts(dropna=False)\nprint(\"\\ntreatments.treatment_or_therapy distribution:\")\nprint(treatment_or_therapy_counts)\n\n\ntreatments.treatment_or_therapy distribution:\ntreatments.treatment_or_therapy\nyes        4289\nno          559\nunknown      72\nName: count, dtype: int64\n\n\n\n\nClean NA values\nReplace the missing values in the following columns based on the assigned strategy: - cases.index_date: ‘Diagnosis’ (most frequent) - diagnoses.method_of_diagnosis: ‘Core Biopsy’ (most frequent) - demographic.age_is_obfuscated: ‘False’ (age is still present despite na) - diagnoses.ajcc_pathologic_n: ‘N0’ (most frequent) - diagnoses.ajcc_pathologic_m: ‘M0’ (most frequent) - diagnoses.ajcc_pathologic_t: ‘T2’ (most frequent) - diagnoses.ajcc_pathologic_stage: infered from other ajcc_pathologic columns according to the following mapping: - T1, N0, M0 -&gt; Stage I - T2, N0, M0 -&gt; Stage II - T3, N0, M0 -&gt; Stage III - T4, N0, M0 -&gt; Stage IV - T1, N1, M0 -&gt; Stage II - T2, N1, M0 -&gt; Stage III - T3, N1, M0 -&gt; Stage III - T4, N1, M0 -&gt; Stage IV - diagnoses.diagnosis_is_primary_disease: ‘True’ (most frequent) - diagnoses.laterality : ‘Left’ (most frequent) - diagnoses.prior_malignancy: ‘False’ (most frequent) - diagnoses.prior_treatment: ‘False’ (most frequent) - diagnoses.sites_of_involvement: ‘Breast’ (most frequent) - diagnoses.synchronous_malignancy: ‘False’ (most frequent) - diagnoses.treatment_or_therapy: True (most frequent)\n\n# Replace missing values based on the strategy above:\n\n# Replace with most frequent values\nbrca_df['cases.index_date'] = brca_df['cases.index_date'].fillna('diagnosis')\nbrca_df['diagnoses.method_of_diagnosis'] = brca_df['diagnoses.method_of_diagnosis'].fillna('core biopsy')\nbrca_df['demographic.age_is_obfuscated'] = brca_df['demographic.age_is_obfuscated'].fillna('false')\nbrca_df['diagnoses.ajcc_pathologic_n'] = brca_df['diagnoses.ajcc_pathologic_n'].fillna('n0')\nbrca_df['diagnoses.ajcc_pathologic_m'] = brca_df['diagnoses.ajcc_pathologic_m'].fillna('m0')\nbrca_df['diagnoses.ajcc_pathologic_t'] = brca_df['diagnoses.ajcc_pathologic_t'].fillna('t2')\nbrca_df['diagnoses.diagnosis_is_primary_disease'] = brca_df['diagnoses.diagnosis_is_primary_disease'].fillna('true')\nbrca_df['diagnoses.laterality'] = brca_df['diagnoses.laterality'].fillna('left')\nbrca_df['diagnoses.prior_malignancy'] = brca_df['diagnoses.prior_malignancy'].fillna('no')\nbrca_df['diagnoses.prior_treatment'] = brca_df['diagnoses.prior_treatment'].fillna('no')\nbrca_df['diagnoses.sites_of_involvement'] = brca_df['diagnoses.sites_of_involvement'].fillna('breast')\nbrca_df['diagnoses.synchronous_malignancy'] = brca_df['diagnoses.synchronous_malignancy'].fillna('no')\nbrca_df['treatments.treatment_or_therapy'] = brca_df['treatments.treatment_or_therapy'].fillna('True')\n\n# Define AJCC staging mapping\ndef get_ajcc_stage(t, n, m):\n    \"\"\"Map T, N, M values to AJCC stage\"\"\"\n    # Extract numeric/classification parts (remove 'T', 'N', 'M' prefixes)\n    t_val = t.lower().replace('t', '') if pd.notna(t) else '2'\n    n_val = n.lower().replace('n', '') if pd.notna(n) else '0'\n    m_val = m.lower().replace('m', '') if pd.notna(m) else '0'\n    \n    # Stage mapping logic\n    if m_val != '0':\n        return 'stage iv'  # Any distant metastasis is Stage IV\n    elif t_val == '1' and n_val == '0':\n        return 'stage i'\n    elif (t_val == '2' and n_val == '0') or (t_val == '1' and n_val == '1'):\n        return 'stage ii'\n    elif (t_val == '3' and n_val == '0') or (t_val == '2' and n_val == '1') or (t_val == '3' and n_val == '1'):\n        return 'stage iii'\n    elif t_val == '4':\n        return 'stage iv'\n    else:\n        return 'stage ii'  # Default fallback\n\n# Apply staging logic to fill missing values\nfor idx, row in brca_df.iterrows():\n    if pd.isna(row['diagnoses.ajcc_pathologic_stage']):\n        stage = get_ajcc_stage(\n            row['diagnoses.ajcc_pathologic_t'],\n            row['diagnoses.ajcc_pathologic_n'], \n            row['diagnoses.ajcc_pathologic_m']\n        )\n        brca_df.at[idx, 'diagnoses.ajcc_pathologic_stage'] = stage\n\n\n# Check missing values after replacement\nprint(\"Missing values after replacement:\")\nfor col in brca_df.columns:\n    missing_count = brca_df[col].isnull().sum()\n    if missing_count &gt; 0:\n        print(f\"{col}: {missing_count} missing values\")\n\nprint(f\"\\nTotal missing values across all columns: {brca_df.isnull().sum().sum()}\")\n\nMissing values after replacement:\ndemographic.days_to_death: 4335 missing values\ndiagnoses.days_to_last_follow_up: 24 missing values\n\nTotal missing values across all columns: 4359\n\n\n\n\nCheck for consistent data types\n\n# Check column data types\n\nbrca_df.info()\n\n&lt;class 'pandas.core.frame.DataFrame'&gt;\nIndex: 4920 entries, 0 to 5545\nData columns (total 36 columns):\n #   Column                                  Non-Null Count  Dtype \n---  ------                                  --------------  ----- \n 0   project.project_id                      4920 non-null   object\n 1   cases.case_id                           4920 non-null   object\n 2   cases.disease_type                      4920 non-null   object\n 3   cases.index_date                        4920 non-null   object\n 4   cases.primary_site                      4920 non-null   object\n 5   cases.submitter_id                      4920 non-null   object\n 6   demographic.age_is_obfuscated           4920 non-null   object\n 7   demographic.days_to_death               585 non-null    object\n 8   demographic.ethnicity                   4920 non-null   object\n 9   demographic.gender                      4920 non-null   object\n 10  demographic.race                        4920 non-null   object\n 11  demographic.submitter_id                4920 non-null   object\n 12  demographic.vital_status                4920 non-null   object\n 13  diagnoses.age_at_diagnosis              4920 non-null   object\n 14  diagnoses.ajcc_pathologic_m             4920 non-null   object\n 15  diagnoses.ajcc_pathologic_n             4920 non-null   object\n 16  diagnoses.ajcc_pathologic_stage         4920 non-null   object\n 17  diagnoses.ajcc_pathologic_t             4920 non-null   object\n 18  diagnoses.classification_of_tumor       4920 non-null   object\n 19  diagnoses.days_to_diagnosis             4920 non-null   object\n 20  diagnoses.days_to_last_follow_up        4896 non-null   object\n 21  diagnoses.diagnosis_is_primary_disease  4920 non-null   object\n 22  diagnoses.laterality                    4920 non-null   object\n 23  diagnoses.method_of_diagnosis           4920 non-null   object\n 24  diagnoses.morphology                    4920 non-null   object\n 25  diagnoses.primary_diagnosis             4920 non-null   object\n 26  diagnoses.prior_malignancy              4920 non-null   object\n 27  diagnoses.prior_treatment               4920 non-null   object\n 28  diagnoses.site_of_resection_or_biopsy   4920 non-null   object\n 29  diagnoses.sites_of_involvement          4920 non-null   object\n 30  diagnoses.submitter_id                  4920 non-null   object\n 31  diagnoses.synchronous_malignancy        4920 non-null   object\n 32  diagnoses.tissue_or_organ_of_origin     4920 non-null   object\n 33  treatments.submitter_id                 4920 non-null   object\n 34  treatments.treatment_or_therapy         4920 non-null   object\n 35  treatments.treatment_type               4920 non-null   object\ndtypes: object(36)\nmemory usage: 1.5+ MB\n\n\n\n# Check the statistical summary of diagnoses.age_at_diagnosis\n\n# Convert to numeric \nbrca_df['diagnoses.age_at_diagnosis'] = pd.to_numeric(brca_df['diagnoses.age_at_diagnosis'], errors='coerce')\n\n# Statistical summary\nprint(\"Statistical Summary of Age at Diagnosis:\")\nprint(brca_df['diagnoses.age_at_diagnosis'].describe())\n\nprint(f\"\\nMean: {brca_df['diagnoses.age_at_diagnosis'].mean():.2f}\")\nprint(f\"Median: {brca_df['diagnoses.age_at_diagnosis'].median():.2f}\")\nprint(f\"Standard Deviation: {brca_df['diagnoses.age_at_diagnosis'].std():.2f}\")\nprint(f\"Missing values: {brca_df['diagnoses.age_at_diagnosis'].isna().sum()}\")\n\nStatistical Summary of Age at Diagnosis:\ncount     4920.000000\nmean     20899.613618\nstd       4578.709865\nmin       9706.000000\n25%      17561.500000\n50%      20708.500000\n75%      23699.750000\nmax      32872.000000\nName: diagnoses.age_at_diagnosis, dtype: float64\n\nMean: 20899.61\nMedian: 20708.50\nStandard Deviation: 4578.71\nMissing values: 0\n\n\nThe age at diagnosis column has been converted to numeric but the values are in days. For analysis we will convert these to years by dividing by 365.25 (accounting for leap years) and rounding down\n\n# Convert age at diagnosis from days to years (integer)\nbrca_df['diagnoses.age_at_diagnosis'] = (brca_df['diagnoses.age_at_diagnosis'] / 365.25).apply(np.floor)\n\n\n# Check the statistical summary of diagnoses.age_at_diagnosis\n\n# Convert to numeric \nbrca_df['diagnoses.age_at_diagnosis'] = pd.to_numeric(brca_df['diagnoses.age_at_diagnosis'], errors='coerce')\n\n# Statistical summary\nprint(\"Statistical Summary of Age at Diagnosis:\")\nprint(brca_df['diagnoses.age_at_diagnosis'].describe())\n\nprint(f\"\\nMean: {brca_df['diagnoses.age_at_diagnosis'].mean():.2f}\")\nprint(f\"Median: {brca_df['diagnoses.age_at_diagnosis'].median():.2f}\")\nprint(f\"Standard Deviation: {brca_df['diagnoses.age_at_diagnosis'].std():.2f}\")\nprint(f\"Missing values: {brca_df['diagnoses.age_at_diagnosis'].isna().sum()}\")\n\nStatistical Summary of Age at Diagnosis:\ncount    4920.000000\nmean       56.710569\nstd        12.529500\nmin        26.000000\n25%        48.000000\n50%        56.000000\n75%        64.000000\nmax        89.000000\nName: diagnoses.age_at_diagnosis, dtype: float64\n\nMean: 56.71\nMedian: 56.00\nStandard Deviation: 12.53\nMissing values: 0\n\n\n\n# Convert to integer\nbrca_df['diagnoses.age_at_diagnosis'] = pd.to_numeric(\n    brca_df['diagnoses.age_at_diagnosis'], \n    errors='coerce'\n)\nbrca_df['diagnoses.age_at_diagnosis'].dtype\n\ndtype('float64')\n\n\n\n# Change all object type columns to lowercase\nfor col in brca_df.select_dtypes(include=['object']).columns:\n    brca_df[col] = brca_df[col].astype(str).str.lower().replace('nan', np.nan)\n\n\n# strip whitespace from string columns\nfor col in brca_df.select_dtypes(include=['object']).columns:\n    brca_df[col] = brca_df[col].str.strip()\n\n\n# Change demographic.age_is_obfuscated to boolean\nbrca_df['demographic.age_is_obfuscated'] = brca_df['demographic.age_is_obfuscated'].map({'false': False, 'true': True})\n\n# Check the conversion\nprint(brca_df['demographic.age_is_obfuscated'].value_counts())\n\ndemographic.age_is_obfuscated\nFalse    4862\nTrue       58\nName: count, dtype: int64\n\n\n\n# Convert treatments.treatment_or_therapy to boolean from yes/no\nbrca_df['treatments.treatment_or_therapy'] = brca_df['treatments.treatment_or_therapy'].map({'yes': True, 'no': False}) \n# Check the conversion\nprint(brca_df['treatments.treatment_or_therapy'].value_counts())\n\ntreatments.treatment_or_therapy\nTrue     4289\nFalse     559\nName: count, dtype: int64\n\n\nChange other columns to boolean as appropriate: - diagnoses.diagnosis_is_primary_disease (from true/false strings) - diagnoses.prior_malignancy (from no/yes strings) - diagnoses.prior_treatment (from No/Yes strings) - diagnoses.synchronous_malignancy (from no/yes strings)\n\n# Convert diagnosis-related columns to boolean\n\n# Convert diagnoses.diagnosis_is_primary_disease (true/false to boolean)\nbrca_df['diagnoses.diagnosis_is_primary_disease'] = brca_df['diagnoses.diagnosis_is_primary_disease'].map({'true': True, 'false': False})\n\n# Convert diagnoses.prior_malignancy (yes/no to boolean)\nbrca_df['diagnoses.prior_malignancy'] = brca_df['diagnoses.prior_malignancy'].map({'yes': True, 'no': False})\n\n# Convert diagnoses.prior_treatment (yes/no to boolean)\nbrca_df['diagnoses.prior_treatment'] = brca_df['diagnoses.prior_treatment'].map({'yes': True, 'no': False})\n\n# Convert diagnoses.synchronous_malignancy (yes/no to boolean)\nbrca_df['diagnoses.synchronous_malignancy'] = brca_df['diagnoses.synchronous_malignancy'].map({'yes': True, 'no': False})\n\n# Check the conversions\nprint(\"Conversion results:\")\nprint(f\"diagnoses.diagnosis_is_primary_disease dtype: {brca_df['diagnoses.diagnosis_is_primary_disease'].dtype}\")\nprint(f\"diagnoses.prior_malignancy dtype: {brca_df['diagnoses.prior_malignancy'].dtype}\")\nprint(f\"diagnoses.prior_treatment dtype: {brca_df['diagnoses.prior_treatment'].dtype}\")\nprint(f\"diagnoses.synchronous_malignancy dtype: {brca_df['diagnoses.synchronous_malignancy'].dtype}\")\n\nprint(\"\\nValue counts for each column:\")\nfor col in ['diagnoses.diagnosis_is_primary_disease', 'diagnoses.prior_malignancy', \n           'diagnoses.prior_treatment', 'diagnoses.synchronous_malignancy']:\n    print(f\"\\n{col}:\")\n    print(brca_df[col].value_counts())\n\nConversion results:\ndiagnoses.diagnosis_is_primary_disease dtype: bool\ndiagnoses.prior_malignancy dtype: object\ndiagnoses.prior_treatment dtype: object\ndiagnoses.synchronous_malignancy dtype: object\n\nValue counts for each column:\n\ndiagnoses.diagnosis_is_primary_disease:\ndiagnoses.diagnosis_is_primary_disease\nTrue     4896\nFalse      24\nName: count, dtype: int64\n\ndiagnoses.prior_malignancy:\ndiagnoses.prior_malignancy\nFalse    4738\nTrue      133\nName: count, dtype: int64\n\ndiagnoses.prior_treatment:\ndiagnoses.prior_treatment\nFalse    4862\nTrue       48\nName: count, dtype: int64\n\ndiagnoses.synchronous_malignancy:\ndiagnoses.synchronous_malignancy\nFalse    4763\nTrue      108\nName: count, dtype: int64\n\n\n\n\nData Engineering\n\n# Percentage of missing values in each column\nmissing_percentages = brca_df.isnull().mean() * 100\nprint(\"\\nPercentage of missing values in each column:\")\nprint(missing_percentages)\n\n\nPercentage of missing values in each column:\nproject.project_id                         0.000000\ncases.case_id                              0.000000\ncases.disease_type                         0.000000\ncases.index_date                           0.000000\ncases.primary_site                         0.000000\ncases.submitter_id                         0.000000\ndemographic.age_is_obfuscated              0.000000\ndemographic.days_to_death                 88.109756\ndemographic.ethnicity                      0.000000\ndemographic.gender                         0.000000\ndemographic.race                           0.000000\ndemographic.submitter_id                   0.000000\ndemographic.vital_status                   0.000000\ndiagnoses.age_at_diagnosis                 0.000000\ndiagnoses.ajcc_pathologic_m                0.000000\ndiagnoses.ajcc_pathologic_n                0.000000\ndiagnoses.ajcc_pathologic_stage            0.000000\ndiagnoses.ajcc_pathologic_t                0.000000\ndiagnoses.classification_of_tumor          0.000000\ndiagnoses.days_to_diagnosis                0.000000\ndiagnoses.days_to_last_follow_up           0.487805\ndiagnoses.diagnosis_is_primary_disease     0.000000\ndiagnoses.laterality                       0.000000\ndiagnoses.method_of_diagnosis              0.000000\ndiagnoses.morphology                       0.000000\ndiagnoses.primary_diagnosis                0.000000\ndiagnoses.prior_malignancy                 0.995935\ndiagnoses.prior_treatment                  0.203252\ndiagnoses.site_of_resection_or_biopsy      0.000000\ndiagnoses.sites_of_involvement             0.000000\ndiagnoses.submitter_id                     0.000000\ndiagnoses.synchronous_malignancy           0.995935\ndiagnoses.tissue_or_organ_of_origin        0.000000\ntreatments.submitter_id                    0.000000\ntreatments.treatment_or_therapy            1.463415\ntreatments.treatment_type                  0.000000\ndtype: float64\n\n\n\n# Check percentage of missing values in days_to_death when vital_status is 'dead'\nmissing_death_percentage = brca_df[brca_df['demographic.vital_status'] == 'dead']['demographic.days_to_death'].isnull().mean()\nprint(f\"Percentage of missing values in 'demographic.days_to_death' when vital_status is 'dead': {missing_death_percentage:.2%}\")    \n\nPercentage of missing values in 'demographic.days_to_death' when vital_status is 'dead': 0.00%\n\n\n\n# Percentage of missing values in days_to_last_follow_up when vital_status is 'alive'\nmissing_followup_percentage = brca_df[brca_df['demographic.vital_status'] == 'alive']['diagnoses.days_to_last_follow_up'].isnull().mean()\nprint(f\"Percentage of missing values in 'diagnoses.days_to_last_follow_up' when vital_status is 'alive': {missing_followup_percentage:.2%}\")\n\nPercentage of missing values in 'diagnoses.days_to_last_follow_up' when vital_status is 'alive': 0.55%\n\n\n\n# Change days_to_last_follow_up to numeric\nbrca_df['diagnoses.days_to_last_follow_up'] = pd.to_numeric(\n    brca_df['diagnoses.days_to_last_follow_up'], \n    errors='coerce'\n)\n\n\n# Check distribution of days_to_last_follow_up\nbrca_df['diagnoses.days_to_last_follow_up'].describe()\n\ncount    4896.000000\nmean     1323.354575\nstd      1176.067445\nmin        -7.000000\n25%       525.000000\n50%       972.000000\n75%      1876.000000\nmax      8605.000000\nName: diagnoses.days_to_last_follow_up, dtype: float64\n\n\n\n# Replace days to last follow up values less than 0 to with mean\nbrca_df.loc[brca_df['diagnoses.days_to_last_follow_up'] &lt; 0, 'diagnoses.days_to_last_follow_up'] = np.nan\nmean_followup = brca_df['diagnoses.days_to_last_follow_up'].mean()\nbrca_df['diagnoses.days_to_last_follow_up'].fillna(mean_followup, inplace=True)\n\n\n# Create survival time column based on vital status\ndef calculate_survival_time(row):\n    if row['demographic.vital_status'] == 'dead':\n        return row['demographic.days_to_death']\n    elif row['demographic.vital_status'] == 'alive':\n        return row['diagnoses.days_to_last_follow_up']\n    else:\n        return np.nan\n    \nbrca_df['survival_time_days'] = brca_df.apply(calculate_survival_time, axis=1)\n\n\n# Check percentage of missing values in survival_time_days\nmissing_percentage = brca_df['survival_time_days'].isnull().mean() * 100\nprint(f\"Percentage of missing values in 'survival_time_days': {missing_percentage:.2f}%\")\n\nPercentage of missing values in 'survival_time_days': 0.00%\n\n\n\n# Drop rows with missing survival_time_days\nbrca_df = brca_df[brca_df['survival_time_days'].notna()]\nbrca_df.shape\n\n(4920, 37)\n\n\n\n# Drop duplicate rows before feature engineering\nbrca_df = brca_df.drop_duplicates()\nbrca_df.shape\n\n(4920, 37)\n\n\n\n# Extract diagnoses.behavior from diagnoses.morphology column (e.g., 8500/3 -&gt; 3 where 3 is the behavior code)\n\n# Mappings for behavior codes\nbehavior_mapping = {\n    '0': 'benign',\n    '2': 'in situ',\n    '3': 'malignant'\n}\n# Extract behavior code and map to descriptive labels\nbrca_df['diagnoses.behavior'] = brca_df['diagnoses.morphology'].str.split('/').str[1].map(behavior_mapping)\n# Check the new column\nprint(\"Value counts for diagnoses.behavior:\")\nprint(brca_df['diagnoses.behavior'].value_counts())\n\nValue counts for diagnoses.behavior:\ndiagnoses.behavior\nmalignant    4905\nin situ         6\nName: count, dtype: int64\n\n\nNote: There is a heavy class imbalance for diagnoses.behavior as over 95% of the entries are malignant.\n\nbrca_df.head()\n\n\n\n\n\n\n\n\nproject.project_id\ncases.case_id\ncases.disease_type\ncases.index_date\ncases.primary_site\ncases.submitter_id\ndemographic.age_is_obfuscated\ndemographic.days_to_death\ndemographic.ethnicity\ndemographic.gender\ndemographic.race\ndemographic.submitter_id\ndemographic.vital_status\ndiagnoses.age_at_diagnosis\ndiagnoses.ajcc_pathologic_m\ndiagnoses.ajcc_pathologic_n\ndiagnoses.ajcc_pathologic_stage\ndiagnoses.ajcc_pathologic_t\ndiagnoses.classification_of_tumor\ndiagnoses.days_to_diagnosis\ndiagnoses.days_to_last_follow_up\ndiagnoses.diagnosis_is_primary_disease\ndiagnoses.laterality\ndiagnoses.method_of_diagnosis\ndiagnoses.morphology\ndiagnoses.primary_diagnosis\ndiagnoses.prior_malignancy\ndiagnoses.prior_treatment\ndiagnoses.site_of_resection_or_biopsy\ndiagnoses.sites_of_involvement\ndiagnoses.submitter_id\ndiagnoses.synchronous_malignancy\ndiagnoses.tissue_or_organ_of_origin\ntreatments.submitter_id\ntreatments.treatment_or_therapy\ntreatments.treatment_type\nsurvival_time_days\ndiagnoses.behavior\n\n\n\n\n0\ntcga-brca\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nductal and lobular neoplasms\ndiagnosis\nbreast\ntcga-e2-a1iu\nFalse\nNaN\nnot hispanic or latino\nfemale\nwhite\ntcga-e2-a1iu_demographic\nalive\n60.0\nm0\nn0 (mol+)\nstage ia\nt1c\nprimary\n0\n337.0\nTrue\nright\nsurgical resection\n8500/3\ninfiltrating duct carcinoma, nos\nFalse\nFalse\nbreast, nos\nbreast, right upper outer\ntcga-e2-a1iu_diagnosis\nFalse\nbreast, nos\ntcga-e2-a1iu_treatment2\nFalse\nradiation therapy, nos\n337.0\nmalignant\n\n\n1\ntcga-brca\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nductal and lobular neoplasms\ndiagnosis\nbreast\ntcga-e2-a1iu\nFalse\nNaN\nnot hispanic or latino\nfemale\nwhite\ntcga-e2-a1iu_demographic\nalive\n60.0\nm0\nn0 (mol+)\nstage ia\nt1c\nprimary\n0\n337.0\nTrue\nright\nsurgical resection\n8500/3\ninfiltrating duct carcinoma, nos\nFalse\nFalse\nbreast, nos\nbreast, right upper outer\ntcga-e2-a1iu_diagnosis\nFalse\nbreast, nos\ntcga-e2-a1iu_treatment\nTrue\nhormone therapy\n337.0\nmalignant\n\n\n2\ntcga-brca\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nductal and lobular neoplasms\ndiagnosis\nbreast\ntcga-e2-a1iu\nFalse\nNaN\nnot hispanic or latino\nfemale\nwhite\ntcga-e2-a1iu_demographic\nalive\n60.0\nm0\nn0 (mol+)\nstage ia\nt1c\nprimary\n0\n337.0\nTrue\nright\nsurgical resection\n8500/3\ninfiltrating duct carcinoma, nos\nFalse\nFalse\nbreast, nos\nbreast, right upper outer\ntcga-e2-a1iu_diagnosis\nFalse\nbreast, nos\ntcga-e2-a1iu_treatment3\nTrue\nsurgery, nos\n337.0\nmalignant\n\n\n3\ntcga-brca\n0045349c-69d9-4306-a403-c9c1fa836644\nadenomas and adenocarcinomas\ndiagnosis\nbreast\ntcga-a1-a0sb\nFalse\nNaN\nnot hispanic or latino\nfemale\nwhite\ntcga-a1-a0sb_demographic\nalive\n70.0\nm0\nn0\nstage i\nt1c\nprimary\n0\n259.0\nTrue\nleft\nfine needle aspiration\n8200/3\nadenoid cystic carcinoma\nFalse\nFalse\nbreast, nos\nbreast, nos\ntcga-a1-a0sb_diagnosis\nFalse\nbreast, nos\ntcga-a1-a0sb_treatment\nTrue\nsurgery, nos\n259.0\nmalignant\n\n\n4\ntcga-brca\n00807dae-9f4a-4fd1-aac2-82eb11bf2afb\nadnexal and skin appendage neoplasms\ndiagnosis\nbreast\ntcga-a2-a04w\nFalse\nNaN\nnot hispanic or latino\nfemale\nwhite\ntcga-a2-a04w_demographic\nalive\n50.0\nm0\nn1mi\nstage iib\nt2\nprimary\n0\n3102.0\nTrue\nright\ncore biopsy\n8401/3\napocrine adenocarcinoma\nFalse\nFalse\nbreast, nos\nbreast, right upper outer\ntcga-a2-a04w_diagnosis\nFalse\nbreast, nos\ntcga-a2-a04w_treatment5\nTrue\nbisphosphonate therapy\n3102.0\nmalignant\n\n\n\n\n\n\n\n\n# Check distribution of missing values in columns after cleaning and data engineering\nmissing_percentages = brca_df.isnull().mean() * 100\nprint(\"\\nPercentage of missing values in each column:\")\nprint(missing_percentages)\n\n\nPercentage of missing values in each column:\nproject.project_id                         0.000000\ncases.case_id                              0.000000\ncases.disease_type                         0.000000\ncases.index_date                           0.000000\ncases.primary_site                         0.000000\ncases.submitter_id                         0.000000\ndemographic.age_is_obfuscated              0.000000\ndemographic.days_to_death                 88.109756\ndemographic.ethnicity                      0.000000\ndemographic.gender                         0.000000\ndemographic.race                           0.000000\ndemographic.submitter_id                   0.000000\ndemographic.vital_status                   0.000000\ndiagnoses.age_at_diagnosis                 0.000000\ndiagnoses.ajcc_pathologic_m                0.000000\ndiagnoses.ajcc_pathologic_n                0.000000\ndiagnoses.ajcc_pathologic_stage            0.000000\ndiagnoses.ajcc_pathologic_t                0.000000\ndiagnoses.classification_of_tumor          0.000000\ndiagnoses.days_to_diagnosis                0.000000\ndiagnoses.days_to_last_follow_up           0.000000\ndiagnoses.diagnosis_is_primary_disease     0.000000\ndiagnoses.laterality                       0.000000\ndiagnoses.method_of_diagnosis              0.000000\ndiagnoses.morphology                       0.000000\ndiagnoses.primary_diagnosis                0.000000\ndiagnoses.prior_malignancy                 0.995935\ndiagnoses.prior_treatment                  0.203252\ndiagnoses.site_of_resection_or_biopsy      0.000000\ndiagnoses.sites_of_involvement             0.000000\ndiagnoses.submitter_id                     0.000000\ndiagnoses.synchronous_malignancy           0.995935\ndiagnoses.tissue_or_organ_of_origin        0.000000\ntreatments.submitter_id                    0.000000\ntreatments.treatment_or_therapy            1.463415\ntreatments.treatment_type                  0.000000\nsurvival_time_days                         0.000000\ndiagnoses.behavior                         0.182927\ndtype: float64\n\n\n\n# Replace missing values in diagnoses.prior_malignancy, diagnoses.prior_treatment, diagnoses.synchronous_malignancy with False, treatments.treat_or_therapy with True\nbrca_df['diagnoses.prior_malignancy'] = brca_df['diagnoses.prior_malignancy'].fillna(False)\nbrca_df['diagnoses.prior_treatment'] = brca_df['diagnoses.prior_treatment'].fillna(False)\nbrca_df['diagnoses.synchronous_malignancy'] = brca_df['diagnoses.synchronous_malignancy'].fillna(False)\nbrca_df['treatments.treatment_or_therapy'] = brca_df['treatments.treatment_or_therapy'].fillna(True)\n\n\n\nSave processed dataset\n\n# Save cleaned dataset to a new TSV file\nbrca_df.to_csv(\"../../data/processed-data/brca/brca-clinical-processed.tsv\", sep=\"\\t\", index=False)"
  },
  {
    "objectID": "technical-details/llm-usage-log.html",
    "href": "technical-details/llm-usage-log.html",
    "title": "LLM usage log",
    "section": "",
    "text": "This section documents the use of a large language model (LLM) to assist with various aspects of the project workflow, primarily focused on streamlining writing, formatting, and clarifying analytical decisions. The LLM was leveraged selectively to enhance efficiency, ensure clarity in markdown formatting, and help synthesize modeling findings, exploratory data analysis summaries, and references.\n\nScope of LLM Assistance\n\nWriting Assistance: Helped restructure paragraphs for clarity and conciseness, particularly for EDA summaries and modeling interpretations. Suggestions were adapted and edited, ensuring that scientific accuracy and context-specific interpretations were maintained.\n\nFormatting and Markdown Support: Provided guidance on Quarto markdown syntax, including embedding images, linking pages, creating tables, and configuring YAML front matter. All formatting decisions were verified before committing to the repository.\n\nCitation Management: Assisted in generating BibTeX entries for references cited in the report. Entries were cross-checked for accuracy and completeness.\n\nCode Snippet Guidance: Suggested minor code snippets for data inspection, table previews, and feature selection summaries. All code was tested and modified for compatibility with the project environment.\n\n\n\nLimitations of LLM Assistance\n\nThe LLM did not perform any data analysis, statistical modeling, or code execution. All analytical results—including preprocessing, EDA, feature engineering, and supervised learning—were conducted independently by the author.\n\nInterpretations, conclusions, and contextual understanding of the data were fully curated and verified by the project team. The LLM’s suggestions were strictly advisory and required human validation.\n\nDomain-specific nuances, such as cancer staging interpretations and survival analysis decisions, were not inferred solely from the LLM. They were referenced official sources (GDC documentation, peer-reviewed literature) for all domain-critical decisions.\n\n\n\nSummary\nThe LLM served as a supporting tool for enhancing writing clarity, formatting, and documentation efficiency. Its role was complementary rather than substantive: all analytical reasoning, model selection, and data interpretation were performed independently. This approach ensures transparency, reproducibility, and adherence to rigorous scientific standards."
  },
  {
    "objectID": "report/report.html",
    "href": "report/report.html",
    "title": "Understanding Cancer Outcomes: Breast vs. Cervical",
    "section": "",
    "text": "Our study examines breast and cervical cancer data from the Cancer Genome Atlas (TCGA) using records from over 1200 patients. Our goal is to identify factors related to survival and explore if any distinct patient groups emerge from the available clinical and demographic data. Throughout the study, we came across several key findings. Overall, breast cancer patients had a higher mortality rate than cervical cancer patients, with 14% versus 7% mortality rates. When analyzing patients that died, cervical cancer patients tend to die much sooner than breast cancer patients. The most influential factors were age at diagnosis and treatment characteristics, with early stage diagnosis significantly associated with longer survival for both cancer types.\n\n\nAfter cleaning and de-duplicating the TCGA dataset, our final dataset contained 1081 breast cancer patients and 184 cervical cancer patients, with average ages of 58 and 47 years, and average survival times of 3.6 and 2.8 years, respectively. The variables we considered were age at diagnosis, cancer stage, treatment information, and vital status. We analyzed survival outcomes after clustering but did not use vital status to create patient groups.\n\n\n\n\n\n\n\n\nAge at Diagnosis Distribution BRCA\n\n\n\n\n\n\nAge at Diagnosis Distribution CESC\n\n\n\n\nThe average breast cancer patient in our study is 56 years old, with 70% white and approximately 20% Black/African-American patients. 85% of the patients were alive at their last checkup and had received treatment. Most tumors in our breast cancer group were discovered at stage two, because early stage breast cancer does not present any symptoms, and late-stage cancers are typically more severe. Compared to our breast cancer patients, the cervical cancer patients had a younger average age of 47 years. Most were diagnosed at stage one, indicating the efficacy of cervical cancer screening programs such as Pap smears. In our cervical cancer group, 93% of patients were still alive at the follow-up.\n\n\n\n\n\n\n\n\nSurvival Time by Stage\n\n\n\n\n\n\nSurvival Time by Treatment Type\n\n\n\n\nThe most surprising discovery we made was that breast cancer had a twofold higher mortality rate than cervical cancer, but cervical cancer patients who did die died much sooner after diagnosis. After diagnosis, breast cancer patients lived an average of 4.3 years, while cervical cancer patients lived an average of 1.8 years, demonstrating that cervical cancer can be life-threatening when it is aggressive. Older breast cancer patients have shorter survival times, while older cervical cancer patients appear to survive longer. Regardless of cancer type, patients diagnosed at stage one lived longer than those diagnosed at later stages, with a particularly large difference in survival time between stage one and stage three. Breast cancer patients under the age of 70 who received treatment had a higher survival rate, whereas breast cancer patients over the age of 70 had similar outcomes regardless of whether they received treatment. This highlights the importance of regular cancer screenings such as mammograms and Pap smears. Immunotherapy produced the best results for breast cancer patients, followed by chemotherapy. Radiation combination therapy produced the best results for cervical cancer patients.\n\n\n\n\n\n\n\nSurvival Time by Cluster\n\n\n\nOur study used machine learning models to predict how long patients would live based on the clinical information we had. Our best model predicted survival times that were within two years of the actual outcomes. Because the outcomes of these cancers are highly variable, some patients live for many years while others live for much shorter periods of time, the model captures broad patterns but cannot predict precisely at an individual level. There were four important factors for predicting survival: age at diagnosis, cancer stage, number of treatments, and treatment type. Younger patients had better outcomes, earlier cancer stage meant longer survival, more treatments correlated with different outcomes, and specific therapies produced better results. We also investigated whether smoking affected cervical cancer outcomes, but could not draw conclusions about the effects on survival. The majority of our patients reported that they did not smoke.\nWe combined our data to see if there were any clustering patterns, and our analysis identified three groups of patients: group one had 100% breast cancer patients with a 14.7% mortality rate and an average survival of 3.7 years; group two had 100% breast cancer patients with a 12.3% mortality rate and an average survival of 2.8 years; and group three had cervical cancer patients with a 7.1% mortality rate and an average survival of three years. These cluster groups reflect cancer types, which makes clinical sense, demonstrating that breast and cervical cancer require different approaches and treatments."
  },
  {
    "objectID": "report/report.html#executive-summary",
    "href": "report/report.html#executive-summary",
    "title": "Understanding Cancer Outcomes: Breast vs. Cervical",
    "section": "",
    "text": "Our study examines breast and cervical cancer data from the Cancer Genome Atlas (TCGA) using records from over 1200 patients. Our goal is to identify factors related to survival and explore if any distinct patient groups emerge from the available clinical and demographic data. Throughout the study, we came across several key findings. Overall, breast cancer patients had a higher mortality rate than cervical cancer patients, with 14% versus 7% mortality rates. When analyzing patients that died, cervical cancer patients tend to die much sooner than breast cancer patients. The most influential factors were age at diagnosis and treatment characteristics, with early stage diagnosis significantly associated with longer survival for both cancer types.\n\n\nAfter cleaning and de-duplicating the TCGA dataset, our final dataset contained 1081 breast cancer patients and 184 cervical cancer patients, with average ages of 58 and 47 years, and average survival times of 3.6 and 2.8 years, respectively. The variables we considered were age at diagnosis, cancer stage, treatment information, and vital status. We analyzed survival outcomes after clustering but did not use vital status to create patient groups.\n\n\n\n\n\n\n\n\nAge at Diagnosis Distribution BRCA\n\n\n\n\n\n\nAge at Diagnosis Distribution CESC\n\n\n\n\nThe average breast cancer patient in our study is 56 years old, with 70% white and approximately 20% Black/African-American patients. 85% of the patients were alive at their last checkup and had received treatment. Most tumors in our breast cancer group were discovered at stage two, because early stage breast cancer does not present any symptoms, and late-stage cancers are typically more severe. Compared to our breast cancer patients, the cervical cancer patients had a younger average age of 47 years. Most were diagnosed at stage one, indicating the efficacy of cervical cancer screening programs such as Pap smears. In our cervical cancer group, 93% of patients were still alive at the follow-up.\n\n\n\n\n\n\n\n\nSurvival Time by Stage\n\n\n\n\n\n\nSurvival Time by Treatment Type\n\n\n\n\nThe most surprising discovery we made was that breast cancer had a twofold higher mortality rate than cervical cancer, but cervical cancer patients who did die died much sooner after diagnosis. After diagnosis, breast cancer patients lived an average of 4.3 years, while cervical cancer patients lived an average of 1.8 years, demonstrating that cervical cancer can be life-threatening when it is aggressive. Older breast cancer patients have shorter survival times, while older cervical cancer patients appear to survive longer. Regardless of cancer type, patients diagnosed at stage one lived longer than those diagnosed at later stages, with a particularly large difference in survival time between stage one and stage three. Breast cancer patients under the age of 70 who received treatment had a higher survival rate, whereas breast cancer patients over the age of 70 had similar outcomes regardless of whether they received treatment. This highlights the importance of regular cancer screenings such as mammograms and Pap smears. Immunotherapy produced the best results for breast cancer patients, followed by chemotherapy. Radiation combination therapy produced the best results for cervical cancer patients.\n\n\n\n\n\n\n\nSurvival Time by Cluster\n\n\n\nOur study used machine learning models to predict how long patients would live based on the clinical information we had. Our best model predicted survival times that were within two years of the actual outcomes. Because the outcomes of these cancers are highly variable, some patients live for many years while others live for much shorter periods of time, the model captures broad patterns but cannot predict precisely at an individual level. There were four important factors for predicting survival: age at diagnosis, cancer stage, number of treatments, and treatment type. Younger patients had better outcomes, earlier cancer stage meant longer survival, more treatments correlated with different outcomes, and specific therapies produced better results. We also investigated whether smoking affected cervical cancer outcomes, but could not draw conclusions about the effects on survival. The majority of our patients reported that they did not smoke.\nWe combined our data to see if there were any clustering patterns, and our analysis identified three groups of patients: group one had 100% breast cancer patients with a 14.7% mortality rate and an average survival of 3.7 years; group two had 100% breast cancer patients with a 12.3% mortality rate and an average survival of 2.8 years; and group three had cervical cancer patients with a 7.1% mortality rate and an average survival of three years. These cluster groups reflect cancer types, which makes clinical sense, demonstrating that breast and cervical cancer require different approaches and treatments."
  },
  {
    "objectID": "report/report.html#model-results",
    "href": "report/report.html#model-results",
    "title": "Understanding Cancer Outcomes: Breast vs. Cervical",
    "section": "Model Results",
    "text": "Model Results\nWe evaluated three distinct machine learning approaches for predicting cancer patient survival times across both breast cancer (BRCA) and cervical cancer (CESC) datasets:\n\nBreast Cancer (BRCA) Results\n======================================================================\n                    FINAL MODEL COMPARISON\n======================================================================\n\n                     Model          MAE         RMSE            R²\nStandard Linear Regression 7.691527e+12 6.158508e+13 -2.406669e+21\n  Parametric Curve Fitting 1.288540e+03 1.798930e+03 -1.053500e+00\n   Random Forest Regressor 7.924000e+02 1.156060e+03  1.519000e-01\n\n======================================================================\nBEST MODEL: Random Forest Regressor\n   Achieved lowest MAE of 792.4 days\n======================================================================\nBest Hyperparameters for Random Forest (BRCA):\n\nn_estimators: 300\nmax_depth: None\nmin_samples_split: 5\nmin_samples_leaf: 1\nmax_features: 0.3\nbootstrap: True\nBest Cross-Validation MAE: 755.05\nOut-of-Bag Score (R²): 0.1786\n\n\n\nCervical Cancer (CESC) Results\n======================================================================\n                    FINAL MODEL COMPARISON\n======================================================================\n\n                     Model    MAE    RMSE      R²\nStandard Linear Regression 960.32 1268.35 -0.8628\n  Parametric Curve Fitting 887.97 1285.33 -0.9130\n   Random Forest Regressor 730.73  921.17  0.0174\n\n======================================================================\nBEST MODEL: Random Forest Regressor\n   Achieved lowest MAE of 730.73 days\n======================================================================\nBest Hyperparameters for Random Forest (CESC):\n\nn_estimators: 500\nmax_depth: 10\nmin_samples_split: 2\nmin_samples_leaf: 2\nmax_features: log2\nbootstrap: True\nBest Cross-Validation MAE: 709.13\nOut-of-Bag Score (R²): 0.0970\n\n\n\nModel Performance Analysis\nRandom Forest consistently emerged as the superior model for both cancer types, achieving the lowest Mean Absolute Error (MAE) in both cases. This success can be attributed to several key factors:\n\nNon-linear Relationship Capture: Cancer survival involves complex, non-linear interactions between clinical variables that Random Forest effectively models through its ensemble of decision trees.\nRobust Feature Handling: The algorithm naturally handles mixed data types (categorical staging variables, continuous age/treatment counts) without extensive preprocessing requirements.\nOverfitting Resistance: The ensemble approach and bootstrap sampling provide built-in regularization, preventing overfitting to training data patterns.\nFeature Importance: Random Forest provides interpretable feature importance scores, crucial for clinical applications where understanding driving factors is essential.\n\nThe Standard Linear Regression showed severe overfitting in the BRCA dataset (extremely high MAE and negative R²), while Parametric Curve Fitting with Lasso regularization performed moderately but still struggled with the complex, non-linear nature of cancer survival patterns."
  },
  {
    "objectID": "report/report.html#discussion",
    "href": "report/report.html#discussion",
    "title": "Understanding Cancer Outcomes: Breast vs. Cervical",
    "section": "Discussion",
    "text": "Discussion\n\n\n\n\n\nFeature Importance for BRCA Survival Time Prediction\n\n\n\n\n\n\nFeature Importance for CESC Survival Time Prediction\n\n\n\n\nOur Random Forest models revealed distinct but complementary patterns in feature importance across cancer types, with age at diagnosis consistently emerging as a top predictor for both BRCA and CESC cohorts, reflecting well-established clinical evidence linking advanced age to poorer outcomes due to comorbidity burden and aggressive tumor biology. In breast cancer, the model identified treatment counts and comprehensive tumor staging variables (T, N, M, overall stage) as critical predictors, with spatial descriptors and treatment modalities (radiation, pharmaceutical therapy) collectively explaining over 60% of predictive power, suggesting that survival is dominated by disease extent and treatment intensity. Cervical cancer analysis revealed FIGO staging as the overwhelmingly dominant predictor, consistent with its central role in clinical decision-making, while age, treatment counts, and demographic variables (including race) comprised secondary but important factors, with the top ten features accounting for over 68% of model importance—indicating more concentrated predictive factors than in breast cancer. Notably, despite tobacco exposure being a known cervical cancer risk factor, smoking-related variables did not appear among top predictors, likely due to dataset limitations including predominant non-smoker representation and potential underreporting, highlighting the critical role of data completeness in model performance and clinical interpretation.\nThese results reinforce why cervical cancer screening is recommended to start earlier at age 21 compared to breast cancer (after 30 for high risk individuals)1 2 . However, cervical cancer prevention efforts receive less public visibility than breast cancer campaigns and tying the campaigns together could help catch cervical cancer earlier in the population3 . This could improve survival time as the tumor stage is the dominant predictor for cervical cancer in our findings and cervical cancer has a lower survival rate of 66% compared to that of breast cancer (90%)4 ."
  },
  {
    "objectID": "report/report.html#future-improvements",
    "href": "report/report.html#future-improvements",
    "title": "Understanding Cancer Outcomes: Breast vs. Cervical",
    "section": "Future Improvements",
    "text": "Future Improvements\nSeveral technical enhancements could significantly improve our cancer survival prediction models:\n\nData Enhancement\n\nMulti-modal Integration: Incorporate genomic data, imaging features, and proteomics to create a more comprehensive patient profile\nTemporal Modeling: Include longitudinal treatment response data and biomarker changes over time\nExternal Validation: Test models on independent datasets from different institutions to assess generalizability\n\n\n\nAdvanced Modeling Techniques\n\nDeep Learning Approaches: Implement neural networks specifically designed for survival analysis (DeepSurv, DeepHit)\nEnsemble Methods: Combine multiple algorithms using stacking or voting approaches for improved robustness\nSurvival-Specific Models: Utilize Cox Proportional Hazards models or accelerated failure time models designed for time-to-event data\n\n\n\nFeature Engineering\n\nInteraction Terms: Systematically explore clinically meaningful feature interactions (e.g., stage × treatment combinations)\nDerived Biomarkers: Create composite scores from multiple clinical variables\nTime-Varying Covariates: Model how patient characteristics change during treatment\n\n\n\nModel Optimization\n\nHyperparameter Optimization: Implement Bayesian optimization or genetic algorithms for more efficient parameter tuning\nCross-Validation Strategy: Use stratified or time-series cross-validation appropriate for clinical data\nUncertainty Quantification: Implement confidence intervals and prediction uncertainty estimates for clinical decision support\n\n\n\nClinical Integration\n\nInterpretability Tools: Develop SHAP (SHapley Additive exPlanations) or LIME explanations for individual patient predictions\nRisk Stratification: Create clinically meaningful risk categories rather than continuous predictions\nReal-time Deployment: Build APIs for integration into electronic health record systems\n\n\n\nEvaluation Metrics\n\nClinical Relevance: Include clinically meaningful metrics like concordance index (C-index) for survival models\nSubgroup Analysis: Evaluate model performance across demographic and clinical subgroups to assess fairness\nCalibration Assessment: Ensure predicted survival probabilities match observed outcomes across risk levels"
  },
  {
    "objectID": "report/report.html#conclusion",
    "href": "report/report.html#conclusion",
    "title": "Understanding Cancer Outcomes: Breast vs. Cervical",
    "section": "Conclusion",
    "text": "Conclusion\nOur analysis revealed significant patterns in cervical cancer outcomes, and while these two cancers affect women. Their behavior is quite different in general breast. Cancer may be more fatal, but cervical cancer may be rapidly aggressive when it becomes life-threatening. Our data consistently points to one message: early detection saves lives. This includes her patience receiving regular screenings, understanding your stage, and thoroughly discussing treatment options with healthcare providers. This means that patients with cervical cancer who demonstrate signs of progression may require more aggressive monitoring. Age plays an important role in treatment decisions, and comprehensive data collection, particularly around lifecycle factors, would improve the ability to understand and predict outcomes."
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Understanding Cancer Outcomes: Breast vs. Cervical",
    "section": "",
    "text": "Our project investigates survival patterns in breast cancer and cervical cancer using data from The Cancer Genome Atlas. Cancer patients with the same diagnosis expirence different outcomes based on several factors whether it is treatment recieved, age, cancer stage and other clinical factors. Understanding these patterns will assist in improving patient care and personalizing medicines. Our analysis combines unsupervised learning and supervised learning to identify patient subgroups, predict survival time, and identify top important prognotic factors.\nKey Questions: - What distinct patient subgroups exist within breast and cervical cancer? - How do mortality patterns differ between these cancers, and why? - Which clinical features most strongly predict survival outcomes? - What are the key prognostic factors for each cancer type?"
  },
  {
    "objectID": "index.html#about-the-project",
    "href": "index.html#about-the-project",
    "title": "Understanding Cancer Outcomes: Breast vs. Cervical",
    "section": "",
    "text": "Our project investigates survival patterns in breast cancer and cervical cancer using data from The Cancer Genome Atlas. Cancer patients with the same diagnosis expirence different outcomes based on several factors whether it is treatment recieved, age, cancer stage and other clinical factors. Understanding these patterns will assist in improving patient care and personalizing medicines. Our analysis combines unsupervised learning and supervised learning to identify patient subgroups, predict survival time, and identify top important prognotic factors.\nKey Questions: - What distinct patient subgroups exist within breast and cervical cancer? - How do mortality patterns differ between these cancers, and why? - Which clinical features most strongly predict survival outcomes? - What are the key prognostic factors for each cancer type?"
  },
  {
    "objectID": "index.html#literature-review",
    "href": "index.html#literature-review",
    "title": "Understanding Cancer Outcomes: Breast vs. Cervical",
    "section": "Literature Review",
    "text": "Literature Review\nTo better understand survival patterns in breast cancer (BRCA) and cervical cancer (CESC), multiple intersecting factors should be investigated. The Cancer Genome Atlas (TCGA) has revealed that even with the same diagnosis, different cancer subtypes exist. Known clinical features that predict survival include stage at diagnosis, age, and treatment type, but these may not be equally important for cervical versus breast cancer.\nResearch on cervical cancer discovered patterns that predict treatment response while, breast cancer research has categorized patients based on hormone receptors and genetic characteristics. These cancers also differ in their key predictive factors: cervical cancer outcomes are heavily influenced by HPV status, cell type, and early detection via pap smears, while breast cancer outcomes are influenced by hormone receptor status and HER2 amplification. Treatment approaches also differ substantially, with breast cancer benefiting more from targeted therapies and cervical cancer relying more on radiation and surgery.\nGiven these complex differences, machine learning offers powerful analytical tools. Unsupervised learning methods have shown to identify patient subgroups by revealing cluster structures in clinical and demographic data. Random Forest models excel at predicting survival and comparing feature importance across cancers. Our study combines both unsupervised and supervised approaches, providing a comprehensive framework for understanding what determines survival in cancer patients."
  },
  {
    "objectID": "index.html#about-us",
    "href": "index.html#about-us",
    "title": "Understanding Cancer Outcomes: Breast vs. Cervical",
    "section": "About Us",
    "text": "About Us\n\n\n\nMunashe Mhlanga\n\n\nMunashe Mhlanga\nMS Data Science & Analytics, Georgetown University\nLinkedIn\n\n\n\n\nBetsiet Delelegn\n\n\nBetsiet Delelegn\nMS Data Science & Analytics, Georgetown University\nLinkedIn"
  },
  {
    "objectID": "index.html#additional-resources",
    "href": "index.html#additional-resources",
    "title": "Understanding Cancer Outcomes: Breast vs. Cervical",
    "section": "Additional Resources",
    "text": "Additional Resources\nPlease find additional resources on womens health below:\n\nPodcast: Women’s Health\nWomen’s Health Podcast\nA wide-ranging podcast covering women’s health topics including hormonal health, aging, disease prevention, and overall wellbeing.\nWomen’s Health Podcast\n\n\nYouTube Channel: Cleveland Clinic\nSpeaking of Women’s Health (Cleveland Clinic)\nExpert-led video discussions focused on women’s wellness, preventive care, and clinical health topics.\nSpeaking of Women’s Health – YouTube\n\n\nBlog / Reading Resource\nSpeaking of Women’s Health – Cleveland Clinic\nAn evidence-based blog and educational resource with articles on gynecology, cancer screening, menopause, and general women’s health.\nSpeaking of Women’s Health – Articles\n\n\nLearn More About Care\nGeorgetown Lombardi Comprehensive Cancer Center – Breast Cancer Care\nClinical information, diagnostic pathways, and patient-centered breast cancer care resources.\nGet Diagnosed or Learn More About Breast Cancer Care\n\n\nDonation\nPlease consider donating to CancerServe, a voluntary organization that focuses on education, community mobilisation, and assistance for disadvantaged patients in Zimbabwe."
  },
  {
    "objectID": "technical-details/data-cleaning/overview.html",
    "href": "technical-details/data-cleaning/overview.html",
    "title": "Overview",
    "section": "",
    "text": "Our data cleaning methods were comparable for both the cervical (cesc) and breast (brca) cancer datasets due to the dataset having similar columns due to both diseases being cancer. The clinical breast cancer dataset originally has 5546 rows and 210 columns representing 1098 patients. The clinical cervical cancer dataset originally has 1535 rows and 210 columns representing 307 patients.\nOur data cleaning was focused on three key areas:\nVisualizations below will be centered on the brca dataset due to the larger number of samples. However, the similar process for cleaning the cesc dataset can be found here along with the data cleaning code for the brca dataset."
  },
  {
    "objectID": "technical-details/data-cleaning/overview.html#managing-missing-data",
    "href": "technical-details/data-cleaning/overview.html#managing-missing-data",
    "title": "Overview",
    "section": "Managing Missing Data:",
    "text": "Managing Missing Data:\n\n\n\n\n\n\nRows showing a unique patient (cases.submitter_id) and their different treatments for breast cancer\n\n\n\nproject.project_id\ncases.case_id\ncases.consent_type\ncases.days_to_consent\ncases.days_to_lost_to_followup\ncases.disease_type\ncases.index_date\ncases.lost_to_followup\ncases.primary_site\ncases.submitter_id\n...\ntreatments.treatment_duration\ntreatments.treatment_effect\ntreatments.treatment_effect_indicator\ntreatments.treatment_frequency\ntreatments.treatment_id\ntreatments.treatment_intent_type\ntreatments.treatment_or_therapy\ntreatments.treatment_outcome\ntreatments.treatment_outcome_duration\ntreatments.treatment_type\n\n\n\n\n0\nTCGA-BRCA\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nInformed Consent\n-34\n'--\nDuctal and Lobular Neoplasms\nDiagnosis\n'--\nBreast\nTCGA-E2-A1IU\n...\n'--\n'--\n'--\n'--\n1b884f21-eb24-467f-aba2-208af17070b9\nAdjuvant\nno\n'--\n'--\nRadiation Therapy, NOS\n\n\n1\nTCGA-BRCA\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nInformed Consent\n-34\n'--\nDuctal and Lobular Neoplasms\nDiagnosis\n'--\nBreast\nTCGA-E2-A1IU\n...\n'--\n'--\n'--\n'--\n27868bc3-23c8-5e85-a0e2-314e6cdf9b2a\nAdjuvant\nyes\nTreatment Ongoing\n'--\nHormone Therapy\n\n\n2\nTCGA-BRCA\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nInformed Consent\n-34\n'--\nDuctal and Lobular Neoplasms\nDiagnosis\n'--\nBreast\nTCGA-E2-A1IU\n...\n'--\n'--\n'--\n'--\naedf144c-6b7b-4d76-a3cb-4271aef10f1d\nFirst-Line Therapy\nyes\n'--\n'--\nSurgery, NOS\n\n\n3\nTCGA-BRCA\n0045349c-69d9-4306-a403-c9c1fa836644\nInformed Consent\n76\n'--\nAdenomas and Adenocarcinomas\nDiagnosis\n'--\nBreast\nTCGA-A1-A0SB\n...\n'--\n'--\n'--\n'--\n0a534cae-de91-5e77-a3e7-b52d46bd3966\nFirst-Line Therapy\nyes\n'--\n'--\nSurgery, NOS\n\n\n4\nTCGA-BRCA\n00807dae-9f4a-4fd1-aac2-82eb11bf2afb\nInformed Consent\n19\n'--\nAdnexal and Skin Appendage Neoplasms\nDiagnosis\nNo\nBreast\nTCGA-A2-A04W\n...\n'--\n'--\n'--\n'--\n024faa94-ec57-4d14-b919-62dcab409958\nAdjuvant\nyes\nTreatment Ongoing\n'--\nBisphosphonate Therapy\n\n\n\n\n5 rows × 210 columns\n\n\n\nMissing data: From viewing both datasets, the missing data was represented as ’— and required replacing the placeholder string with numpy nontype in order to handle missing values efficiently.\nThe missing values per columns ranged from 0% to 100%, this was a limitation of the datasets especially due to a lot of demographic columns having a large percentage of missing values, as these columns might have been potential social determinants of survival days depending on the type of cancer,\n\n\ndemographic.year_of_birth: 0.00% missing values\ndemographic.age_at_index: 0.00% missing values\ndemographic.cause_of_death: 0.00% missing values\ndemographic.year_of_death: 0.00% missing values\ndemographic.vital_status: 0.00% missing values\ndemographic.cause_of_death: 0.00% missing values\ndemographic.education_level: 0.00% missing values\ndemographic.days_to_death: 0.00% missing values\n\n\nHowever, the demographic.vital_status column has fewer missing values, which still allowed for some analysis regarding survival status. Despite a large number of missing values in demographic.days_to_death, we reasonable assummed it is because the patient is alive since the missing values corresponded to alive in the vital_status column. In addition, days_to_last_follow_up also has fewer missing values (11% in the brca dataset, and 12% in the cesc dataset), which enabled inferring survival time in feature engineering.\nThe datasets had a lot of columns with missing data. The overall original view of missing data in the brca dataset is showed below:\n\n\n&lt;Figure size 1440x768 with 0 Axes&gt;\n\n\n\n\n\n\n\n\n\nMost of the missing values were initially dropped through the following logic:\n\nDrop of columns with more than 30% data missing (except days_to_death as it is a key column for analysis). This reduced the number of columns by ~75% (e.g., to 46 columns for brca)\nDrop of columns irrelevant to the task of analysing survival time for the two different types of cancers e.g., data consent - not a predictor of how someone will survive a cancer, year of diagnoses - age at diagnoses captures the effect\nDrop of duplicate rows and rows with greater than 30% of the data missing i.e., 30% of information on that patient missing\n\nThe above resulted in a cleaner dataset as shown below:\n\n\n\nDistribution of missing data after dropping missing values as described above\n\n\nAfterwards, missing data was cleaned as follows\n\nFor most of the columns, the missing values were replaced with the mode/most frequent value e.g., diasease_is_primary diasease as True, site_of_involvement as breast, pathologic n (lymph node component of cancer staging) as N0 (no regional lymph node metastasis) due to heavy imbalance towards specific classes\nOverall stage infered from pathologic n, pathologic t (size and extent of primary tumor), and pathologic m (distant metastasis - whether the cancer has spread to distant organs)\nHandling of missing data in days_to_death was handled in the supervised learning section, this was due to the patients still being alive"
  },
  {
    "objectID": "technical-details/data-cleaning/overview.html#data-type-correction-and-formatting",
    "href": "technical-details/data-cleaning/overview.html#data-type-correction-and-formatting",
    "title": "Overview",
    "section": "Data Type Correction and Formatting:",
    "text": "Data Type Correction and Formatting:\n\nData Types: All columns in the dataset are originally stored as object datatype\nTransformation: Columns were changed to numeric, boolean, and strings as needed in the dataset\n\nNumeric: days_to_death and days_to_last_follow_up were changed to numeric integers. age_at_diagnoses was changed from days to years for easier analysis during exploratory data analysis\nBoolean: Boolean columns were primarily coded as yes/no and these values were changed to True/False respectively\nStrings: Object columns were changed to lowercase strings and leading/trailing whitespace trimmed\n\nImpact of changes: These changes were primarily made with exploratory data analysis in mind and a longer term view towards survival time prediction. Changing age at diagnoses to years enabled better synthesis of multivariate analysis and while preserving days_to_death and days_to_last_follow_up preserved information as the columns are a measure of survival time. Boolean columns enabled efficient filtering and subseeting and the string columns were optimal for wordcloud analysis."
  },
  {
    "objectID": "technical-details/data-cleaning/overview.html#data-engineering",
    "href": "technical-details/data-cleaning/overview.html#data-engineering",
    "title": "Overview",
    "section": "Data Engineering:",
    "text": "Data Engineering:\nAfter validating the range and distribution of age_at_diagnosis (min of 26 years and max of 89 years), and handling negative values for days_to_last_follow_up by replacing them with the mean, our data engineering process involved extracting more data from columns. Primarily the two columns below were derived:\n\ndiagnosis.behavior: Tumor behavior was derived from the diagnoses.morphology field using the International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Morphology codes follow the format ####/B, where the digit following the slash encodes tumor behavior (e.g., /3 indicates malignant primary disease). For example, morphology code 8500/3 corresponds to infiltrating duct carcinoma with malignant primary behavior. Behavior values were extracted and mapped to ordinal numeric representations following ICD-O-3 guidelines.1\nsurvival_time_days: Survival time was derived using clinical time-to-event variables provided by the Genomic Data Commons (GDC).2 For patients with a recorded death event, survival time was calculated as the difference between demographic.days_to_death and diagnoses.days_to_diagnosis, yielding the number of days survived following cancer diagnosis. For patients without a recorded death event (i.e., alive at last contact), survival time was defined as diagnoses.days_to_last_follow_up, representing the number of days from diagnosis to the most recent clinical follow-up. This approach follows standard survival analysis practice by treating deaths as observed events and living patients as right-censored observations. Missing values in days_to_death were therefore interpreted as censored outcomes rather than zero survival time. No additional adjustments or imputation were applied to survival duration to preserve the temporal integrity of the observed clinical timelines.\n\nFurther data engineering e.g., handling of multiple rows per patient due to multiple treatment types, were handled in feature engineering before machine learning in order to analyse variables in depth e.g., number of treatments. Additional columns are also dropped and some created after exploratory data analysis (EDA) continuing the process of data engineering.\nFor cervical cancer, data cleaning also included extracting the tobacco smoking status and unique ID from the exposure dataset. Unfortunately, the breast cancer exposure file contained only missing values, limiting our analysis. However, examining tobacco exposure in the cervical cancer dataset and not in the breast cancer dataset is epidemiologically justified as cigarette smoking is a recognized co-factor in cervical carcinogenesis while it is not considered a primary risk factor for breast cancer onset or progression, with prior research indicating weak, inconsistent, or indirect associations compared to dominant hormonal, genetic, and reproductive factors3"
  },
  {
    "objectID": "technical-details/data-collection/overview.html",
    "href": "technical-details/data-collection/overview.html",
    "title": "Overview",
    "section": "",
    "text": "The data used in this project were obtained from the National Cancer Institute (NCI) Genomic Data Commons (GDC)1, a centralized repository designed to support cancer research by providing harmonized clinical, genomic, and exposure-related data across multiple cancer types. The GDC integrates data from large-scale initiatives such as The Cancer Genome Atlas (TCGA)2 and applies standardized data models, vocabularies, and quality control procedures to ensure consistency and reproducibility across studies.\n{alt = “National Cancer Institute Genomic Data Commons home page”}"
  },
  {
    "objectID": "technical-details/data-collection/overview.html#data-source",
    "href": "technical-details/data-collection/overview.html#data-source",
    "title": "Overview",
    "section": "",
    "text": "The data used in this project were obtained from the National Cancer Institute (NCI) Genomic Data Commons (GDC)1, a centralized repository designed to support cancer research by providing harmonized clinical, genomic, and exposure-related data across multiple cancer types. The GDC integrates data from large-scale initiatives such as The Cancer Genome Atlas (TCGA)2 and applies standardized data models, vocabularies, and quality control procedures to ensure consistency and reproducibility across studies.\n{alt = “National Cancer Institute Genomic Data Commons home page”}"
  },
  {
    "objectID": "technical-details/data-collection/overview.html#data-collection-methods",
    "href": "technical-details/data-collection/overview.html#data-collection-methods",
    "title": "Overview",
    "section": "Data Collection Methods",
    "text": "Data Collection Methods\nFor this analysis, we focused on two TCGA cohorts: Breast Invasive Carcinoma (TCGA-BRCA) and Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA-CESC). These datasets were selected to enable comparative analysis of two common cancers affecting women, while allowing investigation into differences in tumor characteristics, treatment patterns, and survival outcomes.\nClinical data were downloaded from the GDC Data Portal in tabular format (clinical.tsv and related files), which aggregate information across several hierarchical entities, including cases, demographic, diagnoses, treatments, and exposures. Variables include patient-level demographics (e.g., age at diagnosis, race, vital status), tumor-specific characteristics (e.g., stage, grade, morphology), treatment indicators (e.g., treatment type), and outcome-related fields (e.g., days to last follow-up). All time-to-event variables in the GDC are reported in days, indexed relative to clinically meaningful anchor points such as diagnosis or enrollment dates.\n{alt = “National Cancer Institute Genomic Data Commons data download page”}"
  },
  {
    "objectID": "technical-details/data-collection/overview.html#data-structure-and-format",
    "href": "technical-details/data-collection/overview.html#data-structure-and-format",
    "title": "Overview",
    "section": "Data Structure and Format",
    "text": "Data Structure and Format\nImportantly, the GDC data are de-identified to protect patient privacy, and certain variables may be obfuscated or missing by design. For example, ages above a threshold may be masked, dates may be offset, and exposure variables such as smoking status may be underreported. Additionally, patients may have multiple rows per case, reflecting repeated diagnoses, treatments, or follow-up events, necessitating aggregation and careful preprocessing prior to modeling.\n\n\n\n\n\n\nRows showing a unique patient (cases.submitter_id) and their different treatments for breast cancer\n\n\n\ncases.submitter_id\ntreatments.treatment_type\ntreatments.treatment_intent_type\ndemographic.vital_status\ndiagnoses.ajcc_pathologic_stage\n\n\n\n\n0\nTCGA-E2-A1IU\nRadiation Therapy, NOS\nAdjuvant\nAlive\nStage IA\n\n\n1\nTCGA-E2-A1IU\nHormone Therapy\nAdjuvant\nAlive\nStage IA\n\n\n2\nTCGA-E2-A1IU\nSurgery, NOS\nFirst-Line Therapy\nAlive\nStage IA"
  },
  {
    "objectID": "technical-details/data-collection/overview.html#data",
    "href": "technical-details/data-collection/overview.html#data",
    "title": "Overview",
    "section": "Data",
    "text": "Data\nWhile TCGA cohorts are not fully representative of the general U.S. population, they remain one of the most comprehensive publicly available cancer datasets, widely used in both biomedical and data science research. The use of GDC data enables reproducible analysis while providing sufficient clinical depth to explore survival patterns and predictive modeling across cancer types.\nOur raw data can be found in our repository here, including a data dictionary.\nAs of 11/05/2025, - the clinical breast cancer dataset originally has 5546 rows and 210 columns representing 1098 patients - the clinical cervical cancer dataset originally has 1535 rows and 210 columns representing 307 patients"
  },
  {
    "objectID": "technical-details/progress-log.html",
    "href": "technical-details/progress-log.html",
    "title": "Progress log",
    "section": "",
    "text": "Write up introduction and motivation\nWrite up Data Science Questions\nConduct Literature Review\nData Collection\nData Cleaning\nExploratory Data Analysis\nDimensionality Reduction\nClustering Analysis\nSupervised Learning\nTechnical Report\nNon-Technical Report"
  },
  {
    "objectID": "technical-details/progress-log.html#to-do",
    "href": "technical-details/progress-log.html#to-do",
    "title": "Progress log",
    "section": "",
    "text": "Write up introduction and motivation\nWrite up Data Science Questions\nConduct Literature Review\nData Collection\nData Cleaning\nExploratory Data Analysis\nDimensionality Reduction\nClustering Analysis\nSupervised Learning\nTechnical Report\nNon-Technical Report"
  },
  {
    "objectID": "technical-details/progress-log.html#munashe-mhlanga",
    "href": "technical-details/progress-log.html#munashe-mhlanga",
    "title": "Progress log",
    "section": "Munashe Mhlanga:",
    "text": "Munashe Mhlanga:\nAbout Me\nProject roles:\n\nData Collection\nData Cleaning\nExploratory Data Analysis\nSupervised Learning\nTechnical Report\n\nWeekly project contribution log:\n10-27-2025\n\nBrainstormed topics and landed on predicting floods and droughts in sub-saharan Africa\n\n11-03-2025\n\nData Collection through NOAA (National Oceanic and Atmospheric Administration) climate data\n\n11-10-2025\n\nLiterature Review and drop of initial project due to have reliance on time series methods. Project focus only required traditional machine learning methods that do not work on time series\n\n11-17-2025\n\nProject brainstorm with partner, landing on predicting survival time for breast cancer and cervical cancer while comparing impact of factors on mortality e.g., age at diagnosis\nData Collection\n\n11-24-2025\n\nProject management and detailed workplan\nData Cleaning\n\n12-01-2025\n\nExploratory Data Analysis\n\n12-08-2025\n\nSupervised Learning\n\n12-12-2025\n\nTechnical Report\nWebsite edits"
  },
  {
    "objectID": "technical-details/progress-log.html#betsiet-delelegn",
    "href": "technical-details/progress-log.html#betsiet-delelegn",
    "title": "Progress log",
    "section": "Betsiet Delelegn",
    "text": "Betsiet Delelegn\nAbout Me\nProject roles:\n\nLiterature Review\nDimensionality Reduction\nClustering Analysis (Unsupervised Learning)\nNon-Technical Report\n\nWeekly project contribution log:\n11-08-2025\n\nBrainstormed topics; initially explored Cherry Blossom Prediction data and NOAA API\n\n11-15-2025\n\nPivoted to breast cancer data for project focus\n\n11-17-2025\n\nProject brainstorm with partner, landing on breast and cervical cancer survival analysis using TCGA data\nBegan literature review on cancer survival patterns and TCGA methodology\n\n12-02-2025\n\nInitial dimensionality reduction experiments\n\n12-06-2025\n\nCompleted dimensionality reduction\nClustering analysis—K\nStatistical validation\n\n12-13-2025\n\nFinalized unsupervised learning notebook\nNon-technical report\n\n12-16-2025\n\nFinal revisions"
  },
  {
    "objectID": "technical-details/data-cleaning/cesc-cleaning.html",
    "href": "technical-details/data-cleaning/cesc-cleaning.html",
    "title": "EDA for cervical cancer dataset",
    "section": "",
    "text": "# Import relevant libraries\nimport pandas as pd\nimport numpy as np\nimport matplotlib.pyplot as plt\nimport seaborn as sns\n%matplotlib inline\nimport plotly.express as px\nimport plotly.graph_objects as go\nimport plotly.io as pio\npio.renderers.default = \"notebook_connected\"\nimport missingno as msno\nimport warnings\nwarnings.filterwarnings('ignore')\nfrom scipy import stats\nfrom scipy.stats import norm, skew\n\n\n# Import dataset\ncesc_df_original = pd.read_csv(\"../../data/raw-data/cesc/cesc-clinical.tsv\", sep=\"\\t\")\n\n# Create a copy of the original dataframe to work on\ncesc_df = cesc_df_original.copy()\n\n# Display first few rows of the dataset\ncesc_df.head()\n\n\n\n\n\n\n\n\nproject.project_id\ncases.case_id\ncases.consent_type\ncases.days_to_consent\ncases.days_to_lost_to_followup\ncases.disease_type\ncases.index_date\ncases.lost_to_followup\ncases.primary_site\ncases.submitter_id\n...\ntreatments.treatment_duration\ntreatments.treatment_effect\ntreatments.treatment_effect_indicator\ntreatments.treatment_frequency\ntreatments.treatment_id\ntreatments.treatment_intent_type\ntreatments.treatment_or_therapy\ntreatments.treatment_outcome\ntreatments.treatment_outcome_duration\ntreatments.treatment_type\n\n\n\n\n0\nTCGA-CESC\n00ad0ffe-2105-4829-a495-1c2aceb5bb31\nInformed Consent\n0\n'--\nSquamous Cell Neoplasms\nDiagnosis\nYes\nCervix uteri\nTCGA-EK-A2R9\n...\n'--\n'--\n'--\n'--\n672b3cf9-bb40-4f6f-a1c9-69ac3383fbd5\n'--\n'--\n'--\n'--\nHysterectomy, NOS\n\n\n1\nTCGA-CESC\n00ad0ffe-2105-4829-a495-1c2aceb5bb31\nInformed Consent\n0\n'--\nSquamous Cell Neoplasms\nDiagnosis\nYes\nCervix uteri\nTCGA-EK-A2R9\n...\n'--\n'--\n'--\n'--\nd4baa31f-8c1f-5333-afcd-836816fd1a2a\nAdjuvant\nunknown\n'--\n'--\nPharmaceutical Therapy, NOS\n\n\n2\nTCGA-CESC\n00ad0ffe-2105-4829-a495-1c2aceb5bb31\nInformed Consent\n0\n'--\nSquamous Cell Neoplasms\nDiagnosis\nYes\nCervix uteri\nTCGA-EK-A2R9\n...\n'--\n'--\n'--\n'--\ne79370ba-36f0-4639-bc8f-119ba2b2457b\nAdjuvant\nunknown\n'--\n'--\nRadiation Therapy, NOS\n\n\n3\nTCGA-CESC\n00bca18c-b3d4-45a3-8f19-034cc40449a4\nInformed Consent\n2108\n'--\nSquamous Cell Neoplasms\nDiagnosis\nYes\nCervix uteri\nTCGA-C5-A2LV\n...\n'--\n'--\n'--\n'--\n277d525e-9674-4954-b427-3e829d469b8f\n'--\n'--\n'--\n'--\nHysterectomy, NOS\n\n\n4\nTCGA-CESC\n00bca18c-b3d4-45a3-8f19-034cc40449a4\nInformed Consent\n2108\n'--\nSquamous Cell Neoplasms\nDiagnosis\nYes\nCervix uteri\nTCGA-C5-A2LV\n...\n'--\n'--\n'--\n'--\n788ff156-d009-46f7-b832-f39b11ed13ac\nAdjuvant\nno\n'--\n'--\nRadiation Therapy, NOS\n\n\n\n\n5 rows × 210 columns\n\n\n\nFrom the first rows, we can see that there are several columns with missing values, represented as ’– . These values will be turned to NA for easier handling\n\n# Replace \"'--\" as NA\ncesc_df_original.replace('\\'--', np.nan, inplace=True)\ncesc_df.replace('\\'--', np.nan, inplace=True)\n\n\nInspect key columns for survival analysis\n\n# List all cols starting with 'demographic'\ndemographic_cols = [col for col in cesc_df.columns if col.startswith('demographic')]\nprint(\"Columns starting with 'demographic':\")\nfor col in demographic_cols:\n    print(f\"  - {col}\")\nprint(f\"\\nTotal demographic columns: {len(demographic_cols)}\")\n\n\nColumns starting with 'demographic':\n  - demographic.age_at_index\n  - demographic.age_is_obfuscated\n  - demographic.cause_of_death\n  - demographic.cause_of_death_source\n  - demographic.country_of_birth\n  - demographic.country_of_residence_at_enrollment\n  - demographic.days_to_birth\n  - demographic.days_to_death\n  - demographic.demographic_id\n  - demographic.education_level\n  - demographic.ethnicity\n  - demographic.gender\n  - demographic.marital_status\n  - demographic.occupation_duration_years\n  - demographic.population_group\n  - demographic.premature_at_birth\n  - demographic.race\n  - demographic.submitter_id\n  - demographic.vital_status\n  - demographic.weeks_gestation_at_birth\n  - demographic.year_of_birth\n  - demographic.year_of_death\n\nTotal demographic columns: 22\n\n\n\n# Check unique values in 'demographic.days_to_death'\ncesc_df[\"demographic.days_to_death\"].unique()\n\narray([nan, '543', '144', '355', '2052', '2859', '348', '469', '1394',\n       '4086', '253', '14', '506', '570', '951', '1245', '861', '2094',\n       '305', '607', '1186', '636', '642', '275', '879', '284', '370',\n       '523', '1118', '1453', '100', '227', '978', '132', '1011', '52',\n       '442', '252', '2520', '955', '166', '1083', '1372', '555', '1065',\n       '157', '414', '74', '908', '266', '471', '837', '3046', '1210',\n       '104', '350', '2888', '633', '492', '494', '829', '477', '638',\n       '582', '715', '1692', '773', '604', '2032', '659', '3097'],\n      dtype=object)\n\n\n\n# Check for percentage of missing values in 'demographic.days_to_death'\nmissing_percentage = cesc_df[\"demographic.days_to_death\"].isnull().mean()\nprint(f\"'Percentage of missing values in 'demographic.days_to_death' {missing_percentage:.2f}\")\n\n'Percentage of missing values in 'demographic.days_to_death' 0.72\n\n\n\n# Check to see if status is 'alive' where days_to_death is missing\nmissing_death_status = cesc_df[cesc_df[\"demographic.days_to_death\"].isnull()][\"demographic.vital_status\"].value_counts()\nmissing_death_status\n\ndemographic.vital_status\nAlive    1103\nName: count, dtype: int64\n\n\nWe can assume that the demographic.days_to_death column is crucial for survival analysis, as it indicates the time until death for each patient. Despite a significant number of missing values in this column, these are for patients who are still alive, as indicated by the demographic.vital_status column. Therefore, we can retain this column for analysis, treating missing values as censored data.\n\n# Drop rows where days_to_death is missing and vital_status is 'Dead'\ncesc_df = cesc_df[~((cesc_df[\"demographic.days_to_death\"].isnull()) & (cesc_df[\"demographic.vital_status\"] == 'Dead'))]\n\n\n# Check for percentage of missing values in diagnoses.days_to_last_follow_up\nmissing_percentage = cesc_df[\"diagnoses.days_to_last_follow_up\"].isnull().mean()\nprint(f\"'Percentage of missing values in 'diagnoses.days_to_last_follow_up' {missing_percentage:.2f}\")\n\n'Percentage of missing values in 'diagnoses.days_to_last_follow_up' 0.12\n\n\n\n# Check the distribution of vital_status when days_to_last_follow_up is missing\nmissing_followup_status = cesc_df[cesc_df[\"diagnoses.days_to_last_follow_up\"].isnull()][\"demographic.vital_status\"].value_counts()\nmissing_followup_status\n\ndemographic.vital_status\nDead     105\nAlive     86\nName: count, dtype: int64\n\n\n\n# Check the percentage of missing values for the following columns:\n# - demographic.year_of_birth\n# - demographic.year_of_death\n# - demographic.vital_status\n# - demographic.cause_of_death\n# - demographic.education_level\ncols_to_check = [\n    'demographic.year_of_birth',\n    'demographic.age_at_index',\n    'demographic.cause_of_death',\n    'demographic.year_of_death',\n    'demographic.vital_status',\n    'demographic.cause_of_death',\n    'demographic.education_level'\n]\nfor col in cols_to_check:\n    missing_percentage = cesc_df[col].isnull().mean() * 100\n    print(f\"{col}: {missing_percentage:.2f}% missing values\")\n\ndemographic.year_of_birth: 100.00% missing values\ndemographic.age_at_index: 0.00% missing values\ndemographic.cause_of_death: 71.86% missing values\ndemographic.year_of_death: 100.00% missing values\ndemographic.vital_status: 0.00% missing values\ndemographic.cause_of_death: 71.86% missing values\ndemographic.education_level: 100.00% missing values\n\n\nA lot of missing values in key demographic columns, especially in cause of death become a limiting factor for analysis.\n\n# Distribution of demographic.vital_status\nvital_status_counts = cesc_df['demographic.vital_status'].value_counts(dropna=False)\nprint(\"\\ndemographic.vital_status distribution:\")\nprint(vital_status_counts)\n\n\ndemographic.vital_status distribution:\ndemographic.vital_status\nAlive    1103\nDead      432\nName: count, dtype: int64\n\n\nHowever, the demographic.vital_status column has fewer missing values, which may still allow for some analysis regarding survival status. Despite large number of missing values in demographic.days_to_death, we can assume it is because the patient is alive since the missing values correspond to alive in the vital_status column. In addition, days_to_last_follow_up in the diagnoses table also has fewer missing values, which may be useful for survival time analysis.\n\n\nCheck for missing values\n\n# Missing data visualization\nplt.figure(figsize=(15, 8))\nmsno.matrix(cesc_df)\nplt.title(\"Missing Data Matrix - cervical cancer Dataset\", fontsize=14, fontweight='bold')\nplt.show()\n\n&lt;Figure size 1500x800 with 0 Axes&gt;\n\n\n\n\n\n\n\n\n\n\n# Drop columns with more than 30% missing values except for demographic.days_to_death and diagnoses.days_to_last_follow_up\n\n# Calculate missing percentage for each column\nmissing_percentages = cesc_df.isnull().mean()\n\n# Identify columns to drop (more than 30% missing, excluding the exceptions)\nexceptions = ['demographic.days_to_death', 'diagnoses.days_to_last_follow_up']\ncolumns_to_drop = []\n\nfor col in cesc_df.columns:\n    if col not in exceptions and missing_percentages[col] &gt; 0.3:\n        columns_to_drop.append(col)\n\nprint(f\"Columns to be dropped due to &gt;30% missing values: {columns_to_drop}\")\n\n# Drop the identified columns\ncesc_df = cesc_df.drop(columns=columns_to_drop)\n\n# Display the shape of the cleaned dataset\ncesc_df.shape\n\nColumns to be dropped due to &gt;30% missing values: ['cases.days_to_lost_to_followup', 'demographic.cause_of_death', 'demographic.cause_of_death_source', 'demographic.country_of_birth', 'demographic.education_level', 'demographic.marital_status', 'demographic.occupation_duration_years', 'demographic.population_group', 'demographic.premature_at_birth', 'demographic.weeks_gestation_at_birth', 'demographic.year_of_birth', 'demographic.year_of_death', 'diagnoses.adrenal_hormone', 'diagnoses.ajcc_clinical_m', 'diagnoses.ajcc_clinical_n', 'diagnoses.ajcc_clinical_stage', 'diagnoses.ajcc_clinical_t', 'diagnoses.ajcc_pathologic_stage', 'diagnoses.ajcc_serum_tumor_markers', 'diagnoses.ajcc_staging_system_edition', 'diagnoses.ann_arbor_b_symptoms', 'diagnoses.ann_arbor_b_symptoms_described', 'diagnoses.ann_arbor_clinical_stage', 'diagnoses.ann_arbor_extranodal_involvement', 'diagnoses.ann_arbor_pathologic_stage', 'diagnoses.best_overall_response', 'diagnoses.burkitt_lymphoma_clinical_variant', 'diagnoses.calgb_risk_group', 'diagnoses.cancer_detection_method', 'diagnoses.child_pugh_classification', 'diagnoses.clark_level', 'diagnoses.cog_liver_stage', 'diagnoses.cog_neuroblastoma_risk_group', 'diagnoses.cog_renal_stage', 'diagnoses.cog_rhabdomyosarcoma_risk_group', 'diagnoses.contiguous_organ_invaded', 'diagnoses.days_to_best_overall_response', 'diagnoses.days_to_last_known_disease_status', 'diagnoses.days_to_recurrence', 'diagnoses.double_expressor_lymphoma', 'diagnoses.double_hit_lymphoma', 'diagnoses.eln_risk_classification', 'diagnoses.enneking_msts_grade', 'diagnoses.enneking_msts_metastasis', 'diagnoses.enneking_msts_stage', 'diagnoses.enneking_msts_tumor_site', 'diagnoses.ensat_clinical_m', 'diagnoses.ensat_pathologic_n', 'diagnoses.ensat_pathologic_stage', 'diagnoses.ensat_pathologic_t', 'diagnoses.esophageal_columnar_dysplasia_degree', 'diagnoses.esophageal_columnar_metaplasia_present', 'diagnoses.fab_morphology_code', 'diagnoses.first_symptom_longest_duration', 'diagnoses.first_symptom_prior_to_diagnosis', 'diagnoses.gastric_esophageal_junction_involvement', 'diagnoses.gleason_grade_group', 'diagnoses.gleason_grade_tertiary', 'diagnoses.gleason_patterns_percent', 'diagnoses.gleason_score', 'diagnoses.goblet_cells_columnar_mucosa_present', 'diagnoses.igcccg_stage', 'diagnoses.inpc_grade', 'diagnoses.inpc_histologic_group', 'diagnoses.inrg_stage', 'diagnoses.inss_stage', 'diagnoses.international_prognostic_index', 'diagnoses.irs_group', 'diagnoses.irs_stage', 'diagnoses.ishak_fibrosis_score', 'diagnoses.iss_stage', 'diagnoses.last_known_disease_status', 'diagnoses.laterality', 'diagnoses.margin_distance', 'diagnoses.margins_involved_site', 'diagnoses.masaoka_stage', 'diagnoses.max_tumor_bulk_site', 'diagnoses.medulloblastoma_molecular_classification', 'diagnoses.melanoma_known_primary', 'diagnoses.metastasis_at_diagnosis', 'diagnoses.metastasis_at_diagnosis_site', 'diagnoses.micropapillary_features', 'diagnoses.mitosis_karyorrhexis_index', 'diagnoses.mitotic_count', 'diagnoses.ovarian_specimen_status', 'diagnoses.ovarian_surface_involvement', 'diagnoses.papillary_renal_cell_type', 'diagnoses.pediatric_kidney_staging', 'diagnoses.peritoneal_fluid_cytological_status', 'diagnoses.pregnant_at_diagnosis', 'diagnoses.primary_disease', 'diagnoses.primary_gleason_grade', 'diagnoses.progression_or_recurrence', 'diagnoses.residual_disease', 'diagnoses.satellite_nodule_present', 'diagnoses.secondary_gleason_grade', 'diagnoses.sites_of_involvement', 'diagnoses.sites_of_involvement_count', 'diagnoses.supratentorial_localization', 'diagnoses.tumor_burden', 'diagnoses.tumor_confined_to_organ_of_origin', 'diagnoses.tumor_depth', 'diagnoses.tumor_focality', 'diagnoses.tumor_grade_category', 'diagnoses.tumor_of_origin', 'diagnoses.tumor_regression_grade', 'diagnoses.uicc_clinical_m', 'diagnoses.uicc_clinical_n', 'diagnoses.uicc_clinical_stage', 'diagnoses.uicc_clinical_t', 'diagnoses.uicc_pathologic_m', 'diagnoses.uicc_pathologic_n', 'diagnoses.uicc_pathologic_stage', 'diagnoses.uicc_pathologic_t', 'diagnoses.uicc_staging_system_edition', 'diagnoses.ulceration_indicator', 'diagnoses.weiss_assessment_findings', 'diagnoses.weiss_assessment_score', 'diagnoses.who_cns_grade', 'diagnoses.who_nte_grade', 'diagnoses.wilms_tumor_histologic_subtype', 'treatments.chemo_concurrent_to_radiation', 'treatments.clinical_trial_indicator', 'treatments.course_number', 'treatments.days_to_treatment_end', 'treatments.days_to_treatment_start', 'treatments.drug_category', 'treatments.embolic_agent', 'treatments.initial_disease_status', 'treatments.lesions_treated_number', 'treatments.margin_distance', 'treatments.margin_status', 'treatments.margins_involved_site', 'treatments.number_of_cycles', 'treatments.number_of_fractions', 'treatments.prescribed_dose', 'treatments.prescribed_dose_units', 'treatments.pretreatment', 'treatments.protocol_identifier', 'treatments.radiosensitizing_agent', 'treatments.reason_treatment_ended', 'treatments.reason_treatment_not_given', 'treatments.regimen_or_line_of_therapy', 'treatments.residual_disease', 'treatments.route_of_administration', 'treatments.therapeutic_agents', 'treatments.therapeutic_level_achieved', 'treatments.therapeutic_levels_achieved', 'treatments.therapeutic_target_level', 'treatments.timepoint_category', 'treatments.treatment_anatomic_site', 'treatments.treatment_anatomic_sites', 'treatments.treatment_arm', 'treatments.treatment_dose', 'treatments.treatment_dose_max', 'treatments.treatment_dose_units', 'treatments.treatment_duration', 'treatments.treatment_effect', 'treatments.treatment_effect_indicator', 'treatments.treatment_frequency', 'treatments.treatment_intent_type', 'treatments.treatment_outcome', 'treatments.treatment_outcome_duration']\n\n\n(1535, 47)\n\n\n\n# Check distribution na values after dropping columns\nplt.figure(figsize=(15, 8))\nmsno.matrix(cesc_df)\nplt.title(\"Missing Data Matrix After Dropping Columns - cesc Clinical Dataset\", fontsize=14, fontweight='bold')\nplt.show()\n\n&lt;Figure size 1500x800 with 0 Axes&gt;\n\n\n\n\n\n\n\n\n\n\n\nCheck for duplicate IDs\n\n# Count unique IDs (cases.submitter_id)\n\nunique_ids = cesc_df['cases.submitter_id'].nunique()\nprint(f\"Number of unique IDs: {unique_ids}\")\n\nNumber of unique IDs: 307\n\n\nThe TGCA cesc dataset contains 1,082 unique patient IDs (cases.submitter_id) but 3554 rows in total. This is because the TCGA Schema is designed to have multiple samples per patient, capturing different aspects of the tumor biology. Each patient may have multiple entries corresponding to different sample types, such as primary tumor, metastatic tumor, or normal tissue adjacent to the tumor. This allows for a more comprehensive analysis of the cancer’s characteristics and progression within the same individual.\nThe tcga schema is hierarchical as follows:\nCase (cesc) -&gt; Diagnosis -&gt; Follow-up -&gt; Treatment -&gt; Biospecimens\nMost cesc patients have: - 1 diagnosis - 1 - 5 follow-up entries - 1 - 3 treatments - 2 - 4 tissue samples (tumor and normal)\n\n\nFilter columns based on task\nColumns that are not relevant to the predictive modeling task will be dropped. These include identifiers, dates, and other metadata that do not contribute to the prediction of breast cancer outcomes such as the following:\n\ncases.consent_type\ncases.days_to_consent\ndemographic.days_to_birth\ndemographic.age_at_index (will preserve diagnosis.age_at_diagnosis instead for age at diagnosis)\ndiagnoses.ajcc_staging_system_edition\ndiagnoses.diagnosis_id (captured in disease_type)\ndiagnoses.icd_10_code (captured in disease_type)\ndiagnoses.year_of_diagnosis (interested in age at diagnosis instead)\ntreatments.treatment_id\n\n\n# Drop irrelevant columns\ncolumns_to_drop = [\n    'cases.consent_type',\n    'cases.days_to_consent',\n    'demographic.days_to_birth',\n    'demographic.age_at_index',\n    'demographic.demographic_id',\n    'diagnoses.diagnosis_id',\n    'diagnoses.icd_10_code',\n    'diagnoses.year_of_diagnosis',\n    'treatments.treatment_id',\n    'demographic.country_of_residence_at_enrollment',\n    'diagnoses.diagnosis_is_primary_disease',\n    'demographic.age_is_obfuscated'\n]\n\n# Drop the existing columns\ncesc_df = cesc_df.drop(columns=columns_to_drop)\n\nprint(f\"Dataset shape after dropping columns: {cesc_df.shape}\")\n\nDataset shape after dropping columns: (1535, 35)\n\n\n\n# Check remaining column names\ncesc_df.columns.tolist()\n\n['project.project_id',\n 'cases.case_id',\n 'cases.disease_type',\n 'cases.index_date',\n 'cases.lost_to_followup',\n 'cases.primary_site',\n 'cases.submitter_id',\n 'demographic.days_to_death',\n 'demographic.ethnicity',\n 'demographic.gender',\n 'demographic.race',\n 'demographic.submitter_id',\n 'demographic.vital_status',\n 'diagnoses.age_at_diagnosis',\n 'diagnoses.ajcc_pathologic_m',\n 'diagnoses.ajcc_pathologic_n',\n 'diagnoses.ajcc_pathologic_t',\n 'diagnoses.classification_of_tumor',\n 'diagnoses.days_to_diagnosis',\n 'diagnoses.days_to_last_follow_up',\n 'diagnoses.figo_stage',\n 'diagnoses.figo_staging_edition_year',\n 'diagnoses.method_of_diagnosis',\n 'diagnoses.morphology',\n 'diagnoses.primary_diagnosis',\n 'diagnoses.prior_malignancy',\n 'diagnoses.prior_treatment',\n 'diagnoses.site_of_resection_or_biopsy',\n 'diagnoses.submitter_id',\n 'diagnoses.synchronous_malignancy',\n 'diagnoses.tissue_or_organ_of_origin',\n 'diagnoses.tumor_grade',\n 'treatments.submitter_id',\n 'treatments.treatment_or_therapy',\n 'treatments.treatment_type']\n\n\n\n# Using msno to visualize missing data in remaining columns\nplt.figure(figsize=(15, 8))\nmsno.matrix(cesc_df)\nplt.title(\"Missing Data Matrix After Dropping irrelevant columns - cesc Clinical Dataset\", fontsize=14, fontweight='bold')\nplt.show()\n\n&lt;Figure size 1500x800 with 0 Axes&gt;\n\n\n\n\n\n\n\n\n\n\n# Check missing value percentages again\n\nfor col in cesc_df.columns:\n    missing_percentage = cesc_df[col].isnull().mean() * 100\n    print(f\"{col}: {missing_percentage:.2f}% missing values\")\n\nproject.project_id: 0.00% missing values\ncases.case_id: 0.00% missing values\ncases.disease_type: 0.00% missing values\ncases.index_date: 0.00% missing values\ncases.lost_to_followup: 27.23% missing values\ncases.primary_site: 0.00% missing values\ncases.submitter_id: 0.00% missing values\ndemographic.days_to_death: 71.86% missing values\ndemographic.ethnicity: 0.00% missing values\ndemographic.gender: 0.00% missing values\ndemographic.race: 0.00% missing values\ndemographic.submitter_id: 0.00% missing values\ndemographic.vital_status: 0.00% missing values\ndiagnoses.age_at_diagnosis: 1.76% missing values\ndiagnoses.ajcc_pathologic_m: 23.52% missing values\ndiagnoses.ajcc_pathologic_n: 22.61% missing values\ndiagnoses.ajcc_pathologic_t: 22.28% missing values\ndiagnoses.classification_of_tumor: 0.00% missing values\ndiagnoses.days_to_diagnosis: 1.04% missing values\ndiagnoses.days_to_last_follow_up: 12.44% missing values\ndiagnoses.figo_stage: 16.22% missing values\ndiagnoses.figo_staging_edition_year: 16.09% missing values\ndiagnoses.method_of_diagnosis: 12.64% missing values\ndiagnoses.morphology: 0.00% missing values\ndiagnoses.primary_diagnosis: 0.00% missing values\ndiagnoses.prior_malignancy: 12.44% missing values\ndiagnoses.prior_treatment: 1.56% missing values\ndiagnoses.site_of_resection_or_biopsy: 0.00% missing values\ndiagnoses.submitter_id: 0.00% missing values\ndiagnoses.synchronous_malignancy: 12.44% missing values\ndiagnoses.tissue_or_organ_of_origin: 0.00% missing values\ndiagnoses.tumor_grade: 13.81% missing values\ntreatments.submitter_id: 0.39% missing values\ntreatments.treatment_or_therapy: 11.40% missing values\ntreatments.treatment_type: 0.39% missing values\n\n\n\n# Drop rows with missing cases.lost_to_followup\ncesc_df = cesc_df.dropna(subset=['cases.lost_to_followup'])\ncesc_df.shape\n\n(1117, 35)\n\n\n\n# Check distribution of rows that have a lot of missing values\ncesc_df[\"na_count\"] = cesc_df.isna().sum(axis=1)\nna_count_distribution = cesc_df['na_count'].value_counts().sort_index()\nprint(\"\\nDistribution of rows by number of missing values:\")\nprint(na_count_distribution)\n\n\nDistribution of rows by number of missing values:\nna_count\n0      52\n1     675\n2     115\n3      51\n4      83\n5      19\n6       6\n8       3\n9       3\n10     31\n11     67\n12      3\n13      3\n14      5\n16      1\nName: count, dtype: int64\n\n\n\n# Delete rows that have 10 or more missing values (representing over 25% of that entity info missing)\ncesc_df = cesc_df[cesc_df['na_count'] &lt; 9].drop(columns=['na_count'])\n\n\n# Delete rows that have missing age_at_diagnosis info since this is a critical variable for our analysis\ncesc_df = cesc_df[cesc_df['diagnoses.age_at_diagnosis'].notna()]\n\n\n# Check missing value percentages again\n\nfor col in cesc_df.columns:\n    missing_percentage = cesc_df[col].isnull().mean() * 100\n    print(f\"{col}: {missing_percentage:.2f}% missing values\")\n\nproject.project_id: 0.00% missing values\ncases.case_id: 0.00% missing values\ncases.disease_type: 0.00% missing values\ncases.index_date: 0.00% missing values\ncases.lost_to_followup: 0.00% missing values\ncases.primary_site: 0.00% missing values\ncases.submitter_id: 0.00% missing values\ndemographic.days_to_death: 91.57% missing values\ndemographic.ethnicity: 0.00% missing values\ndemographic.gender: 0.00% missing values\ndemographic.race: 0.00% missing values\ndemographic.submitter_id: 0.00% missing values\ndemographic.vital_status: 0.00% missing values\ndiagnoses.age_at_diagnosis: 0.00% missing values\ndiagnoses.ajcc_pathologic_m: 12.15% missing values\ndiagnoses.ajcc_pathologic_n: 11.24% missing values\ndiagnoses.ajcc_pathologic_t: 11.24% missing values\ndiagnoses.classification_of_tumor: 0.00% missing values\ndiagnoses.days_to_diagnosis: 0.00% missing values\ndiagnoses.days_to_last_follow_up: 0.30% missing values\ndiagnoses.figo_stage: 4.82% missing values\ndiagnoses.figo_staging_edition_year: 4.62% missing values\ndiagnoses.method_of_diagnosis: 0.30% missing values\ndiagnoses.morphology: 0.00% missing values\ndiagnoses.primary_diagnosis: 0.00% missing values\ndiagnoses.prior_malignancy: 0.30% missing values\ndiagnoses.prior_treatment: 0.30% missing values\ndiagnoses.site_of_resection_or_biopsy: 0.00% missing values\ndiagnoses.submitter_id: 0.00% missing values\ndiagnoses.synchronous_malignancy: 0.30% missing values\ndiagnoses.tissue_or_organ_of_origin: 0.00% missing values\ndiagnoses.tumor_grade: 1.00% missing values\ntreatments.submitter_id: 0.00% missing values\ntreatments.treatment_or_therapy: 12.85% missing values\ntreatments.treatment_type: 0.00% missing values\n\n\n\n# Check the distribution of the method_of_diagnosis since it has a significantly higher missing value percentage\nmethod_of_diagnosis_counts = cesc_df['diagnoses.method_of_diagnosis'].value_counts(dropna=False)\nprint(\"\\ndiagnoses.method_of_diagnosis distribution:\")\nprint(method_of_diagnosis_counts)\n\n\ndiagnoses.method_of_diagnosis distribution:\ndiagnoses.method_of_diagnosis\nBiopsy                              852\nSurgical Resection                   61\nCytology                             54\nDilation and Curettage Procedure     26\nNaN                                   3\nName: count, dtype: int64\n\n\nDue to the heavy imbalance leaning towards Biopsy for the diagnoses.method_of_diagnosis column, we can replace missing values with ‘Biopsy’ to retain more rows for analysis.\n\n# Set pandas options to display all columns\npd.set_option('display.max_columns', None)\npd.set_option('display.width', None)\npd.set_option('display.max_colwidth', None)\n\n\n# Check distribution of diagnoses.ajcc_pathologic_n \najcc_pathologic_stage_counts = cesc_df['diagnoses.ajcc_pathologic_n'].value_counts(dropna=False)\nprint(\"\\ndiagnoses.ajcc_pathologic_n distribution:\")\nprint(ajcc_pathologic_stage_counts)\n\n\ndiagnoses.ajcc_pathologic_n distribution:\ndiagnoses.ajcc_pathologic_n\nN0     452\nNX     265\nN1     167\nNaN    112\nName: count, dtype: int64\n\n\n\n# Check distribution of diagnoses.ajcc_pathologic_m \najcc_pathologic_stage_counts = cesc_df['diagnoses.ajcc_pathologic_m'].value_counts(dropna=False)\nprint(\"\\ndiagnoses.ajcc_pathologic_m distribution:\")\nprint(ajcc_pathologic_stage_counts)\n\n\ndiagnoses.ajcc_pathologic_m distribution:\ndiagnoses.ajcc_pathologic_m\nMX     472\nM0     358\nNaN    121\nM1      45\nName: count, dtype: int64\n\n\n\n# Check distribution of diagnoses.ajcc_pathologic_t \najcc_pathologic_stage_counts = cesc_df['diagnoses.ajcc_pathologic_t'].value_counts(dropna=False)\nprint(\"\\ndiagnoses.ajcc_pathologic_t distribution:\")\nprint(ajcc_pathologic_stage_counts)\n\n\ndiagnoses.ajcc_pathologic_t distribution:\ndiagnoses.ajcc_pathologic_t\nT1b1    246\nT2b     132\nT1b2    115\nNaN     112\nT1b      94\nTX       50\nT2a2     49\nT3b      39\nT2a      35\nT2a1     32\nT4       30\nT2       23\nT3a      13\nT3       12\nTis       6\nT1a1      5\nT1        3\nName: count, dtype: int64\n\n\nThe missing values in the diagnoses.ajcc_pathologic_t, diagnoses.ajcc_pathologic_n, and diagnoses.ajcc_pathologic_m columns will be replaced by the mode of each column respectively due to the high imbalance.\n\n# Check distribution of diagnoses.treatment_or_therapy\ntreatment_or_therapy_counts = cesc_df['treatments.treatment_or_therapy'].value_counts(dropna=False)\nprint(\"\\ntreatments.treatment_or_therapy distribution:\")\nprint(treatment_or_therapy_counts)\n\n\ntreatments.treatment_or_therapy distribution:\ntreatments.treatment_or_therapy\nyes        545\nno         224\nNaN        128\nunknown     99\nName: count, dtype: int64\n\n\n\n# Check distribution od diagnoses.figo_stage\nfigo_stage_counts = cesc_df['diagnoses.figo_stage'].value_counts(dropna=False)\nprint(\"\\ndiagnoses.figo_stage distribution:\")\nprint(figo_stage_counts)\n\n\ndiagnoses.figo_stage distribution:\ndiagnoses.figo_stage\nStage IB1     272\nStage IIB     161\nStage IB2     134\nStage IIIB    117\nStage IB       72\nNaN            48\nStage IIA      34\nStage IVB      33\nStage IIA2     31\nStage IIA1     21\nStage IIIA     19\nStage I        16\nStage II       14\nStage IVA      10\nStage III       6\nStage IA1       5\nStage IA2       3\nName: count, dtype: int64\n\n\n\n# Check the distribution of diagnoses.figo_staging_edition_year\nfigo_staging_edition_year_counts = cesc_df['diagnoses.figo_staging_edition_year'].value_counts(dropna=False)\nprint(\"\\ndiagnoses.figo_staging_edition_year distribution:\")\nprint(figo_staging_edition_year_counts)\n\n\ndiagnoses.figo_staging_edition_year distribution:\ndiagnoses.figo_staging_edition_year\n2009    753\n1995    134\n1988     63\nNaN      46\nName: count, dtype: int64\n\n\n\n# Check the distribution of prior_malignancy\nprior_malignancy_counts = cesc_df['diagnoses.prior_malignancy'].value_counts(dropna=False)\nprint(\"\\ndiagnoses.prior_malignancy distribution:\")\nprint(prior_malignancy_counts)\n\n\ndiagnoses.prior_malignancy distribution:\ndiagnoses.prior_malignancy\nno              962\nyes              20\nnot reported     11\nNaN               3\nName: count, dtype: int64\n\n\n\n# Check distribution of diagnoses.tumor_grade\ntumor_grade_counts = cesc_df['diagnoses.tumor_grade'].value_counts(dropna=False)\nprint(\"\\ndiagnoses.tumor_grade distribution:\")\nprint(tumor_grade_counts)\n\n\ndiagnoses.tumor_grade distribution:\ndiagnoses.tumor_grade\nG2     437\nG3     399\nGX      86\nG1      60\nNaN     10\nG4       4\nName: count, dtype: int64\n\n\n\n\nClean NA values\nReplace the missing values in the following columns based on the assigned strategy: - diagnoses.method_of_diagnosis: ‘Core Biopsy’ (most frequent) - diagnoses.diagnosis_is_primary_disease: ‘True’ (most frequent) - diagnoses.prior_malignancy: ‘False’ (most frequent) - diagnoses.prior_treatment: ‘False’ (most frequent) - diagnoses.sites_of_involvement: ‘Breast’ (most frequent) - diagnoses.synchronous_malignancy: ‘False’ (most frequent) - diagnoses.treatment_or_therapy: True (most frequent) - diagnoses.figo_stage: ‘Stage IB1’ (most frequent) - diagnoses.figo_staging_edition_year: ‘2009’ (most frequent)\nDropping rows with missing diagnoses.ajcc_pathologic_m, diagnoses.ajcc_pathologic_n, diagnoses.ajcc_pathologic_t and tumor_grade since they are a small percentage and there is no clear imbalance to guide imputation.\n\n# Drop rows with missing diagnoses.ajcc_pathologic_m, diagnoses.ajcc_pathologic_n, diagnoses.ajcc_pathologic_t and tumor_grade\ncesc_df = cesc_df.dropna(subset=['diagnoses.ajcc_pathologic_m', 'diagnoses.ajcc_pathologic_n', 'diagnoses.ajcc_pathologic_t', 'diagnoses.tumor_grade'])\n\n\n# Replace missing values based on the strategy above:\n\n# Replace with most frequent values\ncesc_df['diagnoses.method_of_diagnosis'] = cesc_df['diagnoses.method_of_diagnosis'].fillna('Biopsy')\ncesc_df['diagnoses.prior_malignancy'] = cesc_df['diagnoses.prior_malignancy'].fillna('no')\ncesc_df['diagnoses.prior_treatment'] = cesc_df['diagnoses.prior_treatment'].fillna('no')\ncesc_df['diagnoses.synchronous_malignancy'] = cesc_df['diagnoses.synchronous_malignancy'].fillna('no')\ncesc_df['treatments.treatment_or_therapy'] = cesc_df['treatments.treatment_or_therapy'].fillna('yes')\ncesc_df['diagnoses.figo_stage'] = cesc_df['diagnoses.figo_stage'].fillna('Stage IB1')\ncesc_df['diagnoses.figo_staging_edition_year'] = cesc_df['diagnoses.figo_staging_edition_year'].fillna(2009)\n\n\n# Check distribution of treatments.treatment_or_therapy after imputation\ntreatment_or_therapy_counts = cesc_df['treatments.treatment_or_therapy'].value_counts(dropna=False)\nprint(\"\\ntreatments.treatment_or_therapy distribution after imputation:\")\nprint(treatment_or_therapy_counts)\n\n\ntreatments.treatment_or_therapy distribution after imputation:\ntreatments.treatment_or_therapy\nyes        583\nno         216\nunknown     73\nName: count, dtype: int64\n\n\n\n# Percentage of missing values in each column\n\nmissing_percentages = cesc_df.isnull().mean() * 100\nprint(\"\\nPercentage of missing values in each column:\")\nprint(missing_percentages)\n\n\nPercentage of missing values in each column:\nproject.project_id                        0.000000\ncases.case_id                             0.000000\ncases.disease_type                        0.000000\ncases.index_date                          0.000000\ncases.lost_to_followup                    0.000000\ncases.primary_site                        0.000000\ncases.submitter_id                        0.000000\ndemographic.days_to_death                92.889908\ndemographic.ethnicity                     0.000000\ndemographic.gender                        0.000000\ndemographic.race                          0.000000\ndemographic.submitter_id                  0.000000\ndemographic.vital_status                  0.000000\ndiagnoses.age_at_diagnosis                0.000000\ndiagnoses.ajcc_pathologic_m               0.000000\ndiagnoses.ajcc_pathologic_n               0.000000\ndiagnoses.ajcc_pathologic_t               0.000000\ndiagnoses.classification_of_tumor         0.000000\ndiagnoses.days_to_diagnosis               0.000000\ndiagnoses.days_to_last_follow_up          0.000000\ndiagnoses.figo_stage                      0.000000\ndiagnoses.figo_staging_edition_year       0.000000\ndiagnoses.method_of_diagnosis             0.000000\ndiagnoses.morphology                      0.000000\ndiagnoses.primary_diagnosis               0.000000\ndiagnoses.prior_malignancy                0.000000\ndiagnoses.prior_treatment                 0.000000\ndiagnoses.site_of_resection_or_biopsy     0.000000\ndiagnoses.submitter_id                    0.000000\ndiagnoses.synchronous_malignancy          0.000000\ndiagnoses.tissue_or_organ_of_origin       0.000000\ndiagnoses.tumor_grade                     0.000000\ntreatments.submitter_id                   0.000000\ntreatments.treatment_or_therapy           0.000000\ntreatments.treatment_type                 0.000000\ndtype: float64\n\n\n\n\nCheck for consistent data types\n\n# Check column data types\n\ncesc_df.info()\n\n&lt;class 'pandas.core.frame.DataFrame'&gt;\nIndex: 872 entries, 3 to 1523\nData columns (total 35 columns):\n #   Column                                 Non-Null Count  Dtype \n---  ------                                 --------------  ----- \n 0   project.project_id                     872 non-null    object\n 1   cases.case_id                          872 non-null    object\n 2   cases.disease_type                     872 non-null    object\n 3   cases.index_date                       872 non-null    object\n 4   cases.lost_to_followup                 872 non-null    object\n 5   cases.primary_site                     872 non-null    object\n 6   cases.submitter_id                     872 non-null    object\n 7   demographic.days_to_death              62 non-null     object\n 8   demographic.ethnicity                  872 non-null    object\n 9   demographic.gender                     872 non-null    object\n 10  demographic.race                       872 non-null    object\n 11  demographic.submitter_id               872 non-null    object\n 12  demographic.vital_status               872 non-null    object\n 13  diagnoses.age_at_diagnosis             872 non-null    object\n 14  diagnoses.ajcc_pathologic_m            872 non-null    object\n 15  diagnoses.ajcc_pathologic_n            872 non-null    object\n 16  diagnoses.ajcc_pathologic_t            872 non-null    object\n 17  diagnoses.classification_of_tumor      872 non-null    object\n 18  diagnoses.days_to_diagnosis            872 non-null    object\n 19  diagnoses.days_to_last_follow_up       872 non-null    object\n 20  diagnoses.figo_stage                   872 non-null    object\n 21  diagnoses.figo_staging_edition_year    872 non-null    object\n 22  diagnoses.method_of_diagnosis          872 non-null    object\n 23  diagnoses.morphology                   872 non-null    object\n 24  diagnoses.primary_diagnosis            872 non-null    object\n 25  diagnoses.prior_malignancy             872 non-null    object\n 26  diagnoses.prior_treatment              872 non-null    object\n 27  diagnoses.site_of_resection_or_biopsy  872 non-null    object\n 28  diagnoses.submitter_id                 872 non-null    object\n 29  diagnoses.synchronous_malignancy       872 non-null    object\n 30  diagnoses.tissue_or_organ_of_origin    872 non-null    object\n 31  diagnoses.tumor_grade                  872 non-null    object\n 32  treatments.submitter_id                872 non-null    object\n 33  treatments.treatment_or_therapy        872 non-null    object\n 34  treatments.treatment_type              872 non-null    object\ndtypes: object(35)\nmemory usage: 245.2+ KB\n\n\n\n# Check the statistical summary of diagnoses.age_at_diagnosis\n\n# Convert to numeric \ncesc_df['diagnoses.age_at_diagnosis'] = pd.to_numeric(cesc_df['diagnoses.age_at_diagnosis'], errors='coerce')\n\n# Statistical summary\nprint(\"Statistical Summary of Age at Diagnosis:\")\nprint(cesc_df['diagnoses.age_at_diagnosis'].describe())\n\nprint(f\"\\nMean: {cesc_df['diagnoses.age_at_diagnosis'].mean():.2f}\")\nprint(f\"Median: {cesc_df['diagnoses.age_at_diagnosis'].median():.2f}\")\nprint(f\"Standard Deviation: {cesc_df['diagnoses.age_at_diagnosis'].std():.2f}\")\nprint(f\"Missing values: {cesc_df['diagnoses.age_at_diagnosis'].isna().sum()}\")\n\nStatistical Summary of Age at Diagnosis:\ncount      872.000000\nmean     17612.810780\nstd       4448.299744\nmin       9186.000000\n25%      14162.000000\n50%      16894.000000\n75%      20286.000000\nmax      29526.000000\nName: diagnoses.age_at_diagnosis, dtype: float64\n\nMean: 17612.81\nMedian: 16894.00\nStandard Deviation: 4448.30\nMissing values: 0\n\n\nThe age at diagnosis column has been converted to numeric but the values are in days. For analysis we will convert these to years by dividing by 365.25 (accounting for leap years) and rounding down\n\n# Convert age at diagnosis from days to years (integer)\ncesc_df['diagnoses.age_at_diagnosis'] = (cesc_df['diagnoses.age_at_diagnosis'] / 365.25).apply(np.floor)\n\n\n# Convert to integer\ncesc_df['diagnoses.age_at_diagnosis'] = pd.to_numeric(\n    cesc_df['diagnoses.age_at_diagnosis'], \n    errors='coerce'\n)\ncesc_df['diagnoses.age_at_diagnosis'].dtype\n\ndtype('float64')\n\n\n\n# Change all object type columns to lowercase\nfor col in cesc_df.select_dtypes(include=['object']).columns:\n    cesc_df[col] = cesc_df[col].astype(str).str.lower().replace('nan', np.nan)\n\n\n# Strip whitespace from string columns\nfor col in cesc_df.select_dtypes(include=['object']).columns:\n    cesc_df[col] = cesc_df[col].str.strip()\n\nChange other columns to boolean as appropriate: - diagnoses.diagnosis_is_primary_disease (from true/false strings) - diagnoses.prior_malignancy (from no/yes strings) - diagnoses.prior_treatment (from No/Yes strings) - diagnoses.synchronous_malignancy (from no/yes strings)\n\n# Convert diagnosis-related columns to boolean\n\n# Convert diagnoses.prior_malignancy (yes/no to boolean)\ncesc_df['diagnoses.prior_malignancy'] = cesc_df['diagnoses.prior_malignancy'].map({'yes': True, 'no': False})\n\n# Convert diagnoses.prior_treatment (yes/no to boolean)\ncesc_df['diagnoses.prior_treatment'] = cesc_df['diagnoses.prior_treatment'].map({'yes': True, 'no': False})\n\n# Convert diagnoses.synchronous_malignancy (yes/no to boolean)\ncesc_df['diagnoses.synchronous_malignancy'] = cesc_df['diagnoses.synchronous_malignancy'].map({'yes': True, 'no': False})\n\n# Check the conversions\nprint(\"Conversion results:\")\nprint(f\"diagnoses.prior_malignancy dtype: {cesc_df['diagnoses.prior_malignancy'].dtype}\")\nprint(f\"diagnoses.prior_treatment dtype: {cesc_df['diagnoses.prior_treatment'].dtype}\")\nprint(f\"diagnoses.synchronous_malignancy dtype: {cesc_df['diagnoses.synchronous_malignancy'].dtype}\")\n\nprint(\"\\nValue counts for each column:\")\nfor col in ['diagnoses.prior_malignancy', \n           'diagnoses.prior_treatment', 'diagnoses.synchronous_malignancy']:\n    print(f\"\\n{col}:\")\n    print(cesc_df[col].value_counts())\n\nConversion results:\ndiagnoses.prior_malignancy dtype: object\ndiagnoses.prior_treatment dtype: bool\ndiagnoses.synchronous_malignancy dtype: object\n\nValue counts for each column:\n\ndiagnoses.prior_malignancy:\ndiagnoses.prior_malignancy\nFalse    854\nTrue      15\nName: count, dtype: int64\n\ndiagnoses.prior_treatment:\ndiagnoses.prior_treatment\nFalse    872\nName: count, dtype: int64\n\ndiagnoses.synchronous_malignancy:\ndiagnoses.synchronous_malignancy\nFalse    869\nName: count, dtype: int64\n\n\n\n\nData Engineering\n\n# Percentage of missing values in each column\nmissing_percentages = cesc_df.isnull().mean() * 100\nprint(\"\\nPercentage of missing values in each column:\")\nprint(missing_percentages)\n\n\nPercentage of missing values in each column:\nproject.project_id                        0.000000\ncases.case_id                             0.000000\ncases.disease_type                        0.000000\ncases.index_date                          0.000000\ncases.lost_to_followup                    0.000000\ncases.primary_site                        0.000000\ncases.submitter_id                        0.000000\ndemographic.days_to_death                92.889908\ndemographic.ethnicity                     0.000000\ndemographic.gender                        0.000000\ndemographic.race                          0.000000\ndemographic.submitter_id                  0.000000\ndemographic.vital_status                  0.000000\ndiagnoses.age_at_diagnosis                0.000000\ndiagnoses.ajcc_pathologic_m               0.000000\ndiagnoses.ajcc_pathologic_n               0.000000\ndiagnoses.ajcc_pathologic_t               0.000000\ndiagnoses.classification_of_tumor         0.000000\ndiagnoses.days_to_diagnosis               0.000000\ndiagnoses.days_to_last_follow_up          0.000000\ndiagnoses.figo_stage                      0.000000\ndiagnoses.figo_staging_edition_year       0.000000\ndiagnoses.method_of_diagnosis             0.000000\ndiagnoses.morphology                      0.000000\ndiagnoses.primary_diagnosis               0.000000\ndiagnoses.prior_malignancy                0.344037\ndiagnoses.prior_treatment                 0.000000\ndiagnoses.site_of_resection_or_biopsy     0.000000\ndiagnoses.submitter_id                    0.000000\ndiagnoses.synchronous_malignancy          0.344037\ndiagnoses.tissue_or_organ_of_origin       0.000000\ndiagnoses.tumor_grade                     0.000000\ntreatments.submitter_id                   0.000000\ntreatments.treatment_or_therapy           0.000000\ntreatments.treatment_type                 0.000000\ndtype: float64\n\n\n\n# Check percentage of missing values in days_to_death when vital_status is 'dead'\nmissing_death_percentage = cesc_df[cesc_df['demographic.vital_status'] == 'dead']['demographic.days_to_death'].isnull().mean()\nprint(f\"Percentage of missing values in 'demographic.days_to_death' when vital_status is 'dead': {missing_death_percentage:.2%}\")    \n\nPercentage of missing values in 'demographic.days_to_death' when vital_status is 'dead': 0.00%\n\n\n\n# Percentage of missing values in days_to_last_follow_up when vital_status is 'alive'\nmissing_followup_percentage = cesc_df[cesc_df['demographic.vital_status'] == 'alive']['diagnoses.days_to_last_follow_up'].isnull().mean()\nprint(f\"Percentage of missing values in 'diagnoses.days_to_last_follow_up' when vital_status is 'alive': {missing_followup_percentage:.2%}\")\n\nPercentage of missing values in 'diagnoses.days_to_last_follow_up' when vital_status is 'alive': 0.00%\n\n\n\n# Create survival time column based on vital status\ndef calculate_survival_time(row):\n    if row['demographic.vital_status'] == 'dead':\n        return row['demographic.days_to_death']\n    elif row['demographic.vital_status'] == 'alive':\n        return row['diagnoses.days_to_last_follow_up']\n    else:\n        return np.nan\n    \ncesc_df['survival_time_days'] = cesc_df.apply(calculate_survival_time, axis=1)\n\n\n# Check percentage of missing values in survival_time_days\nmissing_percentage = cesc_df['survival_time_days'].isnull().mean() * 100\nprint(f\"Percentage of missing values in 'survival_time_days': {missing_percentage:.2f}%\")\n\nPercentage of missing values in 'survival_time_days': 0.00%\n\n\n\n# Drop rows with missing survival_time_days\ncesc_df = cesc_df[cesc_df['survival_time_days'].notna()]\ncesc_df.shape\n\n(872, 36)\n\n\n\n# Drop duplicate rows before feature engineering\ncesc_df = cesc_df.drop_duplicates()\ncesc_df.shape\n\n(872, 36)\n\n\n\n# Extract diagnoses.behavior from diagnoses.morphology column (e.g., 8500/3 -&gt; 3 where 3 is the behavior code)\n\n# Mappings for behavior codes\nbehavior_mapping = {\n    '0': 'benign',\n    '2': 'in situ',\n    '3': 'malignant'\n}\n# Extract behavior code and map to descriptive labels\ncesc_df['diagnoses.behavior'] = cesc_df['diagnoses.morphology'].str.split('/').str[1].map(behavior_mapping)\n# Check the new column\nprint(\"Value counts for diagnoses.behavior:\")\nprint(cesc_df['diagnoses.behavior'].value_counts())\n\nValue counts for diagnoses.behavior:\ndiagnoses.behavior\nmalignant    872\nName: count, dtype: int64\n\n\nNote: There is a heavy class imbalance for diagnoses.behavior as over 95% of the entries are malignant.\n\ncesc_df.head()\n\n\n\n\n\n\n\n\nproject.project_id\ncases.case_id\ncases.disease_type\ncases.index_date\ncases.lost_to_followup\ncases.primary_site\ncases.submitter_id\ndemographic.days_to_death\ndemographic.ethnicity\ndemographic.gender\ndemographic.race\ndemographic.submitter_id\ndemographic.vital_status\ndiagnoses.age_at_diagnosis\ndiagnoses.ajcc_pathologic_m\ndiagnoses.ajcc_pathologic_n\ndiagnoses.ajcc_pathologic_t\ndiagnoses.classification_of_tumor\ndiagnoses.days_to_diagnosis\ndiagnoses.days_to_last_follow_up\ndiagnoses.figo_stage\ndiagnoses.figo_staging_edition_year\ndiagnoses.method_of_diagnosis\ndiagnoses.morphology\ndiagnoses.primary_diagnosis\ndiagnoses.prior_malignancy\ndiagnoses.prior_treatment\ndiagnoses.site_of_resection_or_biopsy\ndiagnoses.submitter_id\ndiagnoses.synchronous_malignancy\ndiagnoses.tissue_or_organ_of_origin\ndiagnoses.tumor_grade\ntreatments.submitter_id\ntreatments.treatment_or_therapy\ntreatments.treatment_type\nsurvival_time_days\ndiagnoses.behavior\n\n\n\n\n3\ntcga-cesc\n00bca18c-b3d4-45a3-8f19-034cc40449a4\nsquamous cell neoplasms\ndiagnosis\nyes\ncervix uteri\ntcga-c5-a2lv\nNaN\nnot hispanic or latino\nfemale\nblack or african american\ntcga-c5-a2lv_demographic\nalive\n36.0\nmx\nn1\nt1b\nprimary\n0\n2234.0\nstage ib\n1995\nbiopsy\n8070/3\nsquamous cell carcinoma, nos\nFalse\nFalse\ncervix uteri\ntcga-c5-a2lv_diagnosis\nFalse\ncervix uteri\ng3\ntcga-c5-a2lv_treatment3\nyes\nhysterectomy, nos\n2234.0\nmalignant\n\n\n4\ntcga-cesc\n00bca18c-b3d4-45a3-8f19-034cc40449a4\nsquamous cell neoplasms\ndiagnosis\nyes\ncervix uteri\ntcga-c5-a2lv\nNaN\nnot hispanic or latino\nfemale\nblack or african american\ntcga-c5-a2lv_demographic\nalive\n36.0\nmx\nn1\nt1b\nprimary\n0\n2234.0\nstage ib\n1995\nbiopsy\n8070/3\nsquamous cell carcinoma, nos\nFalse\nFalse\ncervix uteri\ntcga-c5-a2lv_diagnosis\nFalse\ncervix uteri\ng3\ntcga-c5-a2lv_treatment2\nno\nradiation therapy, nos\n2234.0\nmalignant\n\n\n5\ntcga-cesc\n00bca18c-b3d4-45a3-8f19-034cc40449a4\nsquamous cell neoplasms\ndiagnosis\nyes\ncervix uteri\ntcga-c5-a2lv\nNaN\nnot hispanic or latino\nfemale\nblack or african american\ntcga-c5-a2lv_demographic\nalive\n36.0\nmx\nn1\nt1b\nprimary\n0\n2234.0\nstage ib\n1995\nbiopsy\n8070/3\nsquamous cell carcinoma, nos\nFalse\nFalse\ncervix uteri\ntcga-c5-a2lv_diagnosis\nFalse\ncervix uteri\ng3\ntcga-c5-a2lv_treatment\nno\npharmaceutical therapy, nos\n2234.0\nmalignant\n\n\n11\ntcga-cesc\n03804f9b-df7c-462c-8984-8eb3a5ed4999\nsquamous cell neoplasms\ndiagnosis\nno\ncervix uteri\ntcga-vs-a9v2\nNaN\nnot reported\nfemale\nwhite\ntcga-vs-a9v2_demographic\nalive\n29.0\nmx\nn0\nt1b\nprimary\n0\n555.0\nstage ib1\n2009\nbiopsy\n8070/3\nsquamous cell carcinoma, nos\nFalse\nFalse\ncervix uteri\ntcga-vs-a9v2_diagnosis\nFalse\ncervix uteri\ng2\ntcga-vs-a9v2_treatment3\nyes\nradiation, 3d conformal\n555.0\nmalignant\n\n\n12\ntcga-cesc\n03804f9b-df7c-462c-8984-8eb3a5ed4999\nsquamous cell neoplasms\ndiagnosis\nno\ncervix uteri\ntcga-vs-a9v2\nNaN\nnot reported\nfemale\nwhite\ntcga-vs-a9v2_demographic\nalive\n29.0\nmx\nn0\nt1b\nprimary\n0\n555.0\nstage ib1\n2009\nbiopsy\n8070/3\nsquamous cell carcinoma, nos\nFalse\nFalse\ncervix uteri\ntcga-vs-a9v2_diagnosis\nFalse\ncervix uteri\ng2\ntcga-vs-a9v2_treatment2\nno\npharmaceutical therapy, nos\n555.0\nmalignant\n\n\n\n\n\n\n\n\n# Check distribution of missing values in columns after cleaning and data engineering\nmissing_percentages = cesc_df.isnull().mean() * 100\nprint(\"\\nPercentage of missing values in each column:\")\nprint(missing_percentages)\n\n\nPercentage of missing values in each column:\nproject.project_id                        0.000000\ncases.case_id                             0.000000\ncases.disease_type                        0.000000\ncases.index_date                          0.000000\ncases.lost_to_followup                    0.000000\ncases.primary_site                        0.000000\ncases.submitter_id                        0.000000\ndemographic.days_to_death                92.889908\ndemographic.ethnicity                     0.000000\ndemographic.gender                        0.000000\ndemographic.race                          0.000000\ndemographic.submitter_id                  0.000000\ndemographic.vital_status                  0.000000\ndiagnoses.age_at_diagnosis                0.000000\ndiagnoses.ajcc_pathologic_m               0.000000\ndiagnoses.ajcc_pathologic_n               0.000000\ndiagnoses.ajcc_pathologic_t               0.000000\ndiagnoses.classification_of_tumor         0.000000\ndiagnoses.days_to_diagnosis               0.000000\ndiagnoses.days_to_last_follow_up          0.000000\ndiagnoses.figo_stage                      0.000000\ndiagnoses.figo_staging_edition_year       0.000000\ndiagnoses.method_of_diagnosis             0.000000\ndiagnoses.morphology                      0.000000\ndiagnoses.primary_diagnosis               0.000000\ndiagnoses.prior_malignancy                0.344037\ndiagnoses.prior_treatment                 0.000000\ndiagnoses.site_of_resection_or_biopsy     0.000000\ndiagnoses.submitter_id                    0.000000\ndiagnoses.synchronous_malignancy          0.344037\ndiagnoses.tissue_or_organ_of_origin       0.000000\ndiagnoses.tumor_grade                     0.000000\ntreatments.submitter_id                   0.000000\ntreatments.treatment_or_therapy           0.000000\ntreatments.treatment_type                 0.000000\nsurvival_time_days                        0.000000\ndiagnoses.behavior                        0.000000\ndtype: float64\n\n\n\n# Replace missing prior_malignancy and synchronous_malignancy with False\ncesc_df['diagnoses.prior_malignancy'] = cesc_df['diagnoses.prior_malignancy'].fillna(False)\ncesc_df['diagnoses.synchronous_malignancy'] = cesc_df['diagnoses.synchronous_malignancy'].fillna(False)\n\n\ncesc_df.head(1)\n\n\n\n\n\n\n\n\nproject.project_id\ncases.case_id\ncases.disease_type\ncases.index_date\ncases.lost_to_followup\ncases.primary_site\ncases.submitter_id\ndemographic.days_to_death\ndemographic.ethnicity\ndemographic.gender\ndemographic.race\ndemographic.submitter_id\ndemographic.vital_status\ndiagnoses.age_at_diagnosis\ndiagnoses.ajcc_pathologic_m\ndiagnoses.ajcc_pathologic_n\ndiagnoses.ajcc_pathologic_t\ndiagnoses.classification_of_tumor\ndiagnoses.days_to_diagnosis\ndiagnoses.days_to_last_follow_up\ndiagnoses.figo_stage\ndiagnoses.figo_staging_edition_year\ndiagnoses.method_of_diagnosis\ndiagnoses.morphology\ndiagnoses.primary_diagnosis\ndiagnoses.prior_malignancy\ndiagnoses.prior_treatment\ndiagnoses.site_of_resection_or_biopsy\ndiagnoses.submitter_id\ndiagnoses.synchronous_malignancy\ndiagnoses.tissue_or_organ_of_origin\ndiagnoses.tumor_grade\ntreatments.submitter_id\ntreatments.treatment_or_therapy\ntreatments.treatment_type\nsurvival_time_days\ndiagnoses.behavior\n\n\n\n\n3\ntcga-cesc\n00bca18c-b3d4-45a3-8f19-034cc40449a4\nsquamous cell neoplasms\ndiagnosis\nyes\ncervix uteri\ntcga-c5-a2lv\nNaN\nnot hispanic or latino\nfemale\nblack or african american\ntcga-c5-a2lv_demographic\nalive\n36.0\nmx\nn1\nt1b\nprimary\n0\n2234.0\nstage ib\n1995\nbiopsy\n8070/3\nsquamous cell carcinoma, nos\nFalse\nFalse\ncervix uteri\ntcga-c5-a2lv_diagnosis\nFalse\ncervix uteri\ng3\ntcga-c5-a2lv_treatment3\nyes\nhysterectomy, nos\n2234.0\nmalignant\n\n\n\n\n\n\n\n\n\nCervical cancer exposure data cleaning\n\n# Open cesc exposure tsv data\n\ncesc_exposure_df = pd.read_csv('../../data/raw-data/cesc/exposure.tsv', sep='\\t')\ncesc_exposure_df.head(3)\n\n\n\n\n\n\n\n\nproject.project_id\ncases.case_id\ncases.submitter_id\nexposures.age_at_last_exposure\nexposures.age_at_onset\nexposures.alcohol_days_per_week\nexposures.alcohol_drinks_per_day\nexposures.alcohol_frequency\nexposures.alcohol_history\nexposures.alcohol_intensity\nexposures.alcohol_type\nexposures.asbestos_exposure\nexposures.asbestos_exposure_type\nexposures.chemical_exposure_type\nexposures.cigarettes_per_day\nexposures.coal_dust_exposure\nexposures.environmental_tobacco_smoke_exposure\nexposures.exposure_duration\nexposures.exposure_duration_hrs_per_day\nexposures.exposure_duration_years\nexposures.exposure_id\nexposures.exposure_source\nexposures.exposure_type\nexposures.occupation_duration_years\nexposures.occupation_type\nexposures.pack_years_smoked\nexposures.parent_with_radiation_exposure\nexposures.radon_exposure\nexposures.respirable_crystalline_silica_exposure\nexposures.secondhand_smoke_as_child\nexposures.smoking_frequency\nexposures.submitter_id\nexposures.time_between_waking_and_first_smoke\nexposures.tobacco_smoking_onset_year\nexposures.tobacco_smoking_quit_year\nexposures.tobacco_smoking_status\nexposures.type_of_smoke_exposure\nexposures.type_of_tobacco_used\nexposures.use_per_day\nexposures.years_smoked\n\n\n\n\n0\nTCGA-CESC\n00ad0ffe-2105-4829-a495-1c2aceb5bb31\nTCGA-EK-A2R9\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\nTobacco\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\nNot Reported\n'--\n'--\n'--\n'--\n\n\n1\nTCGA-CESC\n00bca18c-b3d4-45a3-8f19-034cc40449a4\nTCGA-C5-A2LV\n'--\n20\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\nTobacco\n'--\n'--\n16.0\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\nCurrent Smoker\n'--\n'--\n'--\n'--\n\n\n2\nTCGA-CESC\n010a807f-9dc0-4e14-9533-dcf478f3d947\nTCGA-C5-A902\n'--\n14\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\nTobacco\n'--\n'--\n21.0\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n'--\nCurrent Smoker\n'--\n'--\n'--\n'--\n\n\n\n\n\n\n\n\n# Change every column to lowercase\nfor col in cesc_exposure_df.select_dtypes(include=['object']).columns:\n    cesc_exposure_df[col] = cesc_exposure_df[col].astype(str).str.lower().replace('nan', np.nan)\n\n\n# Strip whitespace from string columns\nfor col in cesc_exposure_df.select_dtypes(include=['object']).columns:\n    cesc_exposure_df[col] = cesc_exposure_df[col].str.strip()\n\n\n# Double check for common cases.submitter_id between clinical and exposure datasets\ncommon_ids = set(cesc_df['cases.submitter_id']).intersection(set(cesc_exposure_df['cases.submitter_id']))\nprint(f\"Number of common cases.submitter_id between clinical and exposure datasets: {len(common_ids)}\")\n\nNumber of common cases.submitter_id between clinical and exposure datasets: 184\n\n\n\n# Replace \"'--\" as NA\ncesc_exposure_df.replace('\\'--', np.nan, inplace=True)\ncesc_exposure_df.replace('\\'--', np.nan, inplace=True)\n\n\n# Check distribution of null values in exposure dataset\nmissing_percentages = cesc_exposure_df.isnull().mean() * 100\nprint(\"\\nPercentage of missing values in each column of exposure dataset:\")\nprint(missing_percentages)\n\n\nPercentage of missing values in each column of exposure dataset:\nproject.project_id                                    0.000000\ncases.case_id                                         0.000000\ncases.submitter_id                                    0.000000\nexposures.age_at_last_exposure                      100.000000\nexposures.age_at_onset                               72.312704\nexposures.alcohol_days_per_week                     100.000000\nexposures.alcohol_drinks_per_day                    100.000000\nexposures.alcohol_frequency                         100.000000\nexposures.alcohol_history                           100.000000\nexposures.alcohol_intensity                         100.000000\nexposures.alcohol_type                              100.000000\nexposures.asbestos_exposure                         100.000000\nexposures.asbestos_exposure_type                    100.000000\nexposures.chemical_exposure_type                    100.000000\nexposures.cigarettes_per_day                        100.000000\nexposures.coal_dust_exposure                        100.000000\nexposures.environmental_tobacco_smoke_exposure      100.000000\nexposures.exposure_duration                         100.000000\nexposures.exposure_duration_hrs_per_day             100.000000\nexposures.exposure_duration_years                   100.000000\nexposures.exposure_id                               100.000000\nexposures.exposure_source                           100.000000\nexposures.exposure_type                               0.000000\nexposures.occupation_duration_years                 100.000000\nexposures.occupation_type                           100.000000\nexposures.pack_years_smoked                          69.706840\nexposures.parent_with_radiation_exposure            100.000000\nexposures.radon_exposure                            100.000000\nexposures.respirable_crystalline_silica_exposure    100.000000\nexposures.secondhand_smoke_as_child                 100.000000\nexposures.smoking_frequency                         100.000000\nexposures.submitter_id                              100.000000\nexposures.time_between_waking_and_first_smoke       100.000000\nexposures.tobacco_smoking_onset_year                100.000000\nexposures.tobacco_smoking_quit_year                  85.993485\nexposures.tobacco_smoking_status                      0.000000\nexposures.type_of_smoke_exposure                    100.000000\nexposures.type_of_tobacco_used                      100.000000\nexposures.use_per_day                               100.000000\nexposures.years_smoked                              100.000000\ndtype: float64\n\n\n\n# Check exposures.tobacco_smoking_status column since they are the only ones with low missing values\nsmoking_status_counts = cesc_exposure_df['exposures.tobacco_smoking_status'].value_counts(dropna=False)\nprint(\"\\nexposures.tobacco_smoking_status distribution:\")\nprint(smoking_status_counts)\n\n\nexposures.tobacco_smoking_status distribution:\nexposures.tobacco_smoking_status\nlifelong non-smoker                                146\ncurrent smoker                                      64\ncurrent reformed smoker for &lt; or = 15 yrs           40\nnot reported                                        32\nunknown                                             12\ncurrent reformed smoker for &gt; 15 yrs                 9\ncurrent reformed smoker, duration not specified      4\nName: count, dtype: int64\n\n\n\n# Join clinical and exposure datasets on cases.submitter_id preserving only exposures.tobacco_smoking_status from exposure dataset\ncesc_merged_df = pd.merge(\n    cesc_df,\n    cesc_exposure_df[['cases.submitter_id', 'exposures.tobacco_smoking_status']],\n    on='cases.submitter_id',\n    how='left'\n)\n\n\ncesc_exposure_df[\"exposures.tobacco_smoking_status\"].head(5)\n\n0                                 not reported\n1                               current smoker\n2                               current smoker\n3                          lifelong non-smoker\n4    current reformed smoker for &lt; or = 15 yrs\nName: exposures.tobacco_smoking_status, dtype: object\n\n\n\ncesc_merged_df.head(1)\n\n\n\n\n\n\n\n\nproject.project_id\ncases.case_id\ncases.disease_type\ncases.index_date\ncases.lost_to_followup\ncases.primary_site\ncases.submitter_id\ndemographic.days_to_death\ndemographic.ethnicity\ndemographic.gender\ndemographic.race\ndemographic.submitter_id\ndemographic.vital_status\ndiagnoses.age_at_diagnosis\ndiagnoses.ajcc_pathologic_m\ndiagnoses.ajcc_pathologic_n\ndiagnoses.ajcc_pathologic_t\ndiagnoses.classification_of_tumor\ndiagnoses.days_to_diagnosis\ndiagnoses.days_to_last_follow_up\ndiagnoses.figo_stage\ndiagnoses.figo_staging_edition_year\ndiagnoses.method_of_diagnosis\ndiagnoses.morphology\ndiagnoses.primary_diagnosis\ndiagnoses.prior_malignancy\ndiagnoses.prior_treatment\ndiagnoses.site_of_resection_or_biopsy\ndiagnoses.submitter_id\ndiagnoses.synchronous_malignancy\ndiagnoses.tissue_or_organ_of_origin\ndiagnoses.tumor_grade\ntreatments.submitter_id\ntreatments.treatment_or_therapy\ntreatments.treatment_type\nsurvival_time_days\ndiagnoses.behavior\nexposures.tobacco_smoking_status\n\n\n\n\n0\ntcga-cesc\n00bca18c-b3d4-45a3-8f19-034cc40449a4\nsquamous cell neoplasms\ndiagnosis\nyes\ncervix uteri\ntcga-c5-a2lv\nNaN\nnot hispanic or latino\nfemale\nblack or african american\ntcga-c5-a2lv_demographic\nalive\n36.0\nmx\nn1\nt1b\nprimary\n0\n2234.0\nstage ib\n1995\nbiopsy\n8070/3\nsquamous cell carcinoma, nos\nFalse\nFalse\ncervix uteri\ntcga-c5-a2lv_diagnosis\nFalse\ncervix uteri\ng3\ntcga-c5-a2lv_treatment3\nyes\nhysterectomy, nos\n2234.0\nmalignant\ncurrent smoker\n\n\n\n\n\n\n\n\n# View percentage of missing values in columns after merging\nmissing_percentages = cesc_merged_df.isnull().mean() * 100\nprint(\"\\nPercentage of missing values in each column after merging:\")\nprint(missing_percentages)\n\n\nPercentage of missing values in each column after merging:\nproject.project_id                        0.000000\ncases.case_id                             0.000000\ncases.disease_type                        0.000000\ncases.index_date                          0.000000\ncases.lost_to_followup                    0.000000\ncases.primary_site                        0.000000\ncases.submitter_id                        0.000000\ndemographic.days_to_death                92.889908\ndemographic.ethnicity                     0.000000\ndemographic.gender                        0.000000\ndemographic.race                          0.000000\ndemographic.submitter_id                  0.000000\ndemographic.vital_status                  0.000000\ndiagnoses.age_at_diagnosis                0.000000\ndiagnoses.ajcc_pathologic_m               0.000000\ndiagnoses.ajcc_pathologic_n               0.000000\ndiagnoses.ajcc_pathologic_t               0.000000\ndiagnoses.classification_of_tumor         0.000000\ndiagnoses.days_to_diagnosis               0.000000\ndiagnoses.days_to_last_follow_up          0.000000\ndiagnoses.figo_stage                      0.000000\ndiagnoses.figo_staging_edition_year       0.000000\ndiagnoses.method_of_diagnosis             0.000000\ndiagnoses.morphology                      0.000000\ndiagnoses.primary_diagnosis               0.000000\ndiagnoses.prior_malignancy                0.000000\ndiagnoses.prior_treatment                 0.000000\ndiagnoses.site_of_resection_or_biopsy     0.000000\ndiagnoses.submitter_id                    0.000000\ndiagnoses.synchronous_malignancy          0.000000\ndiagnoses.tissue_or_organ_of_origin       0.000000\ndiagnoses.tumor_grade                     0.000000\ntreatments.submitter_id                   0.000000\ntreatments.treatment_or_therapy           0.000000\ntreatments.treatment_type                 0.000000\nsurvival_time_days                        0.000000\ndiagnoses.behavior                        0.000000\nexposures.tobacco_smoking_status          0.000000\ndtype: float64\n\n\n\n\nSave processed dataset\n\n# Save cleaned dataset to a new TSV file\ncesc_merged_df.to_csv(\"../../data/processed-data/cesc/cesc-clinical-processed.tsv\", sep=\"\\t\", index=False)"
  },
  {
    "objectID": "technical-details/data-collection/main.html",
    "href": "technical-details/data-collection/main.html",
    "title": "Data Collection",
    "section": "",
    "text": "The data used in this project were obtained from the National Cancer Institute (NCI) Genomic Data Commons (GDC)1, a centralized repository designed to support cancer research by providing harmonized clinical, genomic, and exposure-related data across multiple cancer types. The GDC integrates data from large-scale initiatives such as The Cancer Genome Atlas (TCGA)2 and applies standardized data models, vocabularies, and quality control procedures to ensure consistency and reproducibility across studies.\n{alt = “National Cancer Institute Genomic Data Commons home page”}\n\n\n\nFor this analysis, we focused on two TCGA cohorts: Breast Invasive Carcinoma (TCGA-BRCA) and Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA-CESC). These datasets were selected to enable comparative analysis of two common cancers affecting women, while allowing investigation into differences in tumor characteristics, treatment patterns, and survival outcomes.\nClinical data were downloaded from the GDC Data Portal in tabular format (clinical.tsv and related files), which aggregate information across several hierarchical entities, including cases, demographic, diagnoses, treatments, and exposures. Variables include patient-level demographics (e.g., age at diagnosis, race, vital status), tumor-specific characteristics (e.g., stage, grade, morphology), treatment indicators (e.g., treatment type), and outcome-related fields (e.g., days to last follow-up). All time-to-event variables in the GDC are reported in days, indexed relative to clinically meaningful anchor points such as diagnosis or enrollment dates.\n{alt = “National Cancer Institute Genomic Data Commons data download page”}\n\n\n\nImportantly, the GDC data are de-identified to protect patient privacy, and certain variables may be obfuscated or missing by design. For example, ages above a threshold may be masked, dates may be offset, and exposure variables such as smoking status may be underreported. Additionally, patients may have multiple rows per case, reflecting repeated diagnoses, treatments, or follow-up events, necessitating aggregation and careful preprocessing prior to modeling.\n#| echo: false\n#| warning: false\n#| tbl-cap: Rows showing a unique patient (cases.submitter_id) and their different treatments for breast cancer\nimport pandas as pd\n\n# Import dataset\nbrca_df = pd.read_csv(\"../../data/raw-data/brca/brca-clinical.tsv\", sep=\"\\t\")\n\n# Show rows for patient TCGA-E2-A1IU with selected columns\npatient_data = brca_df[brca_df[\"cases.submitter_id\"] == \"TCGA-E2-A1IU\"]\ncolumns_to_show = [\"cases.submitter_id\", \"treatments.treatment_type\", \n                   \"treatments.treatment_intent_type\", \"demographic.vital_status\",\n                   \"diagnoses.ajcc_pathologic_stage\"]\npatient_data[columns_to_show]\n\n\n\n\nWhile TCGA cohorts are not fully representative of the general U.S. population, they remain one of the most comprehensive publicly available cancer datasets, widely used in both biomedical and data science research. The use of GDC data enables reproducible analysis while providing sufficient clinical depth to explore survival patterns and predictive modeling across cancer types.\nOur raw data can be found in our repository here, including a data dictionary.\nAs of 11/05/2025, - the clinical breast cancer dataset originally has 5546 rows and 210 columns representing 1098 patients - the clinical cervical cancer dataset originally has 1535 rows and 210 columns representing 307 patients"
  },
  {
    "objectID": "technical-details/data-collection/main.html#data-source",
    "href": "technical-details/data-collection/main.html#data-source",
    "title": "Data Collection",
    "section": "",
    "text": "The data used in this project were obtained from the National Cancer Institute (NCI) Genomic Data Commons (GDC)1, a centralized repository designed to support cancer research by providing harmonized clinical, genomic, and exposure-related data across multiple cancer types. The GDC integrates data from large-scale initiatives such as The Cancer Genome Atlas (TCGA)2 and applies standardized data models, vocabularies, and quality control procedures to ensure consistency and reproducibility across studies.\n{alt = “National Cancer Institute Genomic Data Commons home page”}"
  },
  {
    "objectID": "technical-details/data-collection/main.html#data-collection-methods",
    "href": "technical-details/data-collection/main.html#data-collection-methods",
    "title": "Data Collection",
    "section": "",
    "text": "For this analysis, we focused on two TCGA cohorts: Breast Invasive Carcinoma (TCGA-BRCA) and Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA-CESC). These datasets were selected to enable comparative analysis of two common cancers affecting women, while allowing investigation into differences in tumor characteristics, treatment patterns, and survival outcomes.\nClinical data were downloaded from the GDC Data Portal in tabular format (clinical.tsv and related files), which aggregate information across several hierarchical entities, including cases, demographic, diagnoses, treatments, and exposures. Variables include patient-level demographics (e.g., age at diagnosis, race, vital status), tumor-specific characteristics (e.g., stage, grade, morphology), treatment indicators (e.g., treatment type), and outcome-related fields (e.g., days to last follow-up). All time-to-event variables in the GDC are reported in days, indexed relative to clinically meaningful anchor points such as diagnosis or enrollment dates.\n{alt = “National Cancer Institute Genomic Data Commons data download page”}"
  },
  {
    "objectID": "technical-details/data-collection/main.html#data-structure-and-format",
    "href": "technical-details/data-collection/main.html#data-structure-and-format",
    "title": "Data Collection",
    "section": "",
    "text": "Importantly, the GDC data are de-identified to protect patient privacy, and certain variables may be obfuscated or missing by design. For example, ages above a threshold may be masked, dates may be offset, and exposure variables such as smoking status may be underreported. Additionally, patients may have multiple rows per case, reflecting repeated diagnoses, treatments, or follow-up events, necessitating aggregation and careful preprocessing prior to modeling.\n#| echo: false\n#| warning: false\n#| tbl-cap: Rows showing a unique patient (cases.submitter_id) and their different treatments for breast cancer\nimport pandas as pd\n\n# Import dataset\nbrca_df = pd.read_csv(\"../../data/raw-data/brca/brca-clinical.tsv\", sep=\"\\t\")\n\n# Show rows for patient TCGA-E2-A1IU with selected columns\npatient_data = brca_df[brca_df[\"cases.submitter_id\"] == \"TCGA-E2-A1IU\"]\ncolumns_to_show = [\"cases.submitter_id\", \"treatments.treatment_type\", \n                   \"treatments.treatment_intent_type\", \"demographic.vital_status\",\n                   \"diagnoses.ajcc_pathologic_stage\"]\npatient_data[columns_to_show]"
  },
  {
    "objectID": "technical-details/data-collection/main.html#data",
    "href": "technical-details/data-collection/main.html#data",
    "title": "Data Collection",
    "section": "",
    "text": "While TCGA cohorts are not fully representative of the general U.S. population, they remain one of the most comprehensive publicly available cancer datasets, widely used in both biomedical and data science research. The use of GDC data enables reproducible analysis while providing sufficient clinical depth to explore survival patterns and predictive modeling across cancer types.\nOur raw data can be found in our repository here, including a data dictionary.\nAs of 11/05/2025, - the clinical breast cancer dataset originally has 5546 rows and 210 columns representing 1098 patients - the clinical cervical cancer dataset originally has 1535 rows and 210 columns representing 307 patients"
  },
  {
    "objectID": "technical-details/data-collection/main.html#breast-brca-cancer-dataset",
    "href": "technical-details/data-collection/main.html#breast-brca-cancer-dataset",
    "title": "Data Collection",
    "section": "Breast (BRCA) Cancer Dataset",
    "text": "Breast (BRCA) Cancer Dataset\n\n# Open BRCA clinical tsv data\n\nbrca = pd.read_csv('../../data/raw-data/brca/brca-clinical.tsv', sep='\\t')\nbrca.head()\n\n/var/folders/pk/q040shz17k97bg4ndnn1q0b00000gn/T/ipykernel_45563/1166326151.py:3: DtypeWarning: Columns (10) have mixed types. Specify dtype option on import or set low_memory=False.\n  brca = pd.read_csv('../../data/raw-data/brca/brca-clinical.tsv', sep='\\t')\n\n\n\n\n\n\n\n\n\nproject.project_id\ncases.case_id\ncases.consent_type\ncases.days_to_consent\ncases.days_to_lost_to_followup\ncases.disease_type\ncases.index_date\ncases.lost_to_followup\ncases.primary_site\ncases.submitter_id\n...\ntreatments.treatment_duration\ntreatments.treatment_effect\ntreatments.treatment_effect_indicator\ntreatments.treatment_frequency\ntreatments.treatment_id\ntreatments.treatment_intent_type\ntreatments.treatment_or_therapy\ntreatments.treatment_outcome\ntreatments.treatment_outcome_duration\ntreatments.treatment_type\n\n\n\n\n0\nTCGA-BRCA\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nInformed Consent\n-34\n'--\nDuctal and Lobular Neoplasms\nDiagnosis\n'--\nBreast\nTCGA-E2-A1IU\n...\n'--\n'--\n'--\n'--\n1b884f21-eb24-467f-aba2-208af17070b9\nAdjuvant\nno\n'--\n'--\nRadiation Therapy, NOS\n\n\n1\nTCGA-BRCA\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nInformed Consent\n-34\n'--\nDuctal and Lobular Neoplasms\nDiagnosis\n'--\nBreast\nTCGA-E2-A1IU\n...\n'--\n'--\n'--\n'--\n27868bc3-23c8-5e85-a0e2-314e6cdf9b2a\nAdjuvant\nyes\nTreatment Ongoing\n'--\nHormone Therapy\n\n\n2\nTCGA-BRCA\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nInformed Consent\n-34\n'--\nDuctal and Lobular Neoplasms\nDiagnosis\n'--\nBreast\nTCGA-E2-A1IU\n...\n'--\n'--\n'--\n'--\naedf144c-6b7b-4d76-a3cb-4271aef10f1d\nFirst-Line Therapy\nyes\n'--\n'--\nSurgery, NOS\n\n\n3\nTCGA-BRCA\n0045349c-69d9-4306-a403-c9c1fa836644\nInformed Consent\n76\n'--\nAdenomas and Adenocarcinomas\nDiagnosis\n'--\nBreast\nTCGA-A1-A0SB\n...\n'--\n'--\n'--\n'--\n0a534cae-de91-5e77-a3e7-b52d46bd3966\nFirst-Line Therapy\nyes\n'--\n'--\nSurgery, NOS\n\n\n4\nTCGA-BRCA\n00807dae-9f4a-4fd1-aac2-82eb11bf2afb\nInformed Consent\n19\n'--\nAdnexal and Skin Appendage Neoplasms\nDiagnosis\nNo\nBreast\nTCGA-A2-A04W\n...\n'--\n'--\n'--\n'--\n024faa94-ec57-4d14-b919-62dcab409958\nAdjuvant\nyes\nTreatment Ongoing\n'--\nBisphosphonate Therapy\n\n\n\n\n5 rows × 210 columns\n\n\n\n\nnrow, ncol = brca.shape\nprint(f'The data has {nrow} rows and {ncol} columns.')\n\nThe data has 5546 rows and 210 columns.\n\n\n\n# List column names\nprint(\"Column names:\")\nprint(brca.columns.tolist())\n\nColumn names:\n['project.project_id', 'cases.case_id', 'cases.consent_type', 'cases.days_to_consent', 'cases.days_to_lost_to_followup', 'cases.disease_type', 'cases.index_date', 'cases.lost_to_followup', 'cases.primary_site', 'cases.submitter_id', 'demographic.age_at_index', 'demographic.age_is_obfuscated', 'demographic.cause_of_death', 'demographic.cause_of_death_source', 'demographic.country_of_birth', 'demographic.country_of_residence_at_enrollment', 'demographic.days_to_birth', 'demographic.days_to_death', 'demographic.demographic_id', 'demographic.education_level', 'demographic.ethnicity', 'demographic.gender', 'demographic.marital_status', 'demographic.occupation_duration_years', 'demographic.population_group', 'demographic.premature_at_birth', 'demographic.race', 'demographic.submitter_id', 'demographic.vital_status', 'demographic.weeks_gestation_at_birth', 'demographic.year_of_birth', 'demographic.year_of_death', 'diagnoses.adrenal_hormone', 'diagnoses.age_at_diagnosis', 'diagnoses.ajcc_clinical_m', 'diagnoses.ajcc_clinical_n', 'diagnoses.ajcc_clinical_stage', 'diagnoses.ajcc_clinical_t', 'diagnoses.ajcc_pathologic_m', 'diagnoses.ajcc_pathologic_n', 'diagnoses.ajcc_pathologic_stage', 'diagnoses.ajcc_pathologic_t', 'diagnoses.ajcc_serum_tumor_markers', 'diagnoses.ajcc_staging_system_edition', 'diagnoses.ann_arbor_b_symptoms', 'diagnoses.ann_arbor_b_symptoms_described', 'diagnoses.ann_arbor_clinical_stage', 'diagnoses.ann_arbor_extranodal_involvement', 'diagnoses.ann_arbor_pathologic_stage', 'diagnoses.best_overall_response', 'diagnoses.burkitt_lymphoma_clinical_variant', 'diagnoses.calgb_risk_group', 'diagnoses.cancer_detection_method', 'diagnoses.child_pugh_classification', 'diagnoses.clark_level', 'diagnoses.classification_of_tumor', 'diagnoses.cog_liver_stage', 'diagnoses.cog_neuroblastoma_risk_group', 'diagnoses.cog_renal_stage', 'diagnoses.cog_rhabdomyosarcoma_risk_group', 'diagnoses.contiguous_organ_invaded', 'diagnoses.days_to_best_overall_response', 'diagnoses.days_to_diagnosis', 'diagnoses.days_to_last_follow_up', 'diagnoses.days_to_last_known_disease_status', 'diagnoses.days_to_recurrence', 'diagnoses.diagnosis_id', 'diagnoses.diagnosis_is_primary_disease', 'diagnoses.double_expressor_lymphoma', 'diagnoses.double_hit_lymphoma', 'diagnoses.eln_risk_classification', 'diagnoses.enneking_msts_grade', 'diagnoses.enneking_msts_metastasis', 'diagnoses.enneking_msts_stage', 'diagnoses.enneking_msts_tumor_site', 'diagnoses.ensat_clinical_m', 'diagnoses.ensat_pathologic_n', 'diagnoses.ensat_pathologic_stage', 'diagnoses.ensat_pathologic_t', 'diagnoses.esophageal_columnar_dysplasia_degree', 'diagnoses.esophageal_columnar_metaplasia_present', 'diagnoses.fab_morphology_code', 'diagnoses.figo_stage', 'diagnoses.figo_staging_edition_year', 'diagnoses.first_symptom_longest_duration', 'diagnoses.first_symptom_prior_to_diagnosis', 'diagnoses.gastric_esophageal_junction_involvement', 'diagnoses.gleason_grade_group', 'diagnoses.gleason_grade_tertiary', 'diagnoses.gleason_patterns_percent', 'diagnoses.gleason_score', 'diagnoses.goblet_cells_columnar_mucosa_present', 'diagnoses.icd_10_code', 'diagnoses.igcccg_stage', 'diagnoses.inpc_grade', 'diagnoses.inpc_histologic_group', 'diagnoses.inrg_stage', 'diagnoses.inss_stage', 'diagnoses.international_prognostic_index', 'diagnoses.irs_group', 'diagnoses.irs_stage', 'diagnoses.ishak_fibrosis_score', 'diagnoses.iss_stage', 'diagnoses.last_known_disease_status', 'diagnoses.laterality', 'diagnoses.margin_distance', 'diagnoses.margins_involved_site', 'diagnoses.masaoka_stage', 'diagnoses.max_tumor_bulk_site', 'diagnoses.medulloblastoma_molecular_classification', 'diagnoses.melanoma_known_primary', 'diagnoses.metastasis_at_diagnosis', 'diagnoses.metastasis_at_diagnosis_site', 'diagnoses.method_of_diagnosis', 'diagnoses.micropapillary_features', 'diagnoses.mitosis_karyorrhexis_index', 'diagnoses.mitotic_count', 'diagnoses.morphology', 'diagnoses.ovarian_specimen_status', 'diagnoses.ovarian_surface_involvement', 'diagnoses.papillary_renal_cell_type', 'diagnoses.pediatric_kidney_staging', 'diagnoses.peritoneal_fluid_cytological_status', 'diagnoses.pregnant_at_diagnosis', 'diagnoses.primary_diagnosis', 'diagnoses.primary_disease', 'diagnoses.primary_gleason_grade', 'diagnoses.prior_malignancy', 'diagnoses.prior_treatment', 'diagnoses.progression_or_recurrence', 'diagnoses.residual_disease', 'diagnoses.satellite_nodule_present', 'diagnoses.secondary_gleason_grade', 'diagnoses.site_of_resection_or_biopsy', 'diagnoses.sites_of_involvement', 'diagnoses.sites_of_involvement_count', 'diagnoses.submitter_id', 'diagnoses.supratentorial_localization', 'diagnoses.synchronous_malignancy', 'diagnoses.tissue_or_organ_of_origin', 'diagnoses.tumor_burden', 'diagnoses.tumor_confined_to_organ_of_origin', 'diagnoses.tumor_depth', 'diagnoses.tumor_focality', 'diagnoses.tumor_grade', 'diagnoses.tumor_grade_category', 'diagnoses.tumor_of_origin', 'diagnoses.tumor_regression_grade', 'diagnoses.uicc_clinical_m', 'diagnoses.uicc_clinical_n', 'diagnoses.uicc_clinical_stage', 'diagnoses.uicc_clinical_t', 'diagnoses.uicc_pathologic_m', 'diagnoses.uicc_pathologic_n', 'diagnoses.uicc_pathologic_stage', 'diagnoses.uicc_pathologic_t', 'diagnoses.uicc_staging_system_edition', 'diagnoses.ulceration_indicator', 'diagnoses.weiss_assessment_findings', 'diagnoses.weiss_assessment_score', 'diagnoses.who_cns_grade', 'diagnoses.who_nte_grade', 'diagnoses.wilms_tumor_histologic_subtype', 'diagnoses.year_of_diagnosis', 'treatments.chemo_concurrent_to_radiation', 'treatments.clinical_trial_indicator', 'treatments.course_number', 'treatments.days_to_treatment_end', 'treatments.days_to_treatment_start', 'treatments.drug_category', 'treatments.embolic_agent', 'treatments.initial_disease_status', 'treatments.lesions_treated_number', 'treatments.margin_distance', 'treatments.margin_status', 'treatments.margins_involved_site', 'treatments.number_of_cycles', 'treatments.number_of_fractions', 'treatments.prescribed_dose', 'treatments.prescribed_dose_units', 'treatments.pretreatment', 'treatments.protocol_identifier', 'treatments.radiosensitizing_agent', 'treatments.reason_treatment_ended', 'treatments.reason_treatment_not_given', 'treatments.regimen_or_line_of_therapy', 'treatments.residual_disease', 'treatments.route_of_administration', 'treatments.submitter_id', 'treatments.therapeutic_agents', 'treatments.therapeutic_level_achieved', 'treatments.therapeutic_levels_achieved', 'treatments.therapeutic_target_level', 'treatments.timepoint_category', 'treatments.treatment_anatomic_site', 'treatments.treatment_anatomic_sites', 'treatments.treatment_arm', 'treatments.treatment_dose', 'treatments.treatment_dose_max', 'treatments.treatment_dose_units', 'treatments.treatment_duration', 'treatments.treatment_effect', 'treatments.treatment_effect_indicator', 'treatments.treatment_frequency', 'treatments.treatment_id', 'treatments.treatment_intent_type', 'treatments.treatment_or_therapy', 'treatments.treatment_outcome', 'treatments.treatment_outcome_duration', 'treatments.treatment_type']\n\n\n\n# Number of unique patients\nunique_patients = brca['cases.submitter_id'].nunique()\nprint(f'The data has {unique_patients} unique patients.')\n\nThe data has 1098 unique patients."
  },
  {
    "objectID": "technical-details/data-collection/main.html#cervical-cesc-cancer-dataset",
    "href": "technical-details/data-collection/main.html#cervical-cesc-cancer-dataset",
    "title": "Data Collection",
    "section": "Cervical (CESC) Cancer Dataset",
    "text": "Cervical (CESC) Cancer Dataset\n\nClinical Data\n\n# Open CESC tsv data\n\ncesc = pd.read_csv('../../data/raw-data/cesc/cesc-clinical.tsv', sep='\\t')\ncesc.head(3)\n\n\n\n\n\n\n\n\nproject.project_id\ncases.case_id\ncases.consent_type\ncases.days_to_consent\ncases.days_to_lost_to_followup\ncases.disease_type\ncases.index_date\ncases.lost_to_followup\ncases.primary_site\ncases.submitter_id\n...\ntreatments.treatment_duration\ntreatments.treatment_effect\ntreatments.treatment_effect_indicator\ntreatments.treatment_frequency\ntreatments.treatment_id\ntreatments.treatment_intent_type\ntreatments.treatment_or_therapy\ntreatments.treatment_outcome\ntreatments.treatment_outcome_duration\ntreatments.treatment_type\n\n\n\n\n0\nTCGA-CESC\n00ad0ffe-2105-4829-a495-1c2aceb5bb31\nInformed Consent\n0\n'--\nSquamous Cell Neoplasms\nDiagnosis\nYes\nCervix uteri\nTCGA-EK-A2R9\n...\n'--\n'--\n'--\n'--\n672b3cf9-bb40-4f6f-a1c9-69ac3383fbd5\n'--\n'--\n'--\n'--\nHysterectomy, NOS\n\n\n1\nTCGA-CESC\n00ad0ffe-2105-4829-a495-1c2aceb5bb31\nInformed Consent\n0\n'--\nSquamous Cell Neoplasms\nDiagnosis\nYes\nCervix uteri\nTCGA-EK-A2R9\n...\n'--\n'--\n'--\n'--\nd4baa31f-8c1f-5333-afcd-836816fd1a2a\nAdjuvant\nunknown\n'--\n'--\nPharmaceutical Therapy, NOS\n\n\n2\nTCGA-CESC\n00ad0ffe-2105-4829-a495-1c2aceb5bb31\nInformed Consent\n0\n'--\nSquamous Cell Neoplasms\nDiagnosis\nYes\nCervix uteri\nTCGA-EK-A2R9\n...\n'--\n'--\n'--\n'--\ne79370ba-36f0-4639-bc8f-119ba2b2457b\nAdjuvant\nunknown\n'--\n'--\nRadiation Therapy, NOS\n\n\n3\nTCGA-CESC\n00bca18c-b3d4-45a3-8f19-034cc40449a4\nInformed Consent\n2108\n'--\nSquamous Cell Neoplasms\nDiagnosis\nYes\nCervix uteri\nTCGA-C5-A2LV\n...\n'--\n'--\n'--\n'--\n277d525e-9674-4954-b427-3e829d469b8f\n'--\n'--\n'--\n'--\nHysterectomy, NOS\n\n\n4\nTCGA-CESC\n00bca18c-b3d4-45a3-8f19-034cc40449a4\nInformed Consent\n2108\n'--\nSquamous Cell Neoplasms\nDiagnosis\nYes\nCervix uteri\nTCGA-C5-A2LV\n...\n'--\n'--\n'--\n'--\n788ff156-d009-46f7-b832-f39b11ed13ac\nAdjuvant\nno\n'--\n'--\nRadiation Therapy, NOS\n\n\n\n\n5 rows × 210 columns\n\n\n\n\nnrow, ncol = cesc.shape\nprint(f'The data has {nrow} rows and {ncol} columns.')\n\nThe data has 1535 rows and 210 columns.\n\n\n\n# List column names\nprint(\"Column names:\")\nprint(cesc.columns.tolist())\n\nColumn names:\n['project.project_id', 'cases.case_id', 'cases.consent_type', 'cases.days_to_consent', 'cases.days_to_lost_to_followup', 'cases.disease_type', 'cases.index_date', 'cases.lost_to_followup', 'cases.primary_site', 'cases.submitter_id', 'demographic.age_at_index', 'demographic.age_is_obfuscated', 'demographic.cause_of_death', 'demographic.cause_of_death_source', 'demographic.country_of_birth', 'demographic.country_of_residence_at_enrollment', 'demographic.days_to_birth', 'demographic.days_to_death', 'demographic.demographic_id', 'demographic.education_level', 'demographic.ethnicity', 'demographic.gender', 'demographic.marital_status', 'demographic.occupation_duration_years', 'demographic.population_group', 'demographic.premature_at_birth', 'demographic.race', 'demographic.submitter_id', 'demographic.vital_status', 'demographic.weeks_gestation_at_birth', 'demographic.year_of_birth', 'demographic.year_of_death', 'diagnoses.adrenal_hormone', 'diagnoses.age_at_diagnosis', 'diagnoses.ajcc_clinical_m', 'diagnoses.ajcc_clinical_n', 'diagnoses.ajcc_clinical_stage', 'diagnoses.ajcc_clinical_t', 'diagnoses.ajcc_pathologic_m', 'diagnoses.ajcc_pathologic_n', 'diagnoses.ajcc_pathologic_stage', 'diagnoses.ajcc_pathologic_t', 'diagnoses.ajcc_serum_tumor_markers', 'diagnoses.ajcc_staging_system_edition', 'diagnoses.ann_arbor_b_symptoms', 'diagnoses.ann_arbor_b_symptoms_described', 'diagnoses.ann_arbor_clinical_stage', 'diagnoses.ann_arbor_extranodal_involvement', 'diagnoses.ann_arbor_pathologic_stage', 'diagnoses.best_overall_response', 'diagnoses.burkitt_lymphoma_clinical_variant', 'diagnoses.calgb_risk_group', 'diagnoses.cancer_detection_method', 'diagnoses.child_pugh_classification', 'diagnoses.clark_level', 'diagnoses.classification_of_tumor', 'diagnoses.cog_liver_stage', 'diagnoses.cog_neuroblastoma_risk_group', 'diagnoses.cog_renal_stage', 'diagnoses.cog_rhabdomyosarcoma_risk_group', 'diagnoses.contiguous_organ_invaded', 'diagnoses.days_to_best_overall_response', 'diagnoses.days_to_diagnosis', 'diagnoses.days_to_last_follow_up', 'diagnoses.days_to_last_known_disease_status', 'diagnoses.days_to_recurrence', 'diagnoses.diagnosis_id', 'diagnoses.diagnosis_is_primary_disease', 'diagnoses.double_expressor_lymphoma', 'diagnoses.double_hit_lymphoma', 'diagnoses.eln_risk_classification', 'diagnoses.enneking_msts_grade', 'diagnoses.enneking_msts_metastasis', 'diagnoses.enneking_msts_stage', 'diagnoses.enneking_msts_tumor_site', 'diagnoses.ensat_clinical_m', 'diagnoses.ensat_pathologic_n', 'diagnoses.ensat_pathologic_stage', 'diagnoses.ensat_pathologic_t', 'diagnoses.esophageal_columnar_dysplasia_degree', 'diagnoses.esophageal_columnar_metaplasia_present', 'diagnoses.fab_morphology_code', 'diagnoses.figo_stage', 'diagnoses.figo_staging_edition_year', 'diagnoses.first_symptom_longest_duration', 'diagnoses.first_symptom_prior_to_diagnosis', 'diagnoses.gastric_esophageal_junction_involvement', 'diagnoses.gleason_grade_group', 'diagnoses.gleason_grade_tertiary', 'diagnoses.gleason_patterns_percent', 'diagnoses.gleason_score', 'diagnoses.goblet_cells_columnar_mucosa_present', 'diagnoses.icd_10_code', 'diagnoses.igcccg_stage', 'diagnoses.inpc_grade', 'diagnoses.inpc_histologic_group', 'diagnoses.inrg_stage', 'diagnoses.inss_stage', 'diagnoses.international_prognostic_index', 'diagnoses.irs_group', 'diagnoses.irs_stage', 'diagnoses.ishak_fibrosis_score', 'diagnoses.iss_stage', 'diagnoses.last_known_disease_status', 'diagnoses.laterality', 'diagnoses.margin_distance', 'diagnoses.margins_involved_site', 'diagnoses.masaoka_stage', 'diagnoses.max_tumor_bulk_site', 'diagnoses.medulloblastoma_molecular_classification', 'diagnoses.melanoma_known_primary', 'diagnoses.metastasis_at_diagnosis', 'diagnoses.metastasis_at_diagnosis_site', 'diagnoses.method_of_diagnosis', 'diagnoses.micropapillary_features', 'diagnoses.mitosis_karyorrhexis_index', 'diagnoses.mitotic_count', 'diagnoses.morphology', 'diagnoses.ovarian_specimen_status', 'diagnoses.ovarian_surface_involvement', 'diagnoses.papillary_renal_cell_type', 'diagnoses.pediatric_kidney_staging', 'diagnoses.peritoneal_fluid_cytological_status', 'diagnoses.pregnant_at_diagnosis', 'diagnoses.primary_diagnosis', 'diagnoses.primary_disease', 'diagnoses.primary_gleason_grade', 'diagnoses.prior_malignancy', 'diagnoses.prior_treatment', 'diagnoses.progression_or_recurrence', 'diagnoses.residual_disease', 'diagnoses.satellite_nodule_present', 'diagnoses.secondary_gleason_grade', 'diagnoses.site_of_resection_or_biopsy', 'diagnoses.sites_of_involvement', 'diagnoses.sites_of_involvement_count', 'diagnoses.submitter_id', 'diagnoses.supratentorial_localization', 'diagnoses.synchronous_malignancy', 'diagnoses.tissue_or_organ_of_origin', 'diagnoses.tumor_burden', 'diagnoses.tumor_confined_to_organ_of_origin', 'diagnoses.tumor_depth', 'diagnoses.tumor_focality', 'diagnoses.tumor_grade', 'diagnoses.tumor_grade_category', 'diagnoses.tumor_of_origin', 'diagnoses.tumor_regression_grade', 'diagnoses.uicc_clinical_m', 'diagnoses.uicc_clinical_n', 'diagnoses.uicc_clinical_stage', 'diagnoses.uicc_clinical_t', 'diagnoses.uicc_pathologic_m', 'diagnoses.uicc_pathologic_n', 'diagnoses.uicc_pathologic_stage', 'diagnoses.uicc_pathologic_t', 'diagnoses.uicc_staging_system_edition', 'diagnoses.ulceration_indicator', 'diagnoses.weiss_assessment_findings', 'diagnoses.weiss_assessment_score', 'diagnoses.who_cns_grade', 'diagnoses.who_nte_grade', 'diagnoses.wilms_tumor_histologic_subtype', 'diagnoses.year_of_diagnosis', 'treatments.chemo_concurrent_to_radiation', 'treatments.clinical_trial_indicator', 'treatments.course_number', 'treatments.days_to_treatment_end', 'treatments.days_to_treatment_start', 'treatments.drug_category', 'treatments.embolic_agent', 'treatments.initial_disease_status', 'treatments.lesions_treated_number', 'treatments.margin_distance', 'treatments.margin_status', 'treatments.margins_involved_site', 'treatments.number_of_cycles', 'treatments.number_of_fractions', 'treatments.prescribed_dose', 'treatments.prescribed_dose_units', 'treatments.pretreatment', 'treatments.protocol_identifier', 'treatments.radiosensitizing_agent', 'treatments.reason_treatment_ended', 'treatments.reason_treatment_not_given', 'treatments.regimen_or_line_of_therapy', 'treatments.residual_disease', 'treatments.route_of_administration', 'treatments.submitter_id', 'treatments.therapeutic_agents', 'treatments.therapeutic_level_achieved', 'treatments.therapeutic_levels_achieved', 'treatments.therapeutic_target_level', 'treatments.timepoint_category', 'treatments.treatment_anatomic_site', 'treatments.treatment_anatomic_sites', 'treatments.treatment_arm', 'treatments.treatment_dose', 'treatments.treatment_dose_max', 'treatments.treatment_dose_units', 'treatments.treatment_duration', 'treatments.treatment_effect', 'treatments.treatment_effect_indicator', 'treatments.treatment_frequency', 'treatments.treatment_id', 'treatments.treatment_intent_type', 'treatments.treatment_or_therapy', 'treatments.treatment_outcome', 'treatments.treatment_outcome_duration', 'treatments.treatment_type']\n\n\n\n# Number of unique patients\nunique_patients = cesc['cases.submitter_id'].nunique()\nprint(f'The data has {unique_patients} unique patients.')\n\nThe data has 307 unique patients.\n\n\n\n\nExposure Data\n\n# Open cesc exposure tsv data\n\ncesc_exposure_df = pd.read_csv('../../data/raw-data/cesc/exposure.tsv', sep='\\t')\ncesc_exposure_df.head(3)\n\n\n\n\n\n\n\n\nproject.project_id\ncases.case_id\ncases.submitter_id\nexposures.age_at_last_exposure\nexposures.age_at_onset\nexposures.alcohol_days_per_week\nexposures.alcohol_drinks_per_day\nexposures.alcohol_frequency\nexposures.alcohol_history\nexposures.alcohol_intensity\n...\nexposures.smoking_frequency\nexposures.submitter_id\nexposures.time_between_waking_and_first_smoke\nexposures.tobacco_smoking_onset_year\nexposures.tobacco_smoking_quit_year\nexposures.tobacco_smoking_status\nexposures.type_of_smoke_exposure\nexposures.type_of_tobacco_used\nexposures.use_per_day\nexposures.years_smoked\n\n\n\n\n0\nTCGA-CESC\n00ad0ffe-2105-4829-a495-1c2aceb5bb31\nTCGA-EK-A2R9\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n...\n'--\n'--\n'--\n'--\n'--\nNot Reported\n'--\n'--\n'--\n'--\n\n\n1\nTCGA-CESC\n00bca18c-b3d4-45a3-8f19-034cc40449a4\nTCGA-C5-A2LV\n'--\n20\n'--\n'--\n'--\n'--\n'--\n...\n'--\n'--\n'--\n'--\n'--\nCurrent Smoker\n'--\n'--\n'--\n'--\n\n\n2\nTCGA-CESC\n010a807f-9dc0-4e14-9533-dcf478f3d947\nTCGA-C5-A902\n'--\n14\n'--\n'--\n'--\n'--\n'--\n...\n'--\n'--\n'--\n'--\n'--\nCurrent Smoker\n'--\n'--\n'--\n'--\n\n\n3\nTCGA-CESC\n03804f9b-df7c-462c-8984-8eb3a5ed4999\nTCGA-VS-A9V2\n'--\n'--\n'--\n'--\n'--\n'--\n'--\n...\n'--\n'--\n'--\n'--\n'--\nLifelong Non-Smoker\n'--\n'--\n'--\n'--\n\n\n4\nTCGA-CESC\n03c3fe57-ae85-4e45-9657-c3182ab5e124\nTCGA-C5-A1BL\n'--\n16\n'--\n'--\n'--\n'--\n'--\n...\n'--\n'--\n'--\n'--\n1988\nCurrent Reformed Smoker for &lt; or = 15 yrs\n'--\n'--\n'--\n'--\n\n\n\n\n5 rows × 40 columns\n\n\n\nThe code above can also be found on our repository here"
  },
  {
    "objectID": "technical-details/supervised-learning/main.html",
    "href": "technical-details/supervised-learning/main.html",
    "title": "Supervised Learning",
    "section": "",
    "text": "We had preserved multiple rows from the same patient to track treatments recevied during exploratory data analysis.\n\n\n\n\n\n\nFirst two rows of the eda BRCA clinical dataset\n\n\n\nproject.project_id\ncases.case_id\ncases.disease_type\ncases.index_date\ncases.primary_site\ncases.submitter_id\ndemographic.age_is_obfuscated\ndemographic.days_to_death\ndemographic.ethnicity\ndemographic.gender\ndemographic.race\ndemographic.submitter_id\ndemographic.vital_status\ndiagnoses.age_at_diagnosis\ndiagnoses.ajcc_pathologic_m\ndiagnoses.ajcc_pathologic_n\ndiagnoses.ajcc_pathologic_stage\ndiagnoses.ajcc_pathologic_t\ndiagnoses.classification_of_tumor\ndiagnoses.days_to_diagnosis\ndiagnoses.days_to_last_follow_up\ndiagnoses.diagnosis_is_primary_disease\ndiagnoses.laterality\ndiagnoses.method_of_diagnosis\ndiagnoses.morphology\ndiagnoses.primary_diagnosis\ndiagnoses.prior_malignancy\ndiagnoses.prior_treatment\ndiagnoses.site_of_resection_or_biopsy\ndiagnoses.sites_of_involvement\ndiagnoses.submitter_id\ndiagnoses.synchronous_malignancy\ndiagnoses.tissue_or_organ_of_origin\ntreatments.submitter_id\ntreatments.treatment_or_therapy\ntreatments.treatment_type\nsurvival_time_days\ndiagnoses.behavior\n\n\n\n\n0\ntcga-brca\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nductal and lobular neoplasms\ndiagnosis\nbreast\ntcga-e2-a1iu\nFalse\nNaN\nnot hispanic or latino\nfemale\nwhite\ntcga-e2-a1iu_demographic\nalive\n60.0\nm0\nn0 (mol+)\nstage ia\nt1c\nprimary\n0\n337.0\nTrue\nright\nsurgical resection\n8500/3\ninfiltrating duct carcinoma, nos\nFalse\nFalse\nbreast, nos\nbreast, right upper outer\ntcga-e2-a1iu_diagnosis\nFalse\nbreast, nos\ntcga-e2-a1iu_treatment2\nFalse\nradiation therapy, nos\n337.0\nmalignant\n\n\n1\ntcga-brca\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nductal and lobular neoplasms\ndiagnosis\nbreast\ntcga-e2-a1iu\nFalse\nNaN\nnot hispanic or latino\nfemale\nwhite\ntcga-e2-a1iu_demographic\nalive\n60.0\nm0\nn0 (mol+)\nstage ia\nt1c\nprimary\n0\n337.0\nTrue\nright\nsurgical resection\n8500/3\ninfiltrating duct carcinoma, nos\nFalse\nFalse\nbreast, nos\nbreast, right upper outer\ntcga-e2-a1iu_diagnosis\nFalse\nbreast, nos\ntcga-e2-a1iu_treatment\nTrue\nhormone therapy\n337.0\nmalignant\n\n\n\n\n\n\n\nHowever, for supervised learning, this could lead to data leakage during model training and evaluation. To mitigate this, we implemented a preprocessing step to retain only one record per patient. We selected the most recent record for each patient who received treatment, and created a column treatment.count to captuure the effect of multiple treatments a patient received.\n\n\n\nAfter deduplication:\nDeduplicated dataset shape: (1081, 39)\nUnique cases.submitter_id: 1081\nRows removed: 3815\n\nTreatment distribution in deduplicated data:\ntreatments.treatment_or_therapy\nTrue     1076\nFalse       5\nName: count, dtype: int64\n\nFinal BRCA dataset shape: (1081, 39)\n\n\nOur next step involved feature selection to enhance model performance and interpretability. We focused on removing non-informative features that exhibited low variance across the dataset. Features with little to no variability do not contribute meaningful information for predicting survival time and can introduce noise into the model.\nRemove Non-informative Features: Exclude features with low variance e.g., behavior of the tumor is malignant for all samples. Dropped features:\n\nproject_id: represents the project and is constant for all samples.\ncase_id: unique identifier for each case, not useful for prediction.\nsubmitter_id: unique identifier for each submitter, not useful for prediction.\nprimary_site: all samples are from the breast, so this feature has no variance.\nindex_date: date of indexing, not relevant for prediction.\nage_is_obfuscated: flag indicating if age is obfuscated, not useful for prediction.\ndays_to_death: not applicable for all samples, leading to missing values.\nethnicity: heavy imbalance to not hispanic or latino (over 80% of samples), leading to low variance. Race might capture the variance better.\ngender: all samples are female, so this feature has no variance\nclassification_of_tumor: all samples are primary, so this feature has no variance.\ndays_to_diagnosis: 0 for all samples, so this feature has no variance.\ndays_to _last_follow_up: not applicable for all samples, leading to missing values.\nvital_status: does not make sense to predict survival time based on whether the patient is alive or dead at last follow-up.\nlaterality: research indicates no significant difference in breast cancer outcomes based on laterality. Dataset does not show imbalance in laterality distribution.\ndiagnoses.prior_treatment: heavy imbalance to false (97% of samples), leading to low variance. Assuming number of treatments is more informative.\nsite_of_resection_or_biopsy: all samples are from the breast, so this feature has no variance. Specific location within the breast (sites_of_involvement) may provide more detailed information.\nsynchronous_malignancy: heavy imbalance to false (&gt; 97%), so this feature has no variance.\ntreatments.submitter_id: unique identifier for each submitter, not useful for prediction.\ntreatments_or_therapy: Heavy imbalance to true as most patients receive treatment, so this feature has low variance. Specific treatment types may provide more information.\ndiagnoses.diagnosis_is_primary_disease: all samples are primary, so this feature has no variance.\ndiagnoses.method_of_diagnosis: Not informative to how long a patient survives. The primary diagnosis might be more relevant.\n\n\n\nOriginal dataset shape: (1081, 39)\nCleaned dataset shape: (1081, 14)\nColumns removed: 25\n\n\nLastly, we prepared the data for modeling by applying appropriate transformations to different types of variables:\n\nNormalization: Numerical columns age_at_diagnosis and treatments.count normalized using Min-Max scaling.\nBoolean Variables: Converted boolean variables to integers (0 and 1) for model compatibility, vital status to 1 for alive\nOrdinal Categorical Variables: Used Ordinal Encoding for features with an inherent order (e.g., tumor_stage).\nEncoding Categorical Variables: Categorical variables were be encoded using One-Hot Encoding to convert them into a format suitable for machine learning algorithms.\n\nAJCC Cancer Staging Has a Natural Order\nStage I → Stage II → Stage III → Stage IV Earlier = less severe → later = more severe.\nWithin each major stage, letters (A, B, C) represent increasing severity, e.g.:\nI &lt; IA &lt; IB &lt; II &lt; IIA &lt; IIB &lt; III &lt; IIIA &lt; IIIB &lt; IIIC &lt; IV\nT = primary tumor size AND local extent of invasion\nThe N (nodes) category in the TNM system describes regional lymph node involvement:\nThe M (metastasis) part of TNM describes presence of distant metastasis.\n\n\n\nThe following models were evaluated for predicting patient survival time based on the preprocessed BRCA dataset: 1. Standard Linear Regression: Benchmark model for comparison 2. Regression Trees: XGBoost Regressor for capturing non-linear relationships and interactions between features. 3. Parametric Linear Regression: With Lasso regularization to prevent overfitting and eliminate potentially redundant features.\n\n\n\nThe dataset was split into training and testing sets using an 80-20 split. Cross-validation was employed during model training to ensure robustness and generalizability of the models.\n\n\n\n\nLinear Regression Model Evaluation on Test Set:\nRMSE: 61585077470726.38\nMAE: 7691527358667.03\nR2 Score: -2406669127225213190144.0000\n\n\n\n\n\nWe do a parametric Curve Fitting with L1 regularization (Lasso) to predict patient survival time based on the preprocessed BRCA dataset. Design choicces include: - Model Choice: Lasso regression is chosen for its ability to perform both variable selection and regularization, which helps enhance the prediction accuracy and interpretability of the statistical model it produces. In addition, early stopping is implemented to prevent overfitting during training. - Hyperparameter Tuning: The regularization parameter (alpha) tuned using cross-validation to find the optimal balance between bias and variance. - Evaluation Metrics: Model performance was evaluated using Mean Absolute Error (MAE), Root Mean Squared Error (RMSE), and R-squared (R²) to provide a comprehensive assessment of prediction accuracy. - SGDRegressor is used for optimization due to its efficiency with large datasets and ability to handle L1 regularization effectively.\n\n\nTraining MAE Linear Regression with Lasso Regularization...\n============================================================\n\nTesting alpha = 0.001\nEpoch 500: Train MAE = 1217.1975, Val MAE = 1269.3982\nEpoch 500: Train MAE = 1217.1975, Val MAE = 1269.3982\nEpoch 1000: Train MAE = 1216.7116, Val MAE = 1268.9919\nEpoch 1000: Train MAE = 1216.7116, Val MAE = 1268.9919\nEpoch 1500: Train MAE = 1216.2261, Val MAE = 1268.5873\nEpoch 1500: Train MAE = 1216.2261, Val MAE = 1268.5873\nEpoch 2000: Train MAE = 1215.7407, Val MAE = 1268.1848\n\nTesting alpha = 0.01\nEpoch 2000: Train MAE = 1215.7407, Val MAE = 1268.1848\n\nTesting alpha = 0.01\nEpoch 500: Train MAE = 1217.2068, Val MAE = 1269.3909\nEpoch 500: Train MAE = 1217.2068, Val MAE = 1269.3909\nEpoch 1000: Train MAE = 1216.7332, Val MAE = 1268.9616\nEpoch 1000: Train MAE = 1216.7332, Val MAE = 1268.9616\nEpoch 1500: Train MAE = 1216.2613, Val MAE = 1268.5353\nEpoch 1500: Train MAE = 1216.2613, Val MAE = 1268.5353\nEpoch 2000: Train MAE = 1215.7901, Val MAE = 1268.1114\n\nTesting alpha = 0.1\nEpoch 2000: Train MAE = 1215.7901, Val MAE = 1268.1114\n\nTesting alpha = 0.1\nEpoch 500: Train MAE = 1217.2204, Val MAE = 1269.3513\nEpoch 500: Train MAE = 1217.2204, Val MAE = 1269.3513\nEpoch 1000: Train MAE = 1216.7601, Val MAE = 1268.8937\nEpoch 1000: Train MAE = 1216.7601, Val MAE = 1268.8937\nEpoch 1500: Train MAE = 1216.3023, Val MAE = 1268.4425\nEpoch 1500: Train MAE = 1216.3023, Val MAE = 1268.4425\nEpoch 2000: Train MAE = 1215.8448, Val MAE = 1267.9919\n\nTesting alpha = 1.0\nEpoch 2000: Train MAE = 1215.8448, Val MAE = 1267.9919\n\nTesting alpha = 1.0\nEpoch 500: Train MAE = 1217.2207, Val MAE = 1269.3516\nEpoch 500: Train MAE = 1217.2207, Val MAE = 1269.3516\nEpoch 1000: Train MAE = 1216.7604, Val MAE = 1268.8941\nEpoch 1000: Train MAE = 1216.7604, Val MAE = 1268.8941\nEpoch 1500: Train MAE = 1216.3026, Val MAE = 1268.4428\nEpoch 1500: Train MAE = 1216.3026, Val MAE = 1268.4428\nEpoch 2000: Train MAE = 1215.8451, Val MAE = 1267.9922\n\nBest alpha: 0.1\nBest validation MAE: 1267.9919\nEpoch 2000: Train MAE = 1215.8451, Val MAE = 1267.9922\n\nBest alpha: 0.1\nBest validation MAE: 1267.9919\n\n\n\n\n\n\n\n\n\n\n\n\nFinal MAE Linear Regression Model Evaluation on Test Set:\n=======================================================\nMAE: 1288.54 days\nRMSE: 1798.93 days\nR² Score: -1.0535\n\n\n\n\n\nRandom Forest Regressor is implemented to predict patient survival time based on the preprocessed BRCA dataset. Design choices include: - Model Choice: Random Forest is selected for its robustness, ability to handle high-dimensional data, and effectiveness in capturing complex interactions between features. - Hyperparameter Tuning: A grid search with cross-validation employed to optimize key hyperparameters such as the number of estimators, maximum depth of the trees, and minimum samples per leaf. - Evaluation Metrics: Model performance evaluated using Mean Absolute Error (MAE), Root Mean Squared Error (RMSE), and R-squared (R²) to provide a comprehensive assessment of prediction accuracy.\n\n\nTraining Random Forest Regressor with Hyperparameter Tuning...\n=================================================================\nPerforming hyperparameter tuning with 5-fold cross-validation...\nFitting 5 folds for each of 50 candidates, totalling 250 fits\n\nBest Random Forest Parameters:\n  random_state: 42\n  n_estimators: 300\n  min_samples_split: 5\n  min_samples_leaf: 1\n  max_features: 0.3\n  max_depth: None\n  bootstrap: True\n\nBest Cross-Validation MAE: 755.05\nOut-of-Bag Score (R²): 0.1786\n\nBest Random Forest Parameters:\n  random_state: 42\n  n_estimators: 300\n  min_samples_split: 5\n  min_samples_leaf: 1\n  max_features: 0.3\n  max_depth: None\n  bootstrap: True\n\nBest Cross-Validation MAE: 755.05\nOut-of-Bag Score (R²): 0.1786\n\n\n\n\nEvaluating Random Forest Model on Test Set...\n==================================================\nRandom Forest Model Evaluation on Test Set:\nMAE: 792.40 days\nRMSE: 1156.06 days\nR² Score: 0.1519\n\nFeature Importance Statistics:\nNumber of features with importance &gt; 0.01: 25\nCumulative importance of top 10 features: 0.6256\n\n\n\n\n\n\n\n\n\n\nRandom Forest Model Complexity:\nNumber of trees: 300\nMax depth: None\nTotal number of nodes: 147756\nAverage tree depth: 29.93\n\n\n\n\n\n\n\n\n======================================================================\n                    FINAL MODEL COMPARISON\n======================================================================\n\n                     Model          MAE         RMSE            R²\nStandard Linear Regression 7.691527e+12 6.158508e+13 -2.406669e+21\n  Parametric Curve Fitting 1.288540e+03 1.798930e+03 -1.053500e+00\n   Random Forest Regressor 7.924000e+02 1.156060e+03  1.519000e-01\n\n======================================================================\nBEST MODEL: Random Forest Regressor\n   Achieved lowest MAE of 792.4 days\n======================================================================"
  },
  {
    "objectID": "technical-details/supervised-learning/main.html#data-preprocessing",
    "href": "technical-details/supervised-learning/main.html#data-preprocessing",
    "title": "Supervised Learning",
    "section": "",
    "text": "We had preserved multiple rows from the same patient to track treatments recevied during exploratory data analysis.\n\n\n\n\n\n\nFirst two rows of the eda BRCA clinical dataset\n\n\n\nproject.project_id\ncases.case_id\ncases.disease_type\ncases.index_date\ncases.primary_site\ncases.submitter_id\ndemographic.age_is_obfuscated\ndemographic.days_to_death\ndemographic.ethnicity\ndemographic.gender\ndemographic.race\ndemographic.submitter_id\ndemographic.vital_status\ndiagnoses.age_at_diagnosis\ndiagnoses.ajcc_pathologic_m\ndiagnoses.ajcc_pathologic_n\ndiagnoses.ajcc_pathologic_stage\ndiagnoses.ajcc_pathologic_t\ndiagnoses.classification_of_tumor\ndiagnoses.days_to_diagnosis\ndiagnoses.days_to_last_follow_up\ndiagnoses.diagnosis_is_primary_disease\ndiagnoses.laterality\ndiagnoses.method_of_diagnosis\ndiagnoses.morphology\ndiagnoses.primary_diagnosis\ndiagnoses.prior_malignancy\ndiagnoses.prior_treatment\ndiagnoses.site_of_resection_or_biopsy\ndiagnoses.sites_of_involvement\ndiagnoses.submitter_id\ndiagnoses.synchronous_malignancy\ndiagnoses.tissue_or_organ_of_origin\ntreatments.submitter_id\ntreatments.treatment_or_therapy\ntreatments.treatment_type\nsurvival_time_days\ndiagnoses.behavior\n\n\n\n\n0\ntcga-brca\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nductal and lobular neoplasms\ndiagnosis\nbreast\ntcga-e2-a1iu\nFalse\nNaN\nnot hispanic or latino\nfemale\nwhite\ntcga-e2-a1iu_demographic\nalive\n60.0\nm0\nn0 (mol+)\nstage ia\nt1c\nprimary\n0\n337.0\nTrue\nright\nsurgical resection\n8500/3\ninfiltrating duct carcinoma, nos\nFalse\nFalse\nbreast, nos\nbreast, right upper outer\ntcga-e2-a1iu_diagnosis\nFalse\nbreast, nos\ntcga-e2-a1iu_treatment2\nFalse\nradiation therapy, nos\n337.0\nmalignant\n\n\n1\ntcga-brca\n001cef41-ff86-4d3f-a140-a647ac4b10a1\nductal and lobular neoplasms\ndiagnosis\nbreast\ntcga-e2-a1iu\nFalse\nNaN\nnot hispanic or latino\nfemale\nwhite\ntcga-e2-a1iu_demographic\nalive\n60.0\nm0\nn0 (mol+)\nstage ia\nt1c\nprimary\n0\n337.0\nTrue\nright\nsurgical resection\n8500/3\ninfiltrating duct carcinoma, nos\nFalse\nFalse\nbreast, nos\nbreast, right upper outer\ntcga-e2-a1iu_diagnosis\nFalse\nbreast, nos\ntcga-e2-a1iu_treatment\nTrue\nhormone therapy\n337.0\nmalignant\n\n\n\n\n\n\n\nHowever, for supervised learning, this could lead to data leakage during model training and evaluation. To mitigate this, we implemented a preprocessing step to retain only one record per patient. We selected the most recent record for each patient who received treatment, and created a column treatment.count to captuure the effect of multiple treatments a patient received.\n\n\n\nAfter deduplication:\nDeduplicated dataset shape: (1081, 39)\nUnique cases.submitter_id: 1081\nRows removed: 3815\n\nTreatment distribution in deduplicated data:\ntreatments.treatment_or_therapy\nTrue     1076\nFalse       5\nName: count, dtype: int64\n\nFinal BRCA dataset shape: (1081, 39)\n\n\nOur next step involved feature selection to enhance model performance and interpretability. We focused on removing non-informative features that exhibited low variance across the dataset. Features with little to no variability do not contribute meaningful information for predicting survival time and can introduce noise into the model.\nRemove Non-informative Features: Exclude features with low variance e.g., behavior of the tumor is malignant for all samples. Dropped features:\n\nproject_id: represents the project and is constant for all samples.\ncase_id: unique identifier for each case, not useful for prediction.\nsubmitter_id: unique identifier for each submitter, not useful for prediction.\nprimary_site: all samples are from the breast, so this feature has no variance.\nindex_date: date of indexing, not relevant for prediction.\nage_is_obfuscated: flag indicating if age is obfuscated, not useful for prediction.\ndays_to_death: not applicable for all samples, leading to missing values.\nethnicity: heavy imbalance to not hispanic or latino (over 80% of samples), leading to low variance. Race might capture the variance better.\ngender: all samples are female, so this feature has no variance\nclassification_of_tumor: all samples are primary, so this feature has no variance.\ndays_to_diagnosis: 0 for all samples, so this feature has no variance.\ndays_to _last_follow_up: not applicable for all samples, leading to missing values.\nvital_status: does not make sense to predict survival time based on whether the patient is alive or dead at last follow-up.\nlaterality: research indicates no significant difference in breast cancer outcomes based on laterality. Dataset does not show imbalance in laterality distribution.\ndiagnoses.prior_treatment: heavy imbalance to false (97% of samples), leading to low variance. Assuming number of treatments is more informative.\nsite_of_resection_or_biopsy: all samples are from the breast, so this feature has no variance. Specific location within the breast (sites_of_involvement) may provide more detailed information.\nsynchronous_malignancy: heavy imbalance to false (&gt; 97%), so this feature has no variance.\ntreatments.submitter_id: unique identifier for each submitter, not useful for prediction.\ntreatments_or_therapy: Heavy imbalance to true as most patients receive treatment, so this feature has low variance. Specific treatment types may provide more information.\ndiagnoses.diagnosis_is_primary_disease: all samples are primary, so this feature has no variance.\ndiagnoses.method_of_diagnosis: Not informative to how long a patient survives. The primary diagnosis might be more relevant.\n\n\n\nOriginal dataset shape: (1081, 39)\nCleaned dataset shape: (1081, 14)\nColumns removed: 25\n\n\nLastly, we prepared the data for modeling by applying appropriate transformations to different types of variables:\n\nNormalization: Numerical columns age_at_diagnosis and treatments.count normalized using Min-Max scaling.\nBoolean Variables: Converted boolean variables to integers (0 and 1) for model compatibility, vital status to 1 for alive\nOrdinal Categorical Variables: Used Ordinal Encoding for features with an inherent order (e.g., tumor_stage).\nEncoding Categorical Variables: Categorical variables were be encoded using One-Hot Encoding to convert them into a format suitable for machine learning algorithms.\n\nAJCC Cancer Staging Has a Natural Order\nStage I → Stage II → Stage III → Stage IV Earlier = less severe → later = more severe.\nWithin each major stage, letters (A, B, C) represent increasing severity, e.g.:\nI &lt; IA &lt; IB &lt; II &lt; IIA &lt; IIB &lt; III &lt; IIIA &lt; IIIB &lt; IIIC &lt; IV\nT = primary tumor size AND local extent of invasion\nThe N (nodes) category in the TNM system describes regional lymph node involvement:\nThe M (metastasis) part of TNM describes presence of distant metastasis."
  },
  {
    "objectID": "technical-details/supervised-learning/main.html#model-selection",
    "href": "technical-details/supervised-learning/main.html#model-selection",
    "title": "Supervised Learning",
    "section": "",
    "text": "The following models were evaluated for predicting patient survival time based on the preprocessed BRCA dataset: 1. Standard Linear Regression: Benchmark model for comparison 2. Regression Trees: XGBoost Regressor for capturing non-linear relationships and interactions between features. 3. Parametric Linear Regression: With Lasso regularization to prevent overfitting and eliminate potentially redundant features."
  },
  {
    "objectID": "technical-details/supervised-learning/main.html#training-and-testing",
    "href": "technical-details/supervised-learning/main.html#training-and-testing",
    "title": "Supervised Learning",
    "section": "",
    "text": "The dataset was split into training and testing sets using an 80-20 split. Cross-validation was employed during model training to ensure robustness and generalizability of the models.\n\n\n\n\nLinear Regression Model Evaluation on Test Set:\nRMSE: 61585077470726.38\nMAE: 7691527358667.03\nR2 Score: -2406669127225213190144.0000\n\n\n\n\n\nWe do a parametric Curve Fitting with L1 regularization (Lasso) to predict patient survival time based on the preprocessed BRCA dataset. Design choicces include: - Model Choice: Lasso regression is chosen for its ability to perform both variable selection and regularization, which helps enhance the prediction accuracy and interpretability of the statistical model it produces. In addition, early stopping is implemented to prevent overfitting during training. - Hyperparameter Tuning: The regularization parameter (alpha) tuned using cross-validation to find the optimal balance between bias and variance. - Evaluation Metrics: Model performance was evaluated using Mean Absolute Error (MAE), Root Mean Squared Error (RMSE), and R-squared (R²) to provide a comprehensive assessment of prediction accuracy. - SGDRegressor is used for optimization due to its efficiency with large datasets and ability to handle L1 regularization effectively.\n\n\nTraining MAE Linear Regression with Lasso Regularization...\n============================================================\n\nTesting alpha = 0.001\nEpoch 500: Train MAE = 1217.1975, Val MAE = 1269.3982\nEpoch 500: Train MAE = 1217.1975, Val MAE = 1269.3982\nEpoch 1000: Train MAE = 1216.7116, Val MAE = 1268.9919\nEpoch 1000: Train MAE = 1216.7116, Val MAE = 1268.9919\nEpoch 1500: Train MAE = 1216.2261, Val MAE = 1268.5873\nEpoch 1500: Train MAE = 1216.2261, Val MAE = 1268.5873\nEpoch 2000: Train MAE = 1215.7407, Val MAE = 1268.1848\n\nTesting alpha = 0.01\nEpoch 2000: Train MAE = 1215.7407, Val MAE = 1268.1848\n\nTesting alpha = 0.01\nEpoch 500: Train MAE = 1217.2068, Val MAE = 1269.3909\nEpoch 500: Train MAE = 1217.2068, Val MAE = 1269.3909\nEpoch 1000: Train MAE = 1216.7332, Val MAE = 1268.9616\nEpoch 1000: Train MAE = 1216.7332, Val MAE = 1268.9616\nEpoch 1500: Train MAE = 1216.2613, Val MAE = 1268.5353\nEpoch 1500: Train MAE = 1216.2613, Val MAE = 1268.5353\nEpoch 2000: Train MAE = 1215.7901, Val MAE = 1268.1114\n\nTesting alpha = 0.1\nEpoch 2000: Train MAE = 1215.7901, Val MAE = 1268.1114\n\nTesting alpha = 0.1\nEpoch 500: Train MAE = 1217.2204, Val MAE = 1269.3513\nEpoch 500: Train MAE = 1217.2204, Val MAE = 1269.3513\nEpoch 1000: Train MAE = 1216.7601, Val MAE = 1268.8937\nEpoch 1000: Train MAE = 1216.7601, Val MAE = 1268.8937\nEpoch 1500: Train MAE = 1216.3023, Val MAE = 1268.4425\nEpoch 1500: Train MAE = 1216.3023, Val MAE = 1268.4425\nEpoch 2000: Train MAE = 1215.8448, Val MAE = 1267.9919\n\nTesting alpha = 1.0\nEpoch 2000: Train MAE = 1215.8448, Val MAE = 1267.9919\n\nTesting alpha = 1.0\nEpoch 500: Train MAE = 1217.2207, Val MAE = 1269.3516\nEpoch 500: Train MAE = 1217.2207, Val MAE = 1269.3516\nEpoch 1000: Train MAE = 1216.7604, Val MAE = 1268.8941\nEpoch 1000: Train MAE = 1216.7604, Val MAE = 1268.8941\nEpoch 1500: Train MAE = 1216.3026, Val MAE = 1268.4428\nEpoch 1500: Train MAE = 1216.3026, Val MAE = 1268.4428\nEpoch 2000: Train MAE = 1215.8451, Val MAE = 1267.9922\n\nBest alpha: 0.1\nBest validation MAE: 1267.9919\nEpoch 2000: Train MAE = 1215.8451, Val MAE = 1267.9922\n\nBest alpha: 0.1\nBest validation MAE: 1267.9919\n\n\n\n\n\n\n\n\n\n\n\n\nFinal MAE Linear Regression Model Evaluation on Test Set:\n=======================================================\nMAE: 1288.54 days\nRMSE: 1798.93 days\nR² Score: -1.0535\n\n\n\n\n\nRandom Forest Regressor is implemented to predict patient survival time based on the preprocessed BRCA dataset. Design choices include: - Model Choice: Random Forest is selected for its robustness, ability to handle high-dimensional data, and effectiveness in capturing complex interactions between features. - Hyperparameter Tuning: A grid search with cross-validation employed to optimize key hyperparameters such as the number of estimators, maximum depth of the trees, and minimum samples per leaf. - Evaluation Metrics: Model performance evaluated using Mean Absolute Error (MAE), Root Mean Squared Error (RMSE), and R-squared (R²) to provide a comprehensive assessment of prediction accuracy.\n\n\nTraining Random Forest Regressor with Hyperparameter Tuning...\n=================================================================\nPerforming hyperparameter tuning with 5-fold cross-validation...\nFitting 5 folds for each of 50 candidates, totalling 250 fits\n\nBest Random Forest Parameters:\n  random_state: 42\n  n_estimators: 300\n  min_samples_split: 5\n  min_samples_leaf: 1\n  max_features: 0.3\n  max_depth: None\n  bootstrap: True\n\nBest Cross-Validation MAE: 755.05\nOut-of-Bag Score (R²): 0.1786\n\nBest Random Forest Parameters:\n  random_state: 42\n  n_estimators: 300\n  min_samples_split: 5\n  min_samples_leaf: 1\n  max_features: 0.3\n  max_depth: None\n  bootstrap: True\n\nBest Cross-Validation MAE: 755.05\nOut-of-Bag Score (R²): 0.1786\n\n\n\n\nEvaluating Random Forest Model on Test Set...\n==================================================\nRandom Forest Model Evaluation on Test Set:\nMAE: 792.40 days\nRMSE: 1156.06 days\nR² Score: 0.1519\n\nFeature Importance Statistics:\nNumber of features with importance &gt; 0.01: 25\nCumulative importance of top 10 features: 0.6256\n\n\n\n\n\n\n\n\n\n\nRandom Forest Model Complexity:\nNumber of trees: 300\nMax depth: None\nTotal number of nodes: 147756\nAverage tree depth: 29.93"
  },
  {
    "objectID": "technical-details/supervised-learning/main.html#final-model-comparison-and-analysis",
    "href": "technical-details/supervised-learning/main.html#final-model-comparison-and-analysis",
    "title": "Supervised Learning",
    "section": "",
    "text": "======================================================================\n                    FINAL MODEL COMPARISON\n======================================================================\n\n                     Model          MAE         RMSE            R²\nStandard Linear Regression 7.691527e+12 6.158508e+13 -2.406669e+21\n  Parametric Curve Fitting 1.288540e+03 1.798930e+03 -1.053500e+00\n   Random Forest Regressor 7.924000e+02 1.156060e+03  1.519000e-01\n\n======================================================================\nBEST MODEL: Random Forest Regressor\n   Achieved lowest MAE of 792.4 days\n======================================================================"
  },
  {
    "objectID": "technical-details/supervised-learning/main.html#data-preprocessing-1",
    "href": "technical-details/supervised-learning/main.html#data-preprocessing-1",
    "title": "Supervised Learning",
    "section": "Data Preprocessing",
    "text": "Data Preprocessing\nSimilar to the brca data, we had preserved multiple rows from the same patient in the cesc data to track treatments recevied during exploratory data analysis.\n\n\n\n\n\n\nFirst two rows of the eda CESC clinical dataset.\n\n\n\nproject.project_id\ncases.case_id\ncases.disease_type\ncases.index_date\ncases.lost_to_followup\ncases.primary_site\ncases.submitter_id\ndemographic.days_to_death\ndemographic.ethnicity\ndemographic.gender\ndemographic.race\ndemographic.submitter_id\ndemographic.vital_status\ndiagnoses.age_at_diagnosis\ndiagnoses.ajcc_pathologic_m\ndiagnoses.ajcc_pathologic_n\ndiagnoses.ajcc_pathologic_t\ndiagnoses.classification_of_tumor\ndiagnoses.days_to_diagnosis\ndiagnoses.days_to_last_follow_up\ndiagnoses.figo_stage\ndiagnoses.figo_staging_edition_year\ndiagnoses.method_of_diagnosis\ndiagnoses.morphology\ndiagnoses.primary_diagnosis\ndiagnoses.prior_malignancy\ndiagnoses.prior_treatment\ndiagnoses.site_of_resection_or_biopsy\ndiagnoses.submitter_id\ndiagnoses.synchronous_malignancy\ndiagnoses.tissue_or_organ_of_origin\ndiagnoses.tumor_grade\ntreatments.submitter_id\ntreatments.treatment_or_therapy\ntreatments.treatment_type\nsurvival_time_days\ndiagnoses.behavior\nexposures.tobacco_smoking_status\n\n\n\n\n0\ntcga-cesc\n00bca18c-b3d4-45a3-8f19-034cc40449a4\nsquamous cell neoplasms\ndiagnosis\nyes\ncervix uteri\ntcga-c5-a2lv\nNaN\nnot hispanic or latino\nfemale\nblack or african american\ntcga-c5-a2lv_demographic\nalive\n36.0\nmx\nn1\nt1b\nprimary\n0\n2234.0\nstage ib\n1995\nbiopsy\n8070/3\nsquamous cell carcinoma, nos\nFalse\nFalse\ncervix uteri\ntcga-c5-a2lv_diagnosis\nFalse\ncervix uteri\ng3\ntcga-c5-a2lv_treatment3\nyes\nhysterectomy, nos\n2234.0\nmalignant\ncurrent smoker\n\n\n1\ntcga-cesc\n00bca18c-b3d4-45a3-8f19-034cc40449a4\nsquamous cell neoplasms\ndiagnosis\nyes\ncervix uteri\ntcga-c5-a2lv\nNaN\nnot hispanic or latino\nfemale\nblack or african american\ntcga-c5-a2lv_demographic\nalive\n36.0\nmx\nn1\nt1b\nprimary\n0\n2234.0\nstage ib\n1995\nbiopsy\n8070/3\nsquamous cell carcinoma, nos\nFalse\nFalse\ncervix uteri\ntcga-c5-a2lv_diagnosis\nFalse\ncervix uteri\ng3\ntcga-c5-a2lv_treatment2\nno\nradiation therapy, nos\n2234.0\nmalignant\ncurrent smoker\n\n\n\n\n\n\n\nHowever, for supervised learning, this could lead to data leakage during model training and evaluation. To mitigate this, we implemented a preprocessing step to retain only one record per patient. We selected the most recent record for each patient based on the ‘days_to_last_followup’ attribute, and created a column treatment.count to captuure the effect of multiple treatments a patient received.\n\n\n\nAfter deduplication:\nDeduplicated dataset shape: (184, 39)\nUnique cases.submitter_id: 184\nRows removed: 688\n\nTreatment distribution in deduplicated data:\ntreatments.treatment_or_therapy\nyes        118\nno          49\nunknown     17\nName: count, dtype: int64\n\nFinal CESC dataset shape: (184, 39)\n\n\nOur next step involved feature selection to enhance model performance and interpretability. We focused on removing non-informative features that exhibited low variance across the dataset. Features with little to no variability do not contribute meaningful information for predicting survival time and can introduce noise into the model.\nRemove Non-informative Features: Exclude features with low variance e.g., behavior of the tumor is malignant for all samples. Dropped features: - project_id: represents the project and is constant for all samples. - case_id: unique identifier for each case, not useful for prediction. - submitter_id: unique identifier for each submitter, not useful for prediction. - primary_site: all samples are from the breast, so this feature has no variance. - index_date: date of indexing, not relevant for prediction. - lost_to_followup: not applicable for prediction, a tracker for patients when patient stopped participating in follow-up before the study recorded their death - days_to_death: not applicable for all samples, leading to missing values. - ethnicity: heavy imbalance to not hispanic or latino (over 80% of samples), leading to low variance. Race might capture the variance better. - gender: all samples are female, so this feature has no variance - classification_of_tumor: all samples are primary, so this feature has no variance. - days_to_diagnosis: 0 for all samples, so this feature has no variance. - diagnoses.figo_staging_edition_year: Used to determine stage, stage will be used instead. - days_to _last_follow_up: not applicable for all samples, leading to missing values. - diagnoses.prior_treatment: heavy imbalance to false , leading to low variance. Assuming number of treatments is more informative. - vital_status: does not make sense to predict survival time based on whether the patient is alive or dead at last follow-up. - diagnoses.tissue_or_organ_of_origin: all samples are from the cervix, so this feature has no variance. - site_of_resection_or_biopsy: all samples are from the cervix, so this feature has no variance. Specific location within the breast (sites_of_involvement) may provide more detailed information. - synchronous_malignancy: heavy imbalance to false (&gt; 97%), so this feature has no variance. - treatments.submitter_id: unique identifier for each submitter, not useful for prediction. - treatments_or_therapy: Heavy imbalance to true as most patients receive treatment, so this feature has low variance. Specific treatment types may provide more information. - diagnoses.diagnosis_is_primary_disease: all samples are primary, so this feature has no variance. - diagnoses.method_of_diagnosis: Not informative to how long a patient survives. The primary diagnosis might be more relevant.\n\n\nOriginal dataset shape: (184, 39)\nCleaned dataset shape: (184, 15)\nColumns removed: 24\n\n\nLastly, we prepared the data for modeling by applying appropriate transformations to different types of variables:\n\nNormalization: Numerical columns age_at_diagnosis and treatments.count normalized using Min-Max scaling.\nBoolean Variables: Converted boolean variables to integers (0 and 1) for model compatibility, vital status to 1 for alive\nOrdinal Categorical Variables: Used Ordinal Encoding for features with an inherent order (e.g., `tumor_stage).\nEncoding Categorical Variables: Categorical variables were encoded using One-Hot Encoding to convert them into a format suitable for machine learning algorithms.\n\n\n\n\nUnique value counts for diagnoses.ajcc_pathologic_t column:\ndiagnoses.figo_stage\nstage ib1     64\nstage ib2     24\nstage iib     23\nstage iiib    18\nstage ib      16\nstage iia2     7\nstage iia      6\nstage iia1     5\nstage ivb      5\nstage ii       4\nstage i        4\nstage iiia     3\nstage iva      2\nstage ia2      1\nstage iii      1\nstage ia1      1\nName: count, dtype: int64"
  },
  {
    "objectID": "technical-details/supervised-learning/main.html#model-selection-1",
    "href": "technical-details/supervised-learning/main.html#model-selection-1",
    "title": "Supervised Learning",
    "section": "Model Selection",
    "text": "Model Selection\nThe following models were evaluated for predicting patient survival time based on the preprocessed CESC dataset: 1. Standard Linear Regression: Benchmark model for comparison 2. Random Forest Regressor: For capturing non-linear relationships and interactions between features. 3. Parametric Curve Fitting: With Lasso regularization to prevent overfitting and eliminate potentially redundant features."
  },
  {
    "objectID": "technical-details/supervised-learning/main.html#training-and-testing-1",
    "href": "technical-details/supervised-learning/main.html#training-and-testing-1",
    "title": "Supervised Learning",
    "section": "Training and Testing",
    "text": "Training and Testing\nThe dataset was split into training and testing sets using an 80-20 split. Cross-validation was employed during model training to ensure robustness and generalizability of the models.\n\nStandard Linear Regression\n\n\nLinear Regression Model Evaluation on Test Set:\nRMSE: 1268.35\nMAE: 960.32\nR2 Score: -0.8628\n\n\n\n\nParametric Curve Fitting\nWe do a parametric Curve Fitting with L1 regularization (Lasso) to predict patient survival time based on the preprocessed CESC dataset. Design choices include: - Model Choice: Lasso regression is chosen for its ability to perform both variable selection and regularization, which helps enhance the prediction accuracy and interpretability of the statistical model it produces. In addition, early stopping is implemented to prevent overfitting during training. - Hyperparameter Tuning: The regularization parameter (alpha) was tuned using cross-validation to find the optimal balance between bias and variance. - Evaluation Metrics: Model performance evaluated using Mean Absolute Error (MAE), Root Mean Squared Error (RMSE), and R-squared (R²) to provide a comprehensive assessment of prediction accuracy. - SGDRegressor is used for optimization due to its efficiency with large datasets and ability to handle L1 regularization effectively.\n\n\nTraining MAE Linear Regression with Lasso Regularization...\n============================================================\n\nTesting alpha = 0.001\nEpoch 500: Train MAE = 1129.6072, Val MAE = 1096.8568\nEpoch 500: Train MAE = 1129.6072, Val MAE = 1096.8568\nEpoch 1000: Train MAE = 1129.0612, Val MAE = 1096.5397\nEpoch 1000: Train MAE = 1129.0612, Val MAE = 1096.5397\nEpoch 1500: Train MAE = 1128.5152, Val MAE = 1096.2226\nEpoch 1500: Train MAE = 1128.5152, Val MAE = 1096.2226\nEpoch 2000: Train MAE = 1127.9692, Val MAE = 1095.9054\n\nTesting alpha = 0.01\nEpoch 500: Train MAE = 1129.6240, Val MAE = 1096.8178\nEpoch 500: Train MAE = 1129.6240, Val MAE = 1096.8178\nEpoch 1000: Train MAE = 1129.0916, Val MAE = 1096.4694\nEpoch 1000: Train MAE = 1129.0916, Val MAE = 1096.4694\nEpoch 1500: Train MAE = 1128.5597, Val MAE = 1096.1201\nEpoch 1500: Train MAE = 1128.5597, Val MAE = 1096.1201\nEpoch 2000: Train MAE = 1128.0280, Val MAE = 1095.7708\n\nTesting alpha = 0.1\nEpoch 2000: Train MAE = 1128.0280, Val MAE = 1095.7708\n\nTesting alpha = 0.1\nEpoch 500: Train MAE = 1129.6547, Val MAE = 1096.6700\nEpoch 500: Train MAE = 1129.6547, Val MAE = 1096.6700\nEpoch 1000: Train MAE = 1129.1546, Val MAE = 1096.1732\nEpoch 1000: Train MAE = 1129.1546, Val MAE = 1096.1732\nEpoch 1500: Train MAE = 1128.6545, Val MAE = 1095.6765\nEpoch 1500: Train MAE = 1128.6545, Val MAE = 1095.6765\nEpoch 2000: Train MAE = 1128.1544, Val MAE = 1095.1798\n\nTesting alpha = 1.0\nEpoch 2000: Train MAE = 1128.1544, Val MAE = 1095.1798\n\nTesting alpha = 1.0\nEpoch 500: Train MAE = 1129.6548, Val MAE = 1096.6667\nEpoch 500: Train MAE = 1129.6548, Val MAE = 1096.6667\nEpoch 1000: Train MAE = 1129.1548, Val MAE = 1096.1667\nEpoch 1000: Train MAE = 1129.1548, Val MAE = 1096.1667\nEpoch 1500: Train MAE = 1128.6548, Val MAE = 1095.6667\nEpoch 1500: Train MAE = 1128.6548, Val MAE = 1095.6667\nEpoch 2000: Train MAE = 1128.1548, Val MAE = 1095.1667\n\nBest alpha: 1.0\nBest validation MAE: 1095.1667\nEpoch 2000: Train MAE = 1128.1548, Val MAE = 1095.1667\n\nBest alpha: 1.0\nBest validation MAE: 1095.1667\n\n\n\n\n\nFinal MAE Linear Regression Model Evaluation on Test Set:\n=======================================================\nMAE: 887.97 days\nRMSE: 1285.33 days\nR² Score: -0.9130\n\n\nRandom Forest Regressor is implemented to predict patient survival time based on the preprocessed CESC dataset. Design choices include: - Model Choice: Random Forest is selected for its robustness, ability to handle high-dimensional data, and effectiveness in capturing complex interactions between features. - Hyperparameter Tuning: A randomized search with cross-validation employed to optimize key hyperparameters such as the number of estimators, maximum depth of the trees, and minimum samples per leaf. - Evaluation Metrics: Model performance evaluated using Mean Absolute Error (MAE), Root Mean Squared Error (RMSE), and R-squared (R²) to provide a comprehensive assessment of prediction accuracy.\n\n\nRandom Forest Regressor\n\n\nTraining Random Forest Regressor with Hyperparameter Tuning...\n=================================================================\nPerforming hyperparameter tuning with 5-fold cross-validation...\nFitting 5 folds for each of 50 candidates, totalling 250 fits\n\nBest Random Forest Parameters:\n  random_state: 42\n  n_estimators: 500\n  min_samples_split: 2\n  min_samples_leaf: 2\n  max_features: log2\n  max_depth: 10\n  bootstrap: True\n\nBest Cross-Validation MAE: 709.13\nOut-of-Bag Score (R²): 0.0970\n\nBest Random Forest Parameters:\n  random_state: 42\n  n_estimators: 500\n  min_samples_split: 2\n  min_samples_leaf: 2\n  max_features: log2\n  max_depth: 10\n  bootstrap: True\n\nBest Cross-Validation MAE: 709.13\nOut-of-Bag Score (R²): 0.0970\n\n\n\n\nEvaluating Random Forest Model on Test Set...\n==================================================\nRandom Forest Model Evaluation on Test Set:\nMAE: 730.73 days\nRMSE: 921.17 days\nR² Score: 0.0174\n\nFeature Importance Statistics:\nNumber of features with importance &gt; 0.01: 23\nCumulative importance of top 10 features: 0.6870\nRandom Forest Model Evaluation on Test Set:\nMAE: 730.73 days\nRMSE: 921.17 days\nR² Score: 0.0174\n\nFeature Importance Statistics:\nNumber of features with importance &gt; 0.01: 23\nCumulative importance of top 10 features: 0.6870\n\n\n\n\n\n\n\n\n\n\nRandom Forest Model Complexity:\nNumber of trees: 500\nMax depth: 10\nTotal number of nodes: 24956\nAverage tree depth: 9.30\n\n\n\n\n======================================================================\n                    FINAL MODEL COMPARISON\n======================================================================\n\n                     Model    MAE    RMSE      R²\nStandard Linear Regression 960.32 1268.35 -0.8628\n  Parametric Curve Fitting 887.97 1285.33 -0.9130\n   Random Forest Regressor 730.73  921.17  0.0174\n\n======================================================================\nBEST MODEL: Random Forest Regressor\n   Achieved lowest MAE of 730.73 days\n======================================================================"
  },
  {
    "objectID": "technical-details/supervised-learning/main.html#final-model-comparison-and-analysis-1",
    "href": "technical-details/supervised-learning/main.html#final-model-comparison-and-analysis-1",
    "title": "Supervised Learning",
    "section": "Final Model Comparison and Analysis",
    "text": "Final Model Comparison and Analysis\nRandom Forest Regressor performs best for predicting patient survival time in both BRCA and CESC datasets, demonstrating its effectiveness in handling complex relationships within clinical data. This model consistently outperforms Standard Linear Regression and Parametric Curve Fitting across all evaluation metrics (MAE, RMSE, R²). The ability of Random Forest to capture non-linear interactions and its robustness to overfitting make it a superior choice for this predictive task."
  }
]